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SUMMARY 
In  eukaryotes,  genetic  material  is  stored  as  chromatin,  a  DNA-protein  complex  whose 
structure  is  tightly  regulated.  Histones  are  the  main  protein  components  of  chromatin  and 
their  post-translational  modifications  (PTMs)  influence  several  cellular  processes,  from  gene 
expression  to  epigenetic  regulation  and  inheritance.  Histone  acetyltransferases  carry  out  the 
acetylation  of  histones,  an  abundant  modification,  the  function  of  which  is  determined  by  the 
position  of  the  modified  residue.  Histone  chaperones  can  influence  the  specificity  of  the 
histone  acetyltransferases,  however,  the  underlying  mechanism  of  this  process  is  not  fully 
understood. 
Rtt109  is  a  fungal  histone  acetyltransferase  which  is  essential  for  the  acetylation  of  newly 
synthesized  histone  H3.  Two  distinct  histone  chaperones,  Asf1  and  Vps75,  have  been 
reported  to  alter  its  activity  and  specificity:  while  Asf1  is  necessary  for  H3  K56  acetylation, 
Vps75  promotes  acetylation  of  H3  K9,  K23  and  K27,  which  are  located  in  a  long  disordered 
N-terminal  tail  of  H3.  Despite  the  availability  of  structures  of  Rtt109  in  complex  with  Vps75, 
the  mechanism  of  regulation  of  Rtt109  activity  by  Asf1  and  Vps75  remains  elusive. 
 
In  order  to  understand  how  Asf1  and  Vps75  stimulate  the  Rtt109  activity  towards  specific 
substrates,  I  reconstituted in  vitro the  complex  containing  Rtt109,  histones  H3:H4  and  both  
chaperones.  With  multi  angle  light  scattering  and  nuclear  magnetic  resonance  (NMR),  I 
could  show  that  the  Vps75  dimer  assembles  a  non-symmetric  complex  with  one  copy  of 
Rtt109  and  Asf1-bound  histones.  Using  an  integrative  structural  biology  approach  combining 
distance  restraint  information  from  NMR  and  low-resolution  shape  information  from 
small-angle  neutron  scattering  (SANS)  data,  I  could  obtain  a  structural  model  of  this 
complex.  The  structure  revealed  that  the  chaperones  form  a  bagel-shaped  complex  with 
Rtt109  and  the  histones,  bringing  the  enzyme  and  the  substrate  together  and  positioning  H3 
K56  next  to  the  Rtt109  active  center.  A  combination  of  NMR  data  with  biochemical 
experiments  and  computational  studies,  revealed  that  the  flexible  H3  tail  is  chaperoned  by 
Asf1  and  is  guided  towards  the  catalytic  pocket  of  Rtt109  by  both  folded  and  unfolded 
structural  elements  of  Vps75.  These  results,  taken  together  with  existing  literature  and 
further  mutational  studies,  allowed  me  to  propose  a  mechanism  by  which  the  histone 
chaperones  promote  acetylation  of  the  disordered  H3  N-terminal  tail. 
 
Keywords:  histone  acetylation,  histone  chaperone,  disorder,  structural  biology. 
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ZUSAMMENFASSUNG  
In  Eukaryonten  wird  das  genetische  Material  im  Chromatin  gespeichert,  diese  DNA-Protein 
Komplexe  sind  streng  reguliert.  Histone  sind  die  wichtigsten  Proteinkomplexe  des 
Chromatins.  Posttranslationale  Proteinmodifikationen  (PTMs)  beeinflussen  zentrale  zelluläre 
Prozesse,  wie  die  Expression  von  Genen,  epigenetische  Regulationen  und  die  Vererbung 
von  Eigenschaften.  Eine  eine  häufig  auftretende  PTM  ist  die  Acetylierung.  Diese 
Modifikation  wird  durch  Histon-  Acetyltransferasen  katalysiert,  dabei  ist  die  Position  der 
Modifikation  von  entscheidender  Bedeutung  für  die  Regulation.  Histon-Chaperone  haben 
einen  Einfluss  auf  die  Spezifität  der  Histon-Acetyltransferasen,  dabei  ist  der 
zugrundeliegende  Prozess  noch  nicht  vollständig  aufgeklärt. 
Rtt109  ist  eine  in  Pilzen  vorkommende  Histon-Acetyltransferase  welche  essenziell  für  die 
Acetylierung  von  neu  synthetisierten  Histon  H3  Proteinen  ist.  Zwei  unterschiedliche  Histon- 
Chaperone,  Asf1  und  Vps75,  haben  einen  Einfluss  auf  die  Aktivität  und  Spezifität  von 
Rtt109.  Asf1  ist  notwendig  für  die  Acetylierung  von  H3  K56,  dagegen  acetyliert  Vps75  H3 
K9,  K23  und  K27,  welche  sich  in  dem  unstrukturierten  N-terminalen  Teil  des  H3  Moleküls 
befindet.  Ungeachtet  der  verfügbaren  Strukturen  von  Rtt109  mit  Vps75,  ist  der  Mechanismus 
der  Regulation  von  Rtt109  durch  Asf1  und  Vps75  nicht  vollständig  aufgeklärt. 
Um  den  zugrundeliegenden  Mechanismus  aufzuklären,  wie  Asf1  und  Vps75  die  Aktivität  von 
Rtt109  hinsichtlich  bestimmter  Substrate  stimuliert,  habe  ich  in  der  vorliegenden  Arbeit  den 
Komplex  Rtt109  mit  den  Histonen  H3:H4  und  beiden  Chaperonen  in  vitro  rekonstruiert.  Mit 
Hilfe  von  Mehrwinkellichtstreuung  und  Kernspinresonanzspektroskopie  (NMR)  konnte  ich 
zeigen,  dass  das  Vps75  Dimer  sich  als  nicht-symmetrischer  Komplex  mit  einer  Kopie  von 
Rtt109  und  Asf1,  in  Verbindung  mit  Histonen  assembliert.  Die  Verbindung  von  integrativ 
strukturbiologischen  Ansätzen  mit  Entfernungsangaben  durch  NMR  und  gering-auflösender 
Strukturinformationen  von  Kleinwinkel  -  Neutronenstreuung  (SANS),  ermöglichte  es  mir  ein 
Strukturmodell  dieses  Komplexes  zu  erstellen. 
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 Abbreviations  and  symbols 
bp:  base  pairs 
CSP:  chemical  shift  perturbation 
CTAD:  C-terminal  acidic  domain 
CTD:  C-terminal  domain 
D max :  maximum  dimension  of  the  particle 
EM:  electron  microscopy 
HAT:  histone  acetyltransferase 
HDAC:  histone  deacetylase 
HMQC:  heteronuclear  multiple-quantum  coherence 
HSQC:  heteronuclear  single-quantum  coherence 
IDR:  intrinsically  disordered  region 
I para /I dia :  ratio  of  peak  intensity  in  the  paramagnetic  and  diamagnetic  states 
K(number)ac:  N -ε-acetyl-lysine  at  position  (number) 
MALS:  multi  angle  light  scattering 
MD:  molecular  dynamics 
M w :  molecular  weight 
NMR:  nuclear  magnetic  resonance 
NOESY:  n uclear  Overhauser  effect  spectroscopy 
NTD:  N-terminal  domain 
o-RMSD:  orientational  root-mean-square  deviation 
PRE:  paramagnetic  relaxation  enhancement 
PTM:  post-translational  modification 
R 2 dia :  transverse  relaxation  rate 
R 2 diaH :  1 H  single-quantum  coherence  transverse  relaxation  rate 
R 2 diaHC : 1 H- 13 C  multiple-quantum  coherence  transverse  relaxation  rate 
R g :  radius  of  gyration 
RVAH:  Rtt109 – Vps75 2 – Asf1 –H3:H4 
SANS:  small-angle  neutron  scattering 
SAS:  small-angle  scattering 
SEC:  size  exclusion  chromatography 
SLD:  scattering  length  density 
TROSY:  transverse  relaxation  optimized  spectroscopy 
Γ 2 :  paramagnetic  contribution  to  the  transverse  relaxation  rate 
𝜏 C :  correlation  time  for  the  electron-nucleus  interaction  vector 
WT:  wild-type  
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 1.  Introduction 
1.1.  Architecture  and  mechanism  of  nucleosome  assembly. 
In  eukaryotes,  genetic  information  is  present  in  the  form  of  chromatin,  a  DNA-protein 
complex  which  ensures  packing  of  long  DNA  molecules.  The  main  protein  components  of 
chromatin  are  histones,  small  alkaline  proteins  which  are  able  to  form  nucleosomes,  around 
which  DNA  is  wrapped.  The  first  level  of  chromatin  organisation  is  the  formation  of 
DNA-histone  complexes,  the  nucleosomes,  which  are  regularly  spaced  along  the  DNA 
strand.  After  this  step,  DNA  can  be  further  compacted  into  higher  order  structures  (Fig. 
1.1.1.) 
 
Figure  1.1.1.  DNA  packing. The  first  level  of  DNA  packing  is  the  assembly  of  nucleosomes,  namely 
the  formation  of  so-called  “beads  on  a  string”;  DNA  can  be  further  compacted  with  the  aid  of  histone 
H1  and  scaffold  proteins  into  30  nm  fibres  that  can,  in  turn,  form  condensed  loops.  The  figure  is 
adapted  from  (Kristie,  2016) . 
 
DNA  compaction  provides  the  cell  with  a  way  to  regulate  gene  expression  by  regulating  the 
accessibility  of  protein-coding  regions.  The  level  of  packing  determines  the  accessibility  of 
DNA  to  the  protein  machinery  and  therefore  regulates  DNA  replication,  repair  and  gene 
expression.  Cellular  DNA  is  packed  inhomogeneously  and  contains  both  the  tightly  packed, 
transcriptionally-inactive  heterochromatin  and  the  more  “open”  transcriptionally-active 
euchromatin.  Differential  gene  expression  is  regulated  at  the  nucleosome-DNA  level  by 
selective  methylation  of  DNA,  inclusion  of  specific  histone  variants  into  nucleosomes  and, 
most  importantly,  by  histone  post-translational  modifications  (PTMs).  Additionally,  epigenetic 
euchromatin  and  heterochromatin  markers  may  be  inherited  from  a  cell  to  its  progeny. 
Nucleosomes  consist  of  ~146  bp  of  DNA  wrapped  around  eight  core  histones,  one  H3:H4 
tetramer  and  two  H2A:H2B  dimers,  and  linker  DNA  (the  DNA  sequences  between  the 
nucleosomes,  up  to  ~80  bp) (Luger et  al ,  1997) .  The  linker  DNA  at  the  nucleosome  entrance 
and  exit  can  be  stapled  with  the  linker  histone  H1  to  form  a  more  compact  structure. 
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Figure  1.1.2.  Structural  organisation  of  the  nucleosome  and  its  components. A .  Nucleosome 
core  structure  (PDB  entry  1eqz).  DNA  is  in  blue,  histones  H3,  H4,  H2A  and  H2B  are  shown  in  green, 
grey,  orange  and  beige,  respectively.  N-terminal  tails  of  H2B  and  H3  exit  through  the  minor  groove 
formed  by  two  DNA  strands,  the  N-terminal  tails  of  H2A  and  H4  exit  without  going  through  the 
nucleosomal  DNA;  H2A  C-terminal  tail  is  located  at  the  entrance/exit  point  of  the  nucleosomal  DNA. 
Accessible  histone  tails  interact  with  various  protein  partners  and  also  influence  the  higher  order 
packing. B .  Schematic  representation  of  the  structural  domains  of  the  histones.  Colored  boxes 
represent  α-helices. 
 
All  core  histones  contain  a  histone-fold  motif,  which  consists  of  three  helices  (α1,  α2  and  α3) 
connected  by  2  short  loops,  and  posses  unfolded  N-  and  C-terminal  tails  (Figure  1.1.2) (Xu 
et  al ,  2010;  Arents  &  Moudrianakis,  1995) .  This  conserved  fold  allows  histones  to  adopt 
regular  structures  such  as  a  heterodimer,  tetramer  and,  ultimately,  the  octamer.  The  long 
unstructured  tails,  in  turn,  act  as  a  platform  for  numerous  post-translational  modifications 
(PTMs),  which  play  a  role  in  nucleosome  assembly,  gene  expression  regulation  and 
epigenetic  mechanisms. 
 
The  composition  of  the  nucleosomes  and  their  positioning  on  the  DNA  is  tightly  regulated  by 
the  following  functional  groups  of  proteins: 
1)  Histone  chaperones,  which  facilitate  histone  folding,  transport  and  nucleosome  assembly 
in  an  ATP-independent  manner (Eitoku et  al ,  2008) .  As  histones  have  a  high  positive  charge 
at  neutral  pH,  they  are  prone  to  aggregation  and  therefore  require  chaperones  to  handle 
them  from  the  time  they  are  synthesized  until  the  incorporation  into  chromatin.  The  term 
“histone  chaperone”  was  introduced  by  Ron  Laskey  for  nucleoplasmin,  a  protein  which 
prevents  nonspecific  interactions  between  H2A,  H2B  and  DNA (Laskey et  al ,  1993) . 
Nowadays  histone  chaperones  are  known  to  include  over  seven  families  of  proteins,  which 
are  structurally  diverse  but  share  the  ability  to  bind  and  shield  histones  from  promiscuous 
interactions  (Fig.  1.1.3). 
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Fig.  1.1.3.  Major  families  of  histone  chaperones. Histone  chaperones  are  classified  into  families  by 
sequence  homology.  They  are  structurally  very  diverse,  ranging  from  a  small  single  subunit  (ASF)  and 
homodimeric  (NAP)  proteins  to  large  multisubunit  complexes  (HIRA,  CAF-1,  FACT).  While  some 
families  show  a  general  preference  towards  certain  histones  or  specific  histone  variants,  others 
include  members  that  can  interact  with  all  classes  of  histones.  The  structures  of  the  representatives  of 
the  chaperone  families  are  shown  in  cartoon  representation  and  are  colored  by  the  secondary 
structure  elements  (pink,  α-helices;  yellow,  ß-sheets);  in  addition  to  the  structured  elements,  many 
histone  chaperones  possess  intrinsically  disordered  acidic  regions. 
 
2)  Histone  modifying  enzymes,  which  introduce  and  remove  PTMs.  Histones  are  known  to 
undergo  at  least  12  different  kinds  of  PTMs:  methylation,  acetylation,  phosphorylation, 
sumoylation,  ubiquitination,  poly-ADP-ribosylation, formylation,  propionylation,  butyrylation, 
citrullination,  proline  isomerization,  and  crotonylation (Tan et  al ,  2011) .  The  unstructured 
N-terminal  tails  are  the  main,  although  not  sole,  platforms  for  these  modifications,  which  can 
be  mutually  exclusive  or  complementary.  Specific  PTMs  of  histones  act  to  change  the 
interaction  mode  between  the  histones  and  the  DNA,  as  well  as  recruit  various  protein 
partners  (known  as  PTM  readers)  to  their  location.  Histone  PTMs  (the  “histone  code”)  are 
the  main  players  in  epigenetic  mechanisms,  as  the  number  of  PTM  combinations 
significantly  exceeds  the  number  of  histone  variants. 
3)  Chromatin  remodelers,  which  rearrange  the  nucleosomes  in  an  ATP-dependent  manner. 
The  currently  known  chromatin  remodelers  are  classified  into  5  families;  all  of  them  contain 
an  ATPase  domain  and  act  to  alter  chromatin  architecture.  Among  other  functions,  chromatin 
remodelers  promote  nucleosome  sliding  and  regulate  nucleosome  spacing  as  well  as 
eviction  and  exchange  of  histone  variants. 
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 The  major  biological  processes  that  depend  on  nucleosome  biogenesis  involve  DNA 
replication,  transcription,  and  DNA  repair.  The  general  pathway  of  nucleosome  assembly  in 
eukaryotes  is  shown  in  Fig.  1.1.4: 
 
Figure  1.1.4.  Key  steps  of  nucleosome  assembly.  Histones  H3  and  H4  are  shown  in  mint  and  grey 
(newly  synthesized)  or  in  dark  blue  and  light  blue  (recycled),  respectively;  H2A  and  H2B  are  shown  in 
brown.  First,  the  (H3:H4) 2  tetramer  is  assembled  onto  the  DNA,  next,  two  H2A:H2B  dimers  are  added.  
In  both  replication-coupled  and  replication-independent  nucleosome  assembly  pathways  old  H3:H4 
histones  are  recycled  for  the  assembly.  In  replication-coupled  nucleosome  assembly,  old  H3:H4  are 
rarely  split  into  dimers  and  are  recycled  as  the  tetramer;  in  replication-independent  pathway,  H3:H4 
tetramers  (if  evicted)  can  be  split  and  reassembled  with  both  old  and  newly  synthesized  histones. 
“Mixed”  tetramers  consist  of  the  H3:H4  dimers  from  previous  nucleosomes  and  of  the  newly 
synthesized  H3:H4  dimers.  Newly  synthesized  H3  and  H4  carry  specific  PTMs  (H3  K56ac  or  H4 
S47ph)  required  for  their  incorporation  into  nucleosomes  by  chromatin  assembly  complexes,  CAF-1 
and  HIRA  (conserved  from  yeast  to  humans).  The  bottom  panels  are  partially  adapted  from (Liu  & 
Churchill,  2012) . 
 
The  assembly  of  the  histone  octamer  follows  a  strict  order:  first,  two  H3:H4  dimers  form  a 
tetramer,  the  most  stable  part  of  the  nucleosome,  which  is  loaded  onto  DNA.  The  (H3:H4) 2  
tetramer  then  acts  as  a  scaffold  to  bind  two  H2A:H2B  dimers.  Nucleosome  disassembly 
follows  the  reverse  sequence,  whereby,  H2A:H2B  dimers  are  removed  first;  then  H3:H4 
tetramers  are  evicted  and  recycled. 
A  proper  regulation  of  histone  recycling  and  nucleosome  assembly  is  essential  for  the 
inheritance  of  epigenetic  information.  The  DNA  methylation  pattern  can  be  copied  from  the 
original  strand  after  replication  by  the  DNA-methyltransferase  DNMT1,  which  exhibits 
preference  for  the  hemi-methylated  DNA,  and  is  subsequently  “proofread”  by  DNMT3 
(Holliday  &  Pugh,  1975;  Jones  &  Liang,  2009) .  The  preservation  and  dynamics  of  the  histone 
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 code,  however,  require  a  more  genuine  regulation,  which  is  fine-tuned  for  either 
replication-dependent  or  -independent  nucleosome  assembly;  some  of  the  basic 
mechanisms  of  such  regulation  are  described  below. 
Histone  recycling  in  transcription.  During  transcription-coupled  nucleosome  assembly 
(right  panel,  Fig.  1.1.4),  chromatin  remodeling  depends  on  the  degree  of  the  transcription 
activity.  In  the  genes  that  are  transcribed  at  low  to  medium  rate,  H2A:H2B  are  found  to  be 
exchanged  at  a  significantly  higher  rate  than  H3:H4. In  vitro  RNA  polymerase  II  can  progress 
through  the  DNA  without  complete  displacement  of  the  histone  octamer,  but  requires  the 
temporary  dissociation  of  only  one  H2A:H2B  dimer (Kulaeva et  al ,  2013) .  This  mechanism 
ensures  that  H3:H4  tetramers  are  kept  at  their  original  positions  and  that  the  PTM  pattern  is 
maintained.  However,  at  a  high  rate  of  transcription,  nucleosomes  are  completely 
disassembled;  recycled  H3:H4  tetramers  are  split  into  dimers  prior  to  nucleosome 
reassembly,  resulting  in  mixed  H3:H4  tetramers,  consisting  of  both  old  and  new  H3:H4 
dimers  ( Katan-Khaykovich  &  Struhl,  2011) .  In  this  case  the  PTMs  are  thought  to  be 
propagated  by  trans-modification,  based  on  the  PTM  pattern  of  the  old  H3:H4  dimers  located 
in  the  vicinity  of  the  new  ones. 
Histone  recycling  in  replication. During  replication,  the  nucleosomes  are  disassembled 
completely.  Pulse-chase  experiments  have  revealed  that,  unlike  in  transcription,  old  H3:H4 
tetramers  do  not  split (Jackson,  1988) ;  this  observation  has  been  supported  by  several  other 
studies (Das  &  Tyler,  2013) .  Current  data  shows  that  the  splitting  of  the  H3:H4  tetramer 
depends  on  the  H3  variant  present  in  the  tetramer:  histone  H3.1  (the  major  variant  of 
mammalian  H3)  preserved  the  H3:H4  tetrameric  form,  while  H3.3  promotes  spitting  of  the 
tetramer  into  dimers  during  replication-coupled  disassembly (Xu et  al ,  2010) .  This  histone 
variant,  which  differs  from  H3.1  by  only  5  amino  acids,  is  associated  with 
transcriptionally-active  chromatin  and  is  deposited  onto  the  DNA  during  both  replication  and 
transcription (Ahmad  &  Henikoff,  2002) .  The  difference  in  the  behaviour  of  these  histone 
variants  suggests  that  the  mechanisms  of  inheritance  of  histone  PTMs  might  depend  on  the 
state  of  chromatin:  the  propagation  of  euchromatin  marks  requires  H3:H4  tetramer  splitting, 
while  the  heterochromatic  modifications  are  preserved  through  retention  of  the  original 
H3:H4  tetramers (Das  &  Tyler,  2013) .  While  it  is  unclear  whether  these  two  modes  result  in  a 
different  precision  of  PTM  conservation,  it  is  clear  that  careful  re-deposition  of  old  H3:H4  (as 
dimers  or  tetramers)  to  their  original  position  on  the  DNA  is  essential (Reverón-Gómez et  al , 
2018) . 
Regulation  of  inclusion  of  new  H3:H4  into  nucleosomes. The  majority  of  newly 
synthesized  histones  is  incorporated  into  chromatin  during  DNA  replication  (~85%  of  novel 
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 histones  included)  and  transcription  of  active  genes  (~10%) (Dion et  al ,  2007;  Das  &  Tyler, 
2013) .  Newly  synthesized  histones  are  targeted  to  the  different  nucleosome  assembly 
pathways  by  a  complex  network  of  specific  PTMs. 
Nascent  H3  and  H4  are  assembled  into  dimers  and  handled  by  the  ASF1  chaperone,  which 
is  conserved  throughout  eukaryotes (Daganzo et  al ,  2003) .  Prior  to  nucleosome  assembly, 
novel  histones  are  acetylated  in  the  cytoplasm  at  H4  K5  and  K12  (Fig.  1.1.3).  This 
diacetylation  is  introduced  by  homologous  HATs  in  budding  yeast  and  humans,  and  appears 
to  be  an  abundant  and  conserved  mark  of  a  new  histone  H4 (Sobel et  al ,  1995) .  After  the 
dimer  assembly,  acetylation  of  histone  H4  at  lysines  5  (H4  K5ac)  and  12  (H4  K12ac) 
stimulates  the  import  of  H3:H4  into  the  nucleus (Alvarez et  al ,  2011) .  In  addition,  this 
diacetylation  is  associated  with  active  chromatin (Turner,  1991)  and  was  recently  shown  to 
play  a  role  in  the  deposition  of  CENP-A  onto  centromeres (Shang et  al ,  2016) .  These 
acetylations  do  not  appear  to  be  specific  for  either  the  replication-dependent  or  -independent 
nucleosome  assembly  pathways (Liu  &  Churchill,  2012) .  H4  K5ac  and  H4  K12ac  were  also 
detected  in  histones  co-purified  with  the  chromatin  assembly  complex  CAF-1,  which 
incorporates  the  new  histones  into  nucleosomes  during  replication.  However,  the  double 
mutation  of  H3  K5,  K12  is  not  lethal  in S.  cerevisiae  and  the  nucleosome  assembly  still 
occurs,  suggesting  that  nuclear  import  and  other  functions  of  these  acetylations  may  be 
promoted  by  an  alternative  redundant  mechanism  (Ma  et  al ,  1998) . 
After  these  general  steps,  histones  are  further  modified  depending  on  their  specific  function. 
Prominent  H3/H4  modifications  include  phosphorylation  of  H4  S47  (H3  S47ph)  and 
acetylation  of  H3  K56  (H3  K56ac),  which  are  associated  with  HIRA/transcription-coupled  and 
CAF-1/replication-coupled  nucleosome  assemblies,  respectively. 
In  human  cells,  H4  S47ph  promotes  H3.3:H4  deposition  onto  DNA  by  increasing  the  affinity 
of  H3.3:H4  to  HIRA  and  simultaneously  reducing  its  affinity  to  CAF-1 (Kang et  al ,  2011) . 
While  it  is  currently  unclear  whether  the  function  of  this  modification  is  conserved  in  other 
eukaryotes,  H4  S47ph  is  speculated  to  be  inhibitory  to  transcription  silencing  and  mutations 
of  this  residue  were  linked  to  deficiency  in  transcription  in S.cerevisiae (Yu et  al ,  2011; 
Hainer  &  Martens,  2011) . 
Acetylation  of  H3  K56  is  essential  for  the  replication-coupled  nucleosome  assembly  pathway 
in  fungi (Li et  al ,  2008)  and  is  crucial  for  the  DNA  damage  response  and  genomic  stability  in 
both  mammalians  and  yeast (Yuan et  al ,  2009;  Tropberger  &  Schneider,  2013) .  The  detected 
levels  of  H3  K56ac  are  lower  in  mammalian  cells.  Indeed,  the  exact  pathway  involving  this 
modification  in  mammals  is  less  understood  than  in  yeast (Drogaris et  al ,  2012;  Garcia et  al , 
2007) .  In S.cerevisiae ,  H3  K56ac  has  been  directly  linked  to  the  incorporation  of  newly 
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 synthesized  H3  into  chromatin.  This  function  is  carried  out  through  the  recognition  of  H3:H4 
dimers  by  the  histone  chaperone  Rtt106  (fungi-specific)  and  the  increase  of  the  histone 
binding  affinity  to  CAF-1  (Fig.  1.1.5). 
 
Figure  1.1.5.  Pathway  of  incorporation  of  newly  synthesized  histone  H3  in S.  cerevisiae . 
Nascent  histone  H3  is  first  handled  by  general  chaperones  that  assist  its  folding.  After  that  it  is 
handed  over  to  the  histone  chaperone  Hif1  (homolog  of  human  sNASP),  which  facilitates  the 
assembly  of  the  H3:H4  dimer,  and  associates  with  Hat1,  the  histone  acetyltransferase  (HAT)  that 
introduces  the  H4  K5ac  and  H4  K12ac (Campos et  al ,  2010) .  Hif1  transfers  the  H3:H4  dimer  to  Asf1 
(homolog  of  human  Asf1a  and  Asf1b) (Parthun et  al ,  1996) .  Asf1  aids  H3  K56  acetylation  by  HAT 
Rtt109,  which  also  acetylates  other  lysines  in  the  H3  N-terminal  tail.  Asf1  supplies  the  H3:H4  dimers 
for  both  replication-  and  transcription-coupled  nucleosome  assemblies.  However,  H3  K56ac  appears 
to  be  crucial  only  for  the  former.  In  this  case,  H3  K56ac  is  recognized  by  the  downstream  chaperone 
Rtt106  and  H3:H4  dimers  are  assembled  into  tetramers  and  incorporated  into  the  nucleosomes (Liu  & 
Churchill,  2012;  Burgess  &  Zhang,  2013) . 
 
In  fungi,  acetylation  of  H3  K56  is  performed  solely  by  HAT  Rtt109 (Schneider et  al ,  2006; 
Tsubota et  al ,  2007) .  Over  the  past  decade  a  number  of  studies  focused  on  this  enzyme  due 
to  its  potential  therapeutic  importance  (Rosa et  al ,  2010)  and  its  intriguing  acetylation 
mechanism.  The  functional  and  structural  features  of  Rtt109  and  its  histone  chaperone 
regulators,  Asf1  and  Vps75,  are  discussed  in  the  sections  below. 
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 1.2.  Rtt109:  enzyme  which  requires  two  histone  chaperones  for 
the  acetylation  of  H3. 
Histone  acetyltransferases  (HATs)  are  the  enzymes  that  transfer  an  acetyl  group  from 
acetyl-CoA  to  the  ε-amino  group  of  histone  lysines.  HATs  are  divided  into  more  than  four 
families  based  on  the  sequence  conservation:  GNAT  ( Gcn5-related  N-acetyltransferases ), 
MYST  ( MOZ,  Ybf2/Sas3,  Sas2,  and  Tip60 ),  p300/CBP  (p300,  CREB-binding  protein),  Rtt109 
( Regulator  of  Ty1  Transposition  gene  product  109) and  others.  While  the  p300/CPB  and 
Rtt109  are  metazoan  and  fungi-specific,  respectively,  the  two  biggest  families,  GNAT  and 
MYST,  are  conserved  from  yeast  to  humans.  Despite  the  fact  that  all  HATs  carry  out  the 
same  reaction,  the  sequence  homology  between  the  different  families  is  very  low;  HATs  from 
different  families  contain  multiple  additional  domains  and  display  different  specificity, 
selectivity  and  acetylation  mechanisms. 
Rtt109  is  one  of  the  latest  discovered  HAT  families  and  remains  one  of  the  least  studied 
overall.  Rtt109  was  identified  in  a  genome-wide  screen  for  genes  required  for S.  cerevisiae 
resistance  to  ionizing  damage  and  has  been  well-characterised  since  then  for  its  role  in 
resistance  to  DNA  damage (Bennett et  al ,  2001;  Wang et  al ,  2008) .  Despite  a  very  limited 
sequence  similarity  to  p300,  the  fold  of  the  Rtt109  active  site  is  similar  to  that  of  the  HAT 
domain  of  p300  and  the  two  proteins  are  considered  to  be  distant  orthologs.  Interestingly, 
both  enzymes  use  autoacetylation  to  regulate  their  activity (Thompson et  al ,  2004;  Tang et 
al ,  2008a) .  However,  the  autoacetylation  and  substrate  acetylation  mechanisms  between  the 
two  HATs  significantly  differ:  p300  autoacetylation  is  intermolecular  and  the  acetylation  of  the 
substrate  K  is  done  with  the  catalytic  tyrosine  residue  via  a  “hit-and-run”  mechanism;  Rtt109 
employs  the  intramolecular  autoacetylation  and  although  the  details  of  the  acetylation 
mechanism  of  Rtt109  are  unclear,  Rtt109  active  center  does  not  contain  any  typical  catalytic 
residues  (Bazan,  2008) . 
 
Rtt109  consists  of  a  globular  folded  domain  and  two  disordered  regions  (the  α2β5  loop  and 
the  C-terminal  tail);  the  folded  domain  contains  a  conserved  acetyl-CoA  binding  site  and  the 
active  center  (Fig.  1.2.1). 
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 Figure  1.2.1.  Structural  organisation  of  Rtt109.  A. Rtt109  contains  two  unstructured  regions,  the 
α2β5  loop  required  for  Vps75  binding  and  a  positively  charged  C-terminal  tail. B .  Conservation  of 
Rtt109  in  fungi.  The  sequence  alignment  was  done  for  Rtt109  homologs  from S.  cerevisiae,  Candida 
albicans, Schizosaccharomyces  pombe,  Zygosaccharomyces  bailii,  Candida  parapsilosis,  Candida 
orthopsilosis .  The  conservation  is  mapped  on  Rtt109  from  PDB  entry  3q33  (in  complex  with  Vps75); 
on  the  left  in  surface  representation  only  the  core  of  Rtt109  is  shown;  on  the  right,  in  cartoon 
representation,  both  the  core  and  the  Vps75-bound  α2β5  loop  are  shown.  The  dashed  circle  indicates 
the  active  center  of  Rtt109;  K290ac  is  the  auto-acetylated  lysine  residue. C .  Surface  charge 
representation  of  Rtt109.  Surface  electrostatic  potential  was  generated  with  APBS  (pH  7.5,  298  K). 
The  active  center  of  Rtt109  is  apolar  with  a  highly  positively  charged  patch  below. 
 
Two  X-ray  structures  of  acetyl-CoA-bound  Rtt109  were  reported  in  2008  (PDB  entry  3qm0, 
Fig.  1.2.2 (Tang  &  Marmorstein,  2008) ;  PDB  entry  3cz7 (Stavropoulos et  al ,  2008) ).  The  two 
structures  are  nearly  identical,  with  a  Cα-atoms  RMSD  below  0.5  Å.  The  small  differences 
between  the  two  structures  map  on  the  end  of  the  α5  helix  and  the  α6β8  loop,  suggesting 
that  these  conserved  regions  are  mobile  and  their  flexibility  might  be  required  for  the 
interaction  with  the  histones  and  the  histone  chaperones  or  for  the  rearrangement  of  the 
active  center  (Fig.  1.2.2). 
 
Interestingly,  the  catalytic  site  of  Rtt109  is  mostly  apolar  but  features  a  positively  charged 
patch  next  to  it  (in  Fig.  1.2.1  C  the  positively  charged  patch  is  below  the  catalytic  site).  The 
substrate  lysine  is  accommodated  in  the  hydrophobic  tunnel  (the  opening  is  visible  in  Fig. 
1.2.1;  the  depths  of  the  tunnel  (~7  Å)  corresponds  well  to  the  length  of  the  extended  lysine 
side  chain  (~6.8  Å));  the  walls  of  the  tunnel  are  built  by  the  hydrophobic  Rtt109  residues  and 
by  K  or  R  aliphatic  side-chains.  Mutations  of  the  Rtt109  residues  in  the  tunnel  or  next  to  it 
result  in  a  medium-to-complete  loss  of  acetylation  activity  ( Stavropoulos et  al ,  2008,  Tang et 
al ,  2008a). 
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 Mutation  of  K290,  the  auto-acetylated  lysine,  also  impairs  acetylation  catalysis:  the K290R 
mutation  decreases  the  k cat  ~100-fold in  vitro  and  cannot  rescue  the RTT109 Δ  phenotype in  
vivo  (Albaugh et  al ,  2011).  Notably,  the  K290Q  mutation  has  the  same  effect,  showing  that 
glutamine  does  not  properly  mimic  the  acetylated  K290. Nearly  100%  of  Rtt109  purified  from 
E.  coli carries  K290ac  and  the  presence  of  this  acetylation  does  not  depend  on  the  presence 
of  Asf1  or  Vps75.  The  K290ac  is  introduced  via  intramolecular  acetylation  and  presents  a 
self-activation  mechanism,  as  non-acetylated  Rtt109  is  nearly  inactive.  In  early  work,  it  was 
hypothesized  that  K290ac  acts  as  the  catalytic  residue,  accepting  the  acetyl  group  from 
acetyl-CoA  and  transferring  it  to  the  H3  lysine  residue;  however,  subsequent  studies  proved 
that  binding  of  H3  and  acetyl-CoA  by  Rtt109  does  not  follow  any  order  and  that  K290ac  is 
required  for  high  affinity  to  acetyl-CoA (Albaugh et  al ,  2011) .  The  search  for  the  Rtt109 
catalytic  residue  carrying  out  the  acetyl-group  transfer  did  not  yield  any  conclusive  answer: 
Rtt109  has  neither  a  glutamate  (typical  for  GNAT  family)  nor  a  tyrosine  (p300)  in  its  active 
center.  D287  and  D288  were  considered  as  the  potential  catalytic  bases;  however  their 
mutation  did  not  increase  the  pH  dependence  of  k cat  as  expected  if  they  were  catalytic  bases,  
but  even  slightly  decreased  it.  Instead,  D288  has  been  proposed  to  form  a  hydrogen  bond 
with  K290ac,  which  is  thought  to  stabilize  the  position  of  the  α5  helix  and  the  architecture  of 
the  active  center.  The  D288N  mutation  decreases  the  k cat /K M  for  acetyl-CoA  ~10 3 -fold;  this  
effect  is  similar  to  that  of  the  K290ac  mutation,  suggesting  that  both  residues  and  possibly 
their  mutual  interaction  aid  acetyl-CoA  binding (Albaugh et  al ,  2010) .  Overall,  the  data 
support  the  direct  transfer  of  the  acetyl  group  from  acetyl-CoA  to  the  H3  lysine,  with  the 
reaction  intermediate  being  stabilised  by  the  enzymatic  pocket  (Albaugh  et  al ,  2011) . 
 
Figure  1.2.2.  Rtt109  active  center. The  residues  involved  in  the  formation  of  the  hydrophobic  tunnel 
and  the  Rtt109  catalytic  site  are  shown  in  sticks.  The  residues  forming  the  walls  of  the  tunnel  are 
shown  in  the  mesh  representation.  Conserved  residues  whose  mutations  interfere  with  Rtt109 
acetylation  activity  are  shown  in  green  (D89,  R194,  W221  and  H211);  the  negatively  charged  residues 
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 are  shown  in  red;  K290ac  is  shown  in  yellow.  D288  makes  hydrogen  bonds  with  K290ac,  while  D287 
forms  the  base  of  the  hydrophobic  channel. 
 
An  intriguing  feature  of  Rtt109  is  the  requirement  of  two  different  histone  chaperones  for  its 
histone  acetylation  activity  (Fig.  1.2.1). In  vitro ,  activity  of  Rtt109  increases  ~100-fold  when 
Asf1  and/or  Vps75  are  present  (Albaugh et  al ,  2010).  These  histone  chaperones  are  thought 
to  promote  Rtt109-dependent  H3  acetylation  via  different  mechanisms.  While  Asf1  interacts 
with  the  enzyme  transiently,  Vps75  forms  a  tight  complex  with  Rtt109.  The  chaperones  also 
alter  the  specificity  of  the  enzyme.  Asf1  is  known  to  promote  H3  K56  acetylation,  but  Vps75 
increases  the  acetylation  of  H3  K9,  K23,  K27  (discussed  in  detail  in  sections  1.3,  1.4).  The 
mechanism  by  which  the  Asf1  and  Vps75  chaperones  regulate  Rtt109  specificity  is  one  of 
the  focuses  of  this  thesis  work. 
Figure  1.2.1.  H3  acetylation  by  Rtt109  depends  on  histone  chaperones. Asf1  is  associated  with 
all  Rtt109-dependent  acetylation  marks  of  H3  and  is  essential  for  the  H3  K56ac.  Vps75,  in  turn,  is  not 
necessary  for  H3  K56ac in  vivo ,  but  aids  Rtt109-dependent  acetylation  of  the  H3  N-terminal  lysines. 
The  notable  difference  between  these  acetylation  sites  is  that  H3  K56  is  located  in  the  αN  helix  in  the 
nucleosome  and  near  the  folded  core  of  H3  in  the  Asf1–H3:H4  complex.  H3  K9,  K23  and  K27,  on  the 
other  hand,  are  located  in  the  long  disordered  N-terminal  tail. 
 
Rtt109-dependent  acetylation  marks  of  H3  are  associated  either  with  newly  synthesized 
histones  and/or  with  transcriptionally  active  chromatin.  Apart  from  its  function  in 
replication-coupled  nucleosome  assembly  (section  1.1),  H3  K56ac  promotes  the  so-called 
“nucleosome  breathing”,  slightly  weakening  the  contact  between  the  DNA  and  the  histone 
octamer  in  the  nucleosome,  and  allowing  the  DNA  to  slide  past  the  octamer.  This  function  of 
H3  K56ac  is  required  for  the  nucleosome  dis-  and  re-assembly  by  the  FACT  complex  during 
transcription (McCullough et  al ,  2019) .  Acetylation  of  H3  K56  is  reversible  and  the  mark  is 
removed  in  yeast  by  Hst3  and  Hst4  HDATs  in  the  G 2 /M-phase  of  the  cell  cycle (Maas et  al , 
2006) .  The  cyclic  nature  of  H3  K56  acetylation  and  deacetylation  contributes  to  the  fidelity  of 
replication  and  protection  from  mutations. 
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 The  H3  N-terminal  tail  acetylation  is  in  general  linked  to  the  activation  of  transcription  and  is 
incompatible  with  the  methylation  of  the  lysines,  which  in  turn,  is  associated  with  silenced 
chromatin.  In  particular,  H3  K9ac  levels  are  elevated  at  the  5′  ends  of  actively  transcribed 
genes  and  are  thought  to  promote  transcription  by  facilitating  the  interaction  between  TFIID 
(transcription  factor  of  RNA  polymerase  II)  and  chromatin (Fillingham et  al ,  2008) .  Similarly 
to  H3  K9ac,  H3  K27  acetylation  is  abundant  in  the  promoter  regions,  where  it  enhances  the 
transcription  of  the  genes  (Chen  et  al ,  2019a) . 
A  number  of  H3  acetylation  marks  introduced  by  Rtt109  can  be  also  introduced  by  Gcn5  in 
S.  cerevisiae .  The  functions  of  the  two  HATs  partially  overlap,  as  both  of  them  acetylate  H3 
K9,  K23  and  K27 in  vivo .  Unlike  Gcn5,  Rtt109  does  not  contribute  to  H3  K14  acetylation 
(Berndsen et  al ,  2008)  and  does  not  show  any  detectable  activity  towards  nucleosomal  H3 
(Han et  al ,  2007).  Gcn5,  on  the  other  hand,  can  acetylate  the  H3  N-terminal  tail  in  intact 
nucleosomes  and  aids  the  propagation  of  PTMs  in  chromatin (Li  &  Shogren-Knaak,  2009) . 
Nuclear  localization  is  not  required  for  Rtt109-dependent  acetylation  of  H3,  which  suggests 
that  Rtt109  acts  on  newly  synthesized  H3  in  cytosol  (Keck  &  Pemberton,  2011),  further 
highlighting  the  role  of  Rtt109  in  nucleosome  biosynthesis. 
 
Due  to  its  unique  capacity  to  acetylate  H3  K56,  Rtt109  was  identified  as  a  potential  drug 
target  for  the  treatment  of  opportunistic  fungal  infections  caused  by Candida  albicans , 
Pneumocystis  jirovecii  and,  potentially,  other  fungi (Rosa et  al ,  2010;  Dahlin et  al ,  2014) . 
Deletion  of  the  Rtt109  homolog  in C.  albicans  leads  to  hypersensitivity  to  genotoxic  agents 
and  hence  to  the  susceptibility  to  the  host  immune  macrophage-mediated  response.  Mice 
infected  with  a RTT109 Δ C.albicans  strain  showed  a  close  to  100%  survival  rate,  due  to  the 
inability  of  the  pathogen  to  proliferate  efficiently (Rosa et  al ,  2010) .  This  data  together  with 
the  low  sequence  conservation  between  Rtt109  and  its  human  homolog,  p300,  initiated  a 
search  for  the  Rtt109  inhibitors.  Despite  the  structural  similarity  of  the  active  centers  of  p300 
and  Rtt109,  known  p300  inhibitors  had  a  very  weak  effect  on  Rtt109  activity (Tang et  al , 
2008a) .  Several  small-molecule  compounds  were  identified  as  potential  Rtt109  inhibitors 
from  high-throughput  screening (Rosa et  al ,  2013;  Dahlin et  al ,  2013) .  However,  a  large 
portion  of  them  failed  to  proceed  through  clinical  trials  either  because  of  their  promiscuous 
activity  (due  to  their  ability  to  nonspecifically  covalently  bind  to  cysteine  residues)  or  to  their 
inefficiency in  vivo (Dahlin et  al ,  2015) .  Recently,  inhibitors  for P.  jirovecii  Rtt109  were 
designed  via  virtual  screening  in  combination  with  homology  modelling  and  computational 
docking;  however,  the  activity  of  these  compounds in  vivo  has  not  been  reported  yet 
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 (Sugumar et  al ,  2016) .  Further  research  in  this  direction  could  clearly  benefit  from  the  more 
extensive  structural  data  and  understanding  of  the  mechanism  of  Rtt109  activity. 
1.3.  Vps75  and  its  role  in  Rtt109-dependent  acetylation  of  H3. 
The VPS75  gene  (vacuolar  protein  sorting)  was  first  described  during  a  genome-wide  screen 
for  genes  involved  in  vacuolar  protein  sorting  in S.  cerevisiae (Bonangelino et  al ,  2002) .  Only 
later  the  protein  product  of  this  gene,  Vps75,  was  identified  as  a  histone  chaperone 
belonging  to  the  nucleosome  assembly  protein  (NAP)  family (Selth  &  Svejstrup,  2007; 
Bowman et  al ,  2014) .  NAP  family  chaperones  are  characterised  by  a  conserved 
“headphone”  fold  and  constitutive  homodimerization (Bowman et  al ,  2014;  Park  &  Luger, 
2006) .  Members  of  this  family  are  present  in  all  eukaryotes,  where  they  take  part  in 
chromatin-related  processes,  influencing  nucleosome  assembly,  single-stranded  DNA 
nicking  during  apoptosis,  transcription  and  cell-cycle  regulation (Park  &  Luger,  2006;  Fan et 
al ,  2003) .  Members  of  the  NAP  family  of  chaperones  have  been  reported  to  bind  a  wide 
range  of  histone  forms,  ranging  from  the  core  histone  dimer  and  octamer  to  the  linker 
histone  H1 (Shintomi et  al ,  2005) .  While  Vps75  shares  the  characteristic  fold  of  proteins  in 
this  family,  it  displays  several  atypical  features  connected  to  its  role  in  promoting  H3 
acetylation  by  Rtt109  (Tang  et  al ,  2008b;  Selth  &  Svejstrup,  2007) . 
The  Vps75  monomer  consists  of  three  regions:  the  dimerization  helix,  the  earmuff  domain 
(named  so  after  the  “headphone”  homodimer  shape)  and  an  unstructured  C-terminal  acidic 
domain  (CTAD)  (Fig.  1.3.1).  The  most  notable  difference  between  Vps75  and  other 
chaperones  of  this  family  is  the  conserved  positively  charged  area  around  the  α5  helix, 
which  together  with  the  neighbouring  acidic  patch  creates  an  interaction  site  for  both  Rtt109 
binding  and  for  self-tetramerization (Tang et  al ,  2008b;  Selth  &  Svejstrup,  2007;  Bowman et 
al ,  2014;  Su  et  al ,  2011) . 
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Figure  1.3.1.  Vps75  structural  features. A.  Vps75  structural  domains:  dimerization  helix  (blue), 
earmuff  domain  (orange)  and  the  unstructured  C-terminal  acidic  domain  (CTAD,  pink)  which  includes 
nuclear  localization  signal  (NLS,  grey).  Structural  features  are  displayed  on  one  Vps75  monomer, 
Vps75(A),  the  other  one  is  shown  in  dark  grey. B.  Surface  charge  representation  of  Vps75  and  its 
closest  homolog  in S.  cerevisiae ,  Nap1,  which  is  also  able  to  self-tetramerize  and  bind  Rtt109,  but 
does  not  stimulate  its  activity (Park et  al ,  2008;  Bowman et  al ,  2014) . While  both  chaperones  share 
the  overall  fold  and  possess  an  internal  acidic  cavity,  the  Vps75  earmuff  domain  lacks  the  long 
protruding  β  sheets  and  has  a  positively  charged  α5  helix  instead. C .  Conservation  of  Vps75  in  fungal 
species  in  which  histone  acetylation  is  dependent  on  Rtt109  ( Saccharomyces  cerevisiae (Sc), 
Schizosaccharomyces  pombe (Sp), Candida  albicans (Ca), Candida  parapsilosis (Cp), Candida 
glabrata (Cg) ,  Kluyveromyces  lactis (Kl)).  Right  panel,  manual  sequence  alignment  of  the 
unstructured  CTAD  sequences  of  Vps75  orthologs.  Despite  the  low  sequence  conservation  all  CTADs 
share  negatively  charged  patches  (pink)  and  contain  an  NLS  (grey).  The  panel  is  adapted  from 
Danilenko  et  al ,  2019,  and  was  originally  produced  by  myself. 
 
Vps75  is  well-known  for  its  role  in  Rtt109-mediated  acetylation,  but  was  also  demonstrated 
to  have  an  Rtt109-independent  role  in  transcription  and  nucleosome  dynamics.  Notably, 
VPS75  expression  levels  are  stable  throughout  the  cell  cycle,  while RTT109  expression  rises 
only  before  the  S  phase (Selth et  al ,  2009) .  In  accordance  with  this,  a  portion  of  Vps75  in  the 
cell  is  not  Rtt109  bound,  but  Rtt109  exists  in  complex  with  Vps75 in  vivo  and  typically 
co-purifies  in  complex  with  this  chaperone  in  pull-down  experiments (Selth  &  Svejstrup, 
2007;  Keck  &  Pemberton,  2011;  Krogan  et  al ,  2006) . 
Although  deletion  of VPS75  in S.  cerevisiae  is  not  lethal,  the  cells  lacking VPS75  display  an 
increased  sensitivity  to  DNA  damage;  specifically,  the VPS75  deletion  strains  ( VPS75Δ ) 
displayed  a  lower  efficiency  of  DNA  double  strand  break  repair  and  the  loss  of 
Rtt109-dependent  acetylation  of  the  H3  N-terminal  tail (Park et  al ,  2008;  Jessulat et  al ,  2008; 
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 Keck  &  Pemberton,  2011) . In  vivo  data  clearly  shows  the  importance  of  Vps75  for  the 1
Rtt109-dependent  H3  K9,  K23  and  K27  acetylation  (Fig  1.3.2).  On  the  contrary,  the  impact  of 
VPS75  deletion  on  H3  K56  acetylation  is  much  lower  and  is  incomparable  with  the  deletion 
of  RTT109  or  ASF1  (Keck  &  Pemberton,  2011) . 
 
Figure  1.3.2.  Vps75  is  important  for  the  Rtt109-dependent  acetylation  of  the  H3  N-terminal  tail 
(K9,  K23,  K27) in  vivo . Summary  table  of  the  previously  published  data,  the  sign  order  corresponds 
to  the  order  of  the  citations:  the  acetylation  varies  from  “+++”  (identical  to  the  wild-type  strain)  to  “-” 
(acetylation  is  completely  abolished/  reduced  to  below  detection  level);  “n.d.”  stands  for  “no  data”;  the 
asterisk  marks  the  results  from  experiments  in  which  a S . cerevisiae  strain  containing  wild  type  Gcn5 
was  used.  Gcn5  is  able  to  acetylate  H3  K9  and  K23,  so  the  effect  of RTT109 / VPS75  deletion  is 
partially  masked.  Deletion  of VPS75  abolishes  the  H3  N-terminal  tail  acetylation  similarly  to  the 
deletion  of  RTT109 ,  but  has  little  effect  on  the  H3  K56  acetylation. 
 
Vps75  has  a  nanomolar  affinity  for  Rtt109  (K d  =10  ±  2  nM),  with  which  it  forms  a  tight  and  
stable  complex (Albaugh et  al ,  2010) .  In  addition,  Vps75  also  has  nanomolar  affinity  for  the 
H3  and  H4  histones,  but  the  interaction  between  Vps75/Rtt109  and  the  histones  was  poorly 
described  at  the  time  this  thesis  work  began,  preventing  investigation  of  Vps75-promoted 
acetylation (Berndsen et  al ,  2008) .  Thus,  the  data  known  at  the  time  suggested  three 
possible  mechanisms  by  which  Vps75  might  stimulate  Rtt109  activity: 
1. Conformational  change.  It  was  speculated  that  Rtt109  in  isolation  adopts  a 
catalytically  inactive  conformation,  while  association  with  Vps75  causes  a 
conformational  change  and  stabilization  of  an  active  state  of  the  enzyme (Kolonko et 
al ,  2010) .  However,  neither  of  the  structures  of  Rtt109–Vps75  complexes,  discussed 
below,  revealed  significant  changes  in  the  Rtt109  active  center,  challenging  this 
hypothesis  (Fig.  1.3.3). 
1  In  two  other  studies,  deletion  of VPS75  was  reported  to  have  no  influence  on  the  resistance  to  the  
DNA-damaging  agents:  in  Seth et  al ,  2007  and  Tsubota el  al ,  2007 VPS75Δ  was  not  sensitive  to  100 
mM  hydroxyurea  and  camptothecin,  respectively.  However,  the  assays  were  optimised  for  comparison 
to  the  strain  with RTT109  deletion,  which  exhibits  extreme  sensitivity  to  the  DNA  damage.  In  the 
studies  cited  above, VPS75Δ  was  sensitive  to  such  DNA  damaging  agents  as  200  mM  hydroxyurea, 
methyl  methanesulfonate  and  UV. 
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 2. Stabilization  of  Rtt109.  The  long  unstructured  Rtt109  α2β5  loop  contributes  to  the 
enzyme  instability in  vivo .  This  loop  is  necessary  for  the  formation  of  the  complex 
with  Vps75,  where  it  becomes  structured  and  protected  from  degradation (Tang et  al , 
2008a) .  Experiments  with  the  Rtt109  lacking  the  α2β5  loop  demonstrated  that in  vivo 
this  mutant  is  functional,  stable  and  its  stability  no  longer  depends  on  the  presence  of 
Vps75.  Acetylation  of  H3  K56  was  unaffected  by  the  α2β5  loop  deletion,  but  H3  K9 
and  K27  acetylation  was  significantly  decreased.  This  suggested  that  Vps75  has 
more  functions  in  H3  N-terminal  tail  acetylation  than  just  the  maintenance  of  Rtt109 
levels  in  the  cell  (Keck  &  Pemberton,  2011) . 
3. Substrate  presentation.  While  Rtt109  is  able  to  bind  the  H3:H4  by  itself,  its  affinity  to 
the  histones  is  ten  times  lower  than  the  one  for  Vps75  and  H3:H4  together;  thus 
Vps75  might  facilitate  a  tighter  interaction  between  the  enzyme  and  the  histones 
(Kolonko et  al ,  2010) .  Binding  to  Vps75  could  also  lead  to  a  correct  positioning  of 
H3:H4  in  relation  to  Rtt109  and  a  better  accessibility  of  the  H3  N-terminal  tail  for  the 
enzyme  (Tang  et  al ,  2011;  Keck  &  Pemberton,  2011) . 
 
In  total,  three  X-ray  structures  of  Rtt109-Vps75  complexes  were  reported (Tang et  al ,  2011; 
Kolonko et  al ,  2010;  Su et  al ,  2011) .  Unexpectedly,  the  most  notable  difference  between  the 
structures  is  the  stoichiometry  between  the  Rtt109  and  Vps75.  In  the  structure  from  Tang et 
al ,  each  Vps75  monomer  is  bound  to  one  copy  of  Rtt109,  resulting  in  the  formation  of  a  2:2 
complex  (Rtt109 2 –Vps75 2 ,  PDB  entry  3q33,  3q35).  In  the  structures  from  Su  et  al  and 
Kolonko  et  al ,  one  Rtt109  is  bound  to  the  Vps75  homodimer  (1:2  complex,  Rtt109–Vps75 2 , 
PDB  entry  3q66,  3q68  (Su et  al );  the  low  resolution  of  the  data  from  Kolonko  et  al  prevented 
the  authors  from  refining  the  structure  to  a  high  level  of  detail)  (Fig.  1.3.3).  Notably,  all 
structures  show  the  same  interaction  between  the  Rtt109  α2β5  loop  and  the  Vps75 
dimerisation  helix,  as  well  as  between  the  charged  patches  on  the  Vps75  earmuff  domain 
and  the  complementary  surface  of  Rtt109.  These  contacts  were  proven  to  be  essential  for 
the  formation  of  the  Rtt109-Vps75  complex (Tang et  al ,  2011) .  In  addition  to  that,  the  1:2 
structure  has  a  small  interaction  interface  between  Rtt109  α5  and  Vps75(A)  α5.  In  this  case, 
mutations  reversing  charge  distribution  or  deletion  of  Vps75  α5  weakened  the  interaction 
between  the  two  proteins  (Tang  et  al ,  2011) . 
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Figure  1.3.3.  Interaction  of  Rtt109  with  Vps75. A .  The  structures  of  1:2  and  2:2  Rtt109–Vps75 
complexes  (left  and  right,  respectively).  The  interaction  interfaces  between  Rtt109  and  Vps75  are 
highlighted  by  red  boxes.  The  1:2  complex  has  an  additional  small  interaction  interface  between  the 
α5  helix  of  Rtt109  and  the  α5  helix  of  Vps75. B .  The  active  center  of  Rtt109  remains  unchanged  upon 
Vps75  binding.  The  site  in  the  dashed  box  is  shown  in  an  expanded  view  on  the  right.  The  differences 
in  the  lid  loop  of  Rtt109  from  the  PDB  entry  3q66  are  due  to  the  absence  of  bound  acetyl-CoA. 
 
The  possibility  of  the  formation  of  both  1:2  and  2:2  complexes  arises  from  the  flexibility  of  the 
Vps75  homodimer.  The  dimerisation  helix  of  Vps75  can  adopt  various  conformations, 
thereby  affecting  the  degree  of  the  “opening”  of  the  Vps75  homodimer,  allowing  to 
accommodate  one  or  two  copies  of  Rtt109  (Fig  1.3.4).  The  free  Vps75  homodimer  displays 
the  same  type  of  flexibility,  and  it  was  speculated  that  these  conformational  dynamics  may 
be  required  for  its  function  in  H3  acetylation  as  well  as  for  the  self-tetramerization (Berndsen 
et  al ,  2008;  Bowman  et  al ,  2014) . 
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Fig.  1.3.4.  Conformational  flexibility  of  the  Vps75  homodimer .  The  structures  of  Vps75  dimers  in 
isolation  (blue,  mint,  teal)  or  from  1:2  and  2:2  Rtt109–Vps75  complexes  (orange  and  pink, 
respectively).  The  kink  in  the  dimerization  helix  determines  the  degree  of  the  opening  of  the 
homodimer,  which  enables  binding  of  two  copies  of  Rtt109  and  may  play  a  role  in  the  accommodation 
of  the  histones.  The  Vps75  dimers  are  aligned  on  the  Vps75(B)  chain. 
 
The  different  stoichiometry  does  not  stem  from in  vitro  reconstitution  protocols,  as  all  crystals 
were  produced  from  co-expressed  in E.  coli and  co-purified  Rtt109  and  Vps75.  The 
placement  of  the  affinity  tag  does  not  explain  the  enrichment  in  Rtt109  or  Vps75  either,  as 
the  Rtt109 2 –Vps75 2  structure  was  obtained  with  the  GST-tagged  Vps75  and  untagged  
Rtt109.  The  major  differences  between  the  protocols  lie  in  the  co-expression  strategies  and 
in  the  Vps75  constructs.  Tang et  al  used  a  truncated  construct  of  Vps75  (lacking  the  CTAD) 
and  co-expressed  both  proteins  from  the  same  vector,  which  possibly  favoured  the  2:2 
stoichiometry (Tang et  al ,  2011) .  In  the  two  other  cases,  the  full-length  Vps75  and  Rtt109 
were  co-expressed  from  separate  vectors  (Kolonko  et  al ,  2010;  Su  et  al ,  2011) . 
Interestingly,  biochemical  data  did  not  discriminate  clearly  between  the  two  stoichiometries. 
Analytical  ultracentrifugation  experiments  on  the  2:2  mixture  of  Rtt109  and  Vps75  or  Vps75 
lacking  the  CTAD  showed  the  formation  of  complexes  with  identical  sedimentation 
coefficients,  together  with  the  presence  of  unbound  material.  This  suggested  that  the 
stoichiometry  of  the  Rtt109–Vps75  complex  does  not  depend  on  the  Vps75  CTAD;  the 
presence  of  unbound  material  is  likely  due  to  the  formation  of  a  1:2  complex  with  the  excess 
of  Rtt109  appearing  in  the  free  form (Park et  al ,  2008) .  On  the  other  hand,  native  gel  shift 
assays  demonstrated  a  shift  at  a  Rtt109:Vps75  ratio  of  1:2  and  a  super  shift  corresponding 
to  the  2:2  complex:  this  supershift  was  also  independent  of  the  presence  of  the  Vps75  CTAD 
(Park et  al ,  2008) .  In  any  case,  Rtt109  activity  was  found  to  be  higher  in  the  1:2 
Rtt109–Vps75  complex  (Kolonko  et  al ,  2010) . 
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 The  mutations  of  Vps75  which  disrupted  or  weakened  its  interaction  with  Rtt109  also 
reduced  the  H3  N-terminal  tail  acetylation in  vivo  similarly  to  the VPS75  deletion,  confirming 
that  the  acetylation  of  these  sites  is  performed  by  the  Rtt109–Vps75  complex  in  the  cell 
(Tang et  al ,  2011;  Kolonko et  al ,  2010;  Su et  al ,  2011) .  Apart  from  the  Vps75  structural 
elements  directly  involved  in  the  interaction  with  Rtt109,  mutagenesis  analysis  identified  two 
other  Vps75  sites  important  for  its  function:  Vps75-E206  and  E207,  located  on  the  inner 
surface  of  the  Vps75  dimer,  and  the  Vps75  CTAD.  As  Vps75  E206/E207  mutations 
decreased  H3  K9  acetylation  in  vivo ,  but  did  not  affect  binding  to  the  histones  or  the  affinity 
to  Rtt109,  it  was  speculated  that  they  contribute  to  the  dynamics  of  the  Vps75  dimer  that 
may  be  required  for  the  H3  acetylation  (Tang  et  al ,  2011;  Berndsen  et  al ,  2008) . 
The  presence  of  the  CTAD  is  conserved  among  Vps75  homologs,  but  the  sequence 
conservation  of  this  acidic  region  is  low  (Fig.  1.3.1).  While  Vps75  lacking  the  CTAD  was  not 
able  to  rescue  the VPS75 Δ  phenotype,  its  effect  on  the  H3  acetylation  in  vivo  was  not 
characterised (Park et  al ,  2008) .  The  last  eight  residues  of  the  Vps75  CTAD  contain  a 
nuclear  localization  signal  (NLS),  which  promotes  Rtt109  import  into  the  nucleus.  However, 
Vps75  NLS  is  not  crucial  for  Rtt109  stability  or  Rtt109-dependent  acetylation  of  H3  K9,  which 
is  in  agreement  with  the  model  where  Rtt109  acetylates  the  newly  synthesized  H3  in 
cytoplasm  (Keck  &  Pemberton,  2011) . 
 
In  vitro  acetylation  data  on  Rtt109  activity  partially  contradict  the in  vivo  observations.  For 
instance,  Vps75  strongly  stimulated  Rtt109  activity  towards  H3  K56 in  vitro  even  in  the 
absence  of  Asf1,  and  in  some  cases,  H3  K56  was  reported  to  be  the  preferred  acetylation 
site  for  the  Rtt109-Vps75  complex (Fillingham et  al ,  2008;  Tsubota et  al ,  2007;  Radovani et 
al ,  2013;  Berndsen et  al ,  2008) .  However,  the  results  of  these in  vitro  assays  were  affected 
by  the  use  of  the  histones  from  chicken  erythrocytes,  in  which  H3  is  pre-acetylated  at  K14 
and  K23.  These  pre-existing  modifications  were  found  to  influence  the  specificity  of  Rtt109  in 
favour  of  H3  K56  acetylation (Cote et  al ,  2019;  Kuo et  al ,  2015) .  Another  complication  with 
the  interpretation  of  the in  vitro  activity  assays  is  the  differences  in  stoichiometry  between  the 
components:  Vps75  was  added  to  Rtt109  either  in  1:2  or  2:2  ratio,  while  the  substrate 
histones  were  presented  either  as  H3:H4  dimer  or  tetramer  or  as  an  isolated  H3. 
Nevertheless,  the in  vitro  activity  assays  mostly  confirmed  the  effect  of  the  mutations 
observed in  vivo .  In  particular,  deletion  of  the  Vps75  CTAD  and  the  double  mutation  of 
Vps75  E206K,  E207K  reduced  the  Rtt109  activity  rate  ~4-  and  2-fold,  respectively  (Tang  et 
al,  2011).  Deletion  of  the  CTAD  did  not  affect  the  Vps75  affinity  to  Rtt109  or  to  the  histones; 
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 however,  its  role  in  acetylation  was  prominent  and  could  not  be  replaced  by  the  addition  of  a 
polyglutamate  stretch  to  the  reaction  mixture  (Park  et  al,  2008;  Tang  et  al,  2011). 
 
Overall, in  vivo  data  suggest  that  Vps75  is  not  necessary  for  the  H3  K56  acetylation,  but 
instead  promotes  the  acetylation  of  the  N-terminal  tail  of  H3  by  Rtt109,  acting  as  a  specificity 
switch  of  the  enzyme.  The  likely  substrate  for  Rtt109  in  complex  with  Vps75 in  vivo  is  the 
Asf1-bound  histones  (discussed  further  in  the  chapter  1.4;  Bowman  et  al ,  2016). 
1.4.  Asf1  and  its  role  in  Rtt109-dependent  acetylation  of  H3. 
Asf1  (anti-silencing  function  protein  1)  belongs  to  the  Asf1-like  histone  chaperone  family, 
which  includes  eukaryotic  Asf1  homologs (Daganzo et  al ,  2003) . S.cerevisiae ASF1  was 
identified  in  the  screening  for  genes  which  take  part  in  the  anti-silencing  of  the 
transcriptionally  repressed  mating  type  loci (Le et  al ,  1997) .  All  Asf1-like  proteins  possess  a 
conserved  N-terminal  domain  (residues  1-155  of  the S.cerevisiae  Asf1),  while  the  presence, 
the  length  and  the  charge  of  the  disordered  C-terminal  acidic  region  varies  among  different 
species  (Fig  1.4.1.).  The  chaperones  of  this  family  are  known  to  interact  with  the  heterodimer 
H3:H4  and  participate  in  histone  processing  and  modification  as  well  as  nucleosome 
assembly  and  disassembly  (Hamiche  &  Shuaib,  2013) . 
 
Figure  1.4.1.  Asf1  binds  H3:H4  via  conserved  surface  on  its  N-terminal  domain  and  prevents 
H3:H4  tetramerization. A.  Scheme  of  structural  organisation  of S.  cerevisiae  Asf1. B.  Conservation 
of  Asf1  in  eukaryotes  (the  sequence  alignment  was  done  for  Asf1  homologs  from S.  cerevisiae, 
Candida  albicans, Schizosaccharomyces  pombe,  Gibberella  zeae, Debaryomyces  hansenii, 
Cryptococcus  neoformans,  Puccinia  striiformis,  Drosophila  melanogaster,  Xenopus  laevis,  Xenopus 
tropicalis,  Mus  musculus,  Homo  sapiens ).  The  H3:H4  interaction  interface  of  Asf1  is  highly  conserved. 
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 Several  interaction  partners  of  Asf1  (Cac2  (CAF-1  subunit, S.  pombe ),  Hip1  (HIRA  subunit, S.pombe ), 
HIRA  ( H.  sapiens ),  the  C-terminal  peptide  of  Rad53  ( S.  cerevisiae ))  bind  to  the  opposite  side  of  the 
Asf1  NTD. C.  Asf1  (red)  engages  the  H3:H4  dimer  (green  and  grey,  respectively;  PDB  entry  2hue). 
The  H3  residues  involved  in  direct  interaction  with  Asf1  are  shown  in  sticks.  The  H3  N-terminal  tail  is 
unstructured;  the  H4  C-terminal  tail  folds  into  a  short  β-sheet  (bC)  when  in  complex  with  Asf1. D. 
Alignment  of  Asf1-bound  H3:H4  from  ( C )  to  the  H3:H4  in  the  context  of  nucleosome  (the  H3:H4  dimer 
aligned  to  the  Asf1-bound  histones  is  shown  in  light  blue  and  blue;  the  second  copy  of  H3  in  the 
H3:H4  tetramer  is  shown  in  pink;  PDB  entry  1eqz).  In  the  nucleosome  the  same  surface  of  H3  that 
binds  Asf1  is  required  for  the  formation  of  the  H3:H4  tetramer.  Also,  the  N-terminal  tail  of  H3  forms  an 
additional  helix  (aN),  which  comprises  H3  K56. 
  
The  N-terminal  domain  of  Asf1  interacts  with  the  H3:H4  dimer,  engaging  the  same  surface  of 
H3  that  is  responsible  for  the  H3:H4  tetramerization  (Fig.  1.4.1).  Consequently,  it  has  been 
shown  that  Asf1  can  disrupt  (H3:H4) 2 in  vitro ,  but  is  unable  to  bind  cross-linked  tetramers  
(Bowman et  al ,  2011) .  The  C-terminal  domain  (CTD)  of S.  cerevisiae  Asf1  is  dispensable  for 
the  histone  binding  as  well  as  for  the  anti-silencing  function  of  Asf1  and  H3  K56  acetylation 
(Minard et  al ,  2011;  Recht et  al ,  2006) .  The  CTD  was  demonstrated  to  contribute  to 
nonspecific  association  of  Asf1  with  chromatin  and  to  increase  the  affinity  of  Asf1  for  the 
histones (Minard et  al ,  2011;  Dennehey et  al ,  2013) .  Residue  210  of  the  Asf1  CTD 
substituted  to  an  unnatural  amino  acid  cross-links  to  H3 in  vivo ;  Asf1  E210  is  surrounded  by 
poly-E  and  poly-D  stretches,  suggesting  possible  interactions  between  the  Asf1  CTD  and 
H3:H4  positively  charged  DNA-binding  surface,  which  is  not  engaged  by  the  Asf1  NTD 
(Dennehey  et  al ,  2013) . 
 
Apart  from  the  H3:H4  dimer,  Asf1  interacts  with  CAF-1  and  HIRA  complexes,  involved  in 
replication-dependent  and  -independent  nucleosome  assembly (Sharp et  al ,  2001;  Green et 
al ,  2005;  Mousson et  al ,  2007) ;  with  Rad53  to  function  in  the  DNA-damage  response (Jiao et 
al ,  2012) ;  with  the  SAS  complex  for  chromatin  remodelling  and  silencing (Reiter et  al ,  2015) ; 
with  the  replication  factor  C (Franco et  al ,  2005) ,  with  a  subunit  of  the  MCM  helicase  to 
facilitate  eviction,  splitting  and  redeposition  of  (H3:H4) 2 (Huang et  al ,  2015) ;  and  other  
protein  partners.  Some  of  these  interactions  are  compatible  with  the  Asf1–H3:H4  complex, 
as  they  involve  the  surface  of  the  conserved  N-terminal  domain  of  Asf1  which  is  not 
occupied  by  the  H3:H4  dimer  (Fig.  1.4.1B).  This  binding  mode  facilitates  Asf1’s  functions  in 
the  histone  handover  and  its  deep  integration  in  multiple  histone-related  processes. 
 
It  is  well  established  that  the  Rtt109-dependent  H3  K56  acetylation  necessitates  Asf1  (Fig. 
1.4.2).  Alike  the  deletion  of RTT109 , ASF1  deletion  is  not  lethal  but ASF1 Δ cells  display  high 
sensitivity  to  DNA  damaging  stress  and  proliferate  slower  than  the  WT  cells (Mousson et  al , 
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 2007) .  The ASF1 Δ phenotype  is  similar  to  that  of  the  H3  K56R  mutation (Recht et  al ,  2006) ; 
while  the  H3  K56Q  mutation,  which  mimics  acetylated  H3  K56,  is  able  to  partially  rescue  the 
ASF1 Δ  phenotype (Masumoto et  al ,  2005) .  Both ASF1  and RTT109  are  expressed  most 
actively  during  the  S-phase  and  deletion  of  either  one  completely  abolishes  H3  K56 
acetylation (Le et  al ,  1997) .  In  addition  to  H3  K56,  Asf1  is  required  for  Rtt109-dependent  H3 
K9  acetylation.  However,  the  role  of  Asf1  for  the  H3  N-terminal  tail  acetylation  by  Rtt109 in 
vivo  is  less  well  described. 
 
Figure  1.4.2.  Asf1  is  important  for  Rtt109-dependent  acetylation  of  H3 in  vivo . Summary  table  of 
the  previously  published  data;  the  sequence  of  the  symbols  in  each  column  corresponds  to  the  order 
of  the  citations:  the  acetylation  varies  from  “+++”  (identical  to  the  wild-type  strain)  to  “-”  (acetylation  is 
completely  abolished/  reduced  to  below  detection  level);  “n.d.”  stands  for  “no  data”;  the  asterisk  marks 
the  results  from  experiments  that  used  a S . cerevisiae  strain  containing  wild  type  Gcn5.  Gcn5  is  able 
to  acetylate  H3  K9,  so  the  effect  of RTT109 / ASF1  deletion  is  partially  masked.  Deletion  of ASF1 
abolishes  the  Rtt109-dependent  acetylation  of  H3  K9  and  K56. 
 
Deletion  of  either ASF1  or VPS75  abolishes  Rtt109-dependent  H3  K9  acetylation (Fillingham 
et  al ,  2008) ,  suggesting  that  both  of  these  chaperones  are  required  for  the  H3  N-terminal  tail 
acetylation  by  Rtt109  (Fig.  1.4.2,  Fig.  1.3.2)  As  Asf1  co-immunoprecipitated  with 
Vps75-bound  Rtt109  and  this  interaction  was  dependent  on  the  ability  of  Asf1  to  bind  H3:H4, 
it  was  speculated  that  Asf1  can  act  to  present  H3:H4  as  a  substrate  to  the  Rtt109 – Vps75  in 
vivo  (Han  et  al ,  2007) . 
In  vitro ,  Asf1  is  able  to  stimulate  Rtt109  activity  only  towards  the  H3:H4  dimers,  but  not  H3  in 
isolation,  suggesting  that  Asf1  promotes  H3  acetylation  via  a  substrate  presentation 
mechanism.  H3  K56,  K9  and  K23  acetylation  is  enhanced  by  the  addition  of  Asf1  to  the 
Rtt109–Vps75  complex  (Han et  al ,  2007;  Kuo et  al ,  2015).  Mass-spectrometry  also 
suggested  that  Asf1  does  not  alter  the  range  of  the  residues  acetylated  by  Rtt109–Vps75, 
but  increases  its  selectivity  towards  H3  K9  and  K23  (Kuo  et  al ,  2015). 
 
Co-purification  of  Asf1  with  Rtt109  could  only  be  achieved  by  cross-linking  (Han et  al ,  2007), 
suggesting  that  unlike  Vps75,  Asf1  interacts  with  Rtt109  either  transiently  or  solely  through 
the  H3:H4.  In  another  study  it  was  demonstrated  that  truncation  of  the  last  11  C-terminal 
residues  of  Rtt109  (Rtt109ΔC)  reduces  acetylation  of  H3  K9  and  K56 in  vivo (Radovani et  al , 
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 2013) .  Notably,  the  effect  of  the  Rtt109ΔC  mutation  on  H3  K56ac  is  partially  compensated  by 
Vps75,  suggesting  that  (i)  the  Rtt109ΔC  mutation  affects  the  Asf1-dependent  acetylation,  (ii) 
acetylation  of  H3  K56  in  vivo  is  done  by  Rtt109  in  complex  with  Vps75. 
 
In  parallel  with  the  work  in  this  thesis,  an  X-ray  structure  of A.  fumigatus  ( Af )  Rtt109  in 
complex  with Af Asf1 – H3:H4  was  reported  (Fig.  1.4.3) (Zhang et  al ,  2018) .  While Af  Rtt109 
does  not  bind  to  the Af homolog  of  Vps75,  the  sequence  identity  between  the S.  cerevisiae 
and  Af  Rtt109  is  ~20%  and  the  two  proteins  adopt  a  very  similar  fold  in  the  active  center. 
In  the Af  structure,  Asf1  promotes  H3  K56  acetylation  by  substrate  presentation:  Asf1-bound 
H3:H4  interacts  with  Rtt109  in  a  way  that  allows  positioning  H3  K56  near  the  Rtt109  active 
center.  H3  K56  remains  in  the  unfolded  state,  similarly  to  the  Asf1 – H3:H4  complex.  Asf1 
does  not  contact  Rtt109  directly,  but  mediates  the  interaction  of  the  H4  βC  with  Rtt109. 
 
Figure  1.4.3.  Structure  of Af  Rtt109  in Af  Rtt109–Asf1–H3:H4  complex  and  comparison  to S. 
cerevisiae ( Sc )  Rtt109. A.  Structure  of Sc  Rtt109  (PDB  entry  3qm0;  white)  is  aligned  to  the Af 
Rtt109–Asf1–H3:H4  (PDB  entry  5zba;  beige,  Rtt109;  pink,  Asf1;  green,  H3;  grey,  H4). B .  Zoom  on  the 
region  of  the  Rtt109  active  center  and  H3  K56  in  the Af  Rtt109–Asf1–H3:H4  complex. C .  Interaction  of 
Af  Rtt109  with  H3  α2  helix. D .  Interaction  between Af  Asf1  β11  with  H4  C-terminal  β-sheet,  which 
makes  contacts  with Af  Rtt109. E .  Western  blotting  results  from  Zhang et  al report  that  mutations  of 
the  residues  in Sc  proteins  corresponding  to  the Af protein  residues  shown  in  ( C , D )  reduce  H3  K56 
acetylation  in  S.cerevisiae  in  vivo  (the  acetylation  degree  is  denoted  as  in  Fig.  1.4.2). 
 
The  structure  of  the Af Rtt109  complex  was  used  by  the  authors  to  design  mutants  for in  vivo 
acetylation  studies  in S.  cerevisiae  (Fig.  1.4.3).  The  mutations  of  conserved  residues  that 
participate  in  the Af  Rtt109 – Asf1 – H3:H4  complex  significantly  reduce  H3  K56  acetylation  in 
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 S.  cerevisiae ,  suggesting  that  the  Rtt109 – Asf1 – H3:H4  interaction  interfaces  are  conserved 
between  Af  and  budding  yeast. 
 
Although  this  data  provides  valuable  insight  into  the  interaction  of S.  cerevisiae  Rtt109  with 
Asf1 – H3:H4,  it  remains  unclear  how  the  acetylation  of  the  H3  N-terminal  tail  (H3  K9,  K23 
and  K27)  is  promoted  by  the  chaperones,  and  which  role  Vps75  plays.  Given  the  fact  that Af 
Vps75  is  unable  to  interact  with Af  Rtt109,  it  remains  unclear  how  similar  the Af  and S. 
cerevisiae  acetylation  mechanisms  are  and  whether  Asf1 – H3:H4  is  also  a  substrate  of 
Vps75-bound  Rtt109.  
1.5.  Methodological  background. 
Methyl-TROSY  NMR  for  high  weight  biomolecules. 
NMR  allows  to  study  biomolecules  in  solution  in  a  wide  range  of  conditions,  including  intact 
cells.  NMR  experiments  provide  high-resolution  information  on  the  structure  and  dynamics  of 
molecules.  However,  some  of  the  drawbacks  of  the  method  include  its  low  sensitivity  and  an 
upper  limit  in  the  size  of  molecules  that  can  be  studied. 
The  signal-to-noise  ratio  in  a  mono-dimensional  NMR  depends  on  several  parameters: 
 
where N  is  the  number  of  atoms  (for  a  fixed  volume,  this  is  equivalent  to  the  sample 
concentration),  γ exc  and  γ det  are  the  gyromagnetic  ratios  of  excited  and  detected  spins,   
respectively,  B 0  is  the  strength  of  the  external  magnetic  field,  T 2  is  the  transverse  relaxation   
time-constant  of  the  detected  nucleus,  and  NS  is  the  number  of  scans  in  the  NMR 
experiment. 
The  T 2  relaxation  time-constant  becomes  shorter  as  the  molecular  weight  increases,  and  
therefore  the  NMR  signal  typically  decays  rapidly  for  high-molecular-weight  systems.  Over 
the  past  two  decades,  the  size  limit  of  the  systems  that  can  be  studied  with  NMR  has 
increased  from  ~35  kDa to  ~1  MDa  due  to  the  increase  in  the  available  magnetic  field 
strengths  (B 0 )  and,  most  importantly,  the  development  of  novel  labelling  schemes  and  pulse 
sequences. 
TROSY  (transverse-relaxation-optimized  spectroscopy)  NMR  experiments  are  specifically 
designed  to  detect  the  slowest-relaxing  transitions  in  a  particular  spin-system,  therefore 
allowing  the  observation  of  NMR  signals  from  high-molecular-weight  systems. In  an  NMR 
experiment,  the  nuclear  spins  are  initially  aligned  with  the  static  magnetic  field  B 0 ,  resulting  in 
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 a  non-zero  bulk  magnetisation  in  the  direction  of  the  +z-axis.  A  short  radio-frequency  pulse 
transfers  the  bulk  magnetisation  into  the  transverse  plane  (x-y  plane);  the  magnetization 
then  precesses  around  the  z-axis,  generating  a  detectable  NMR  signal.  In  addition  to  the 
precession,  the  magnetisation  begins  to  return  towards  its  equilibrium  state  through  a 
process  called  relaxation.  There  are  two  distinct  relaxation  processes:  transverse  relaxation, 
which  is  characterized  by  the  T 2  time-constant  and  is  the  decay  of  the  transverse  component  
of  the  transverse,  observable  magnetisation  to  zero,  and  longitudinal  relaxation,  which  is 
characterized  by  the  T 1  time-constant  and  is  the  recovery  of  the  bulk  magnetisation  along  the  
+z-axis.  In  biomolecular  NMR,  T 2  is  always  shorter  than  T 1 ,  and  thus  shortening  of  T 2  with   
increasing  molecular  weight  determines  the  limits  of  sensitivity  and  resolution  of  NMR 
spectra  for  high-molecular-weight  biomolecules. 
The  relaxation  is  caused  by  time-varying  fluctuations  of  the  local  magnetic  field  at  each 
nuclear  spin;  the  principal  relaxation  sources  are  the  fluctuating  fields  generated  by  dipolar 
(DD)  interactions  and  chemical  shift  anisotropy  (CSA)  tensors.  DD  relaxation  is  caused  by 
the  rapid  changes  in  the  orientation  of  nucleus-nucleus  dipoles  with  respect  to  the  magnetic 
field  due  to  molecular  tumbling  in  solution.  Similarly,  CSA  relaxation  arises  from  the 
reorientation  of  the  chemical  shift  anisotropy  tensor  with  respect  to  the  magnetic  field  due  to 
molecular  tumbling  in  solution;  the  change  of  orientation  of  the  CSA  tensor  gives  rise  to  a 
time-dependent  change  in  the  resonance  frequencies,  which  causes  loss  of  coherence.  The 
interference  between  different  relaxation  mechanisms  is  called  cross-correlated  relaxation 
and  can  give  rise  to  variations  in  the  net  relaxation  rates  for  different  transitions  between 
spin-states  in  multi-spin  systems. 
A  TROSY  experiment  is  designed  to  selectively  detect  only  the  slowest-relaxing  component 
of  the  magnetisation  transfer  pathway  occurring  during  an  heteronuclear  2D  correlation 
experiment (Pervushin et  al ,  1997) :  here  the  relaxation  interference  of  1H-15N  dipolar 
relaxation  and  15N  CSA  relaxation  subtracts  or  adds  from  the  transversal  relaxation  of 
different  spin-spin  transitions,  respectively  lengthening  and  shortening  the  T 2 .  If  the  slow 
relaxing  component  is  not  mixed  with  the  fast  relaxing  component  during  the  pulse  sequence 
and  is  selected  for  detection  during  the  final  acquisition  time,  one  can  obtain  a  considerable 
increase  in  sensitivity  and  resolution  of  the  2D  correlation  of  high-molecular  weight 
molecules,  despite  the  fact  that  only  half  of  the  magnetization  (the  slow  relaxing  component) 
is  observed  while  the  other  half  (the  fast-relaxing  component)  is  suppressed. 
 
While  the  first  TROSY  experiment  was  developed  for 1 H- 15 N  correlation  spectra  of  backbone 
amide  groups,  the  TROSY  effect  was  subsequently  exploited  for 1 H- 13 C  methyl  groups 
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 (Ollerenshaw et  al ,  2003) .  Irrespective  of  the  additional  gains  provided  by  TROSY,  the 
advantages  of  methyl  groups  detection  are  the  presence  of  three  pseudo-equivalent  protons, 
which  increases  the  magnitude  of  the  corresponding  bulk  magnetization  vector,  and  the  fast 
rotation  of  the  methyl  group  around  its  three-fold  symmetry  axis,  which  partially  decouples  it 
from  the  slow  tumbling  rates  of  large  molecules  and  results  in  a  slower  decay  of  transverse 
magnetization.  Further  reduction  in  the  transverse  relaxation  rates  is  provided  by 
methyl-TROSY,  which  exploits  the  relaxation  interference  between  the 1 H– 13 C  and 1 H– 1 H  DD 
relaxation  mechanisms  within  the  methyl  group. 
 
The  methyl-TROSY  NMR  experiment  requires  perdeuterated  samples  containing  selectively 
protonated  methyl-groups.  This  is  necessary  to  exploit  the  methyl-group-specific  TROSY 
effect  the  most,  without  leakage  of  magnetization  to  neighbouring  spins.  Commercially 
available  precursors  allow  the  selective  labelling  of  methyl  groups  of  I,  L,  V,  M,  A  &  T 
amino-acids;  additionally  it  is  also  possible  to  make  S-methylthiocysteine,  which  can  be 
detected  also  within  a  non-deuterated  protein.  The  labelled  proteins  are  typically  expressed 
in E.  coli as  recombinant  proteins;  it  is  also  possible  to  achieve  a  sufficient  level  of 
deuteration  and  selective  methyl-group  labelling  via  expression  in Pichia  pastoris  and  insect 
cells,  as  well  as  in  cell-free  expression  systems  (Schütz  &  Sprangers,  2019) . 
The  spectra  of  the  large  systems  can  be  simplified  by  the  use  of  a  ProS  or  ProR  LV 
precursors,  which  result  in 1 H, 13 C  labelling  of  only  one  pro-chiral  methyl  group  of  the  LV 
residues.  This  labelling  scheme  halves  the  number  of  peaks  in  the  LV  region  and  hence 
reduces  the  spectral  overlap  significantly,  without  loss  of  information  on  individual  LV 
residues.  In  addition,  ProS/ProR  labelling  can  be  extremely  useful  for  the  verification  and 
transfer  of  assignments.  The  spectra  of  large  biomolecules  and  complexes  can  be  further 
simplified  by  the  selective  labelling  of  individual  domains  of  one  molecule  of  the  complex. 
This  approach  is  known  as  segmental  labelling  and  LEGO  NMR  (Mund  et  al ,  2013) . 
 
Due  to  the  large  size  of  the  proteins  studied  in  this  thesis  work  (up  to  ~60  kDa  for  individual 
subunits;  ~160  kDa  protein  complex),  the  majority  of  the  NMR  experiments  presented  here 
are  methyl-TROSY  experiments,  that  is 1 H- 13 C  HMQC  (heteronuclear  multiple-quantum 
correlation)  spectra,  recorded  on  perdeuterated  1 H- 13 C  -ILV-methyl  labelled  samples. 
Chemical  shift  perturbations  (CSPs). 
Comparison  of  the  positions  of  the  chemical  shifts  between  the  spectra  of  the  same 
biomolecule/protein  in  different  experimental  conditions  or  in  the  presence  of  potential 
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 binding  partners  provides  information  on  changes  in  the  chemical  environment  of  specific 
sites.  These  changes  are  caused  either  by  a  conformational  change  of  the  protein  or  by  a 
direct  interaction.  Therefore,  monitoring  chemical  shift  perturbations  (CSPs)  is  a  way  to  gain 
insights  into  the  binding  affinity  of  protein-protein  and  protein-ligand  complexes.  Moreover, 
due  to  the  nature  of  the  chemical  shift  evolution  in  an  NMR  experiment,  CSPs  can  inform  on 
the  exchange  regime  between  two  protein  states  (Fig.  1.5.1). 
In  an  experiment  with  a  ligand  (L)  and  a  protein  (P),  where  ligand  reversibly  binds  to  the 
single  site  on  the  protein,  the  observed  states  in  the  reaction  can  be  described  as: 
  P  L + P
↔
L (2) 
where  LP  is  a  ligand-protein  complex.  The  protein  in  this  case  is  observed  in  the  free  and  the 
ligand-bound  states,  which  interconverse  as  in: 
[P ] dt ­ [P ]  d / = K1 + [LP ]  K­1 (3.1) 
[LP ] dt [P ]  d / = K1 ­ [LP ]  K­1 (3.2)  
where  [P]  and  [LP]  are  the  concentrations  of  the  protein  in  the  free  form  and  in  the 
ligand-bound  state,  respectively; K 1  and K -1  are  the  forward  (P  to  LP)  and  back  (LP  to  P)  rate   
constants.  In  the  equilibrium  the  concentration  change  of  L  and  LP  over  time  equals  zero, 
hence  from  the  equations  (3.1)  and  (3.2),  the  ratio  between  the  equilibrium  concentrations 
equals: 
LP ] [P ]  [ / = K1/  K­1 (4) 
The  exchange  rate  K ex   describes  the  return  of  the  system  to  the  equilibrium  state: 
 Kex = K1 + K­1 (5) 
The  reaction  in  (2)  can  also  be  described  in  terms  of  the  dissociation  constant k d ,  which 
describes  the  dissociation  rate  of  the  LP  complex.  Dissociation  constant  is  the  ratio  of  the 
equilibrium  concentrations  of  the  free  ligand  and  protein  to  the  concentration  of  their 
complex: 
L][P ] [LP ]  Kd = [ / = Kof f / Kon (6) 
where  k on  and k off  are  the  rate  constants  for  the  forward  (L  +  P  to  LP)  and  back  (LP  to  L  +  P)   
reactions  of  the  reaction  shown  in  (2).  From  the  equations  (4),  (5)  and  (6),  the  exchange  rate 
K ex   can  also  be  defined  as: 
[L]Kex = Kon + Kof f (7) 
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Fig.  1.5.1.  CSPs.  The  figure  shows  the  behaviour  of  protein  peaks  over  several  2D  NMR  spectra 
acquired  in  the  presence  on  increasing  concentrations  of  a  binding  partner.  The  term  “fast  exchange” 
is  used  when  the  exchange  rate K ex  is  faster  than  the  difference  in  the  chemical  shifts  of  the  bound  
and  free  states  in  Hz  (ΔΩ).  Typically,  fast  exchange  is  observed  for  weak  interactions  with  k d  in  the  μM  
range  or  above;  the  observed  chemical  shift  is  a  population  weighted  average  of  the  chemical  shifts  of 
the  two  states,  and  therefore  chemical  shifts  change  gradually  as  the  concentration  of  the  interaction 
partner  increases.  When K ex  <<(ΔΩ),  which  is  typically  the  case  for  interactions  with  sub-μM  affinity,  
the  chemical  shifts  of  both  states  are  observed  as  separate  signals;  the  intensity  of  the  original  peak 
decreases  gradually  as  the  new  peak  appears  and  gains  its  intensity,  until  the  protein  is  saturated  with 
ligand  and  the  signal  corresponding  to  the  free  state  disappears. 
 
As  CSPs  are  a  function  of  changes  in  the  chemical  environment  around  individual  nuclei, 
they  are  not  a  reliable  source  of  information  on  the  interaction  interfaces,  since  they  may 
arise  both  from  direct  interactions  and  conformational  changes  upon  binding,  which  can 
occur  also  far  from  the  binding  site.  However,  measurement  of  CSPs  and  their  visualization 
on  the  structure  are  useful  to  detect  binding  and  obtain  a  candidate  binding  surface  (to  be 
confirmed  with  other  methods).  CSPs  for  an  NMR  experiment  where  N  nuclei  are  recorded 
are  calculated  as: 
 (8) 
where  δ  is  a  chemical  shift  difference  and  α  is  a  scaling  factor  to  adjust  the  δ  of  the  different 
nuclei  (Williamson,  2013) . 
During  the  titration  of  a  ligand  to  a  protein,  their  total  concentrations  ([L] t  and  [P] t ,  
respectively)  can  be  presented  as  a  sum  of  the  ligand  (or  protein)  concentration  in  a  free 
state  and  in  the  ligand-protein  complex  (bound  state).  In  fast  exchange,  observed  CSP  is  the 
population  weighted  average  of  the  chemical  shifts  of  the  free  and  the  bound  states  and  can 
be  expressed  as: 
CSP obs = (([L] )  ([L] )    4[L] [P ] )  )  2[P ]  CSPmax  t + [P ]t + Kd ­ ( t + [P ]t + Kd
2
­   t t
1 2/ / t (9) 
where  CSP max  is  the  maximal  CSP  for  the  ligand-saturated  state;  it  can  be  either  measured  
directly  or  derived  from  a  fitting  procedure.  Hence,  k d  can  be  extracted  if  the  total  
concentrations  of  the  ligand  and  the  protein  as  well  as  the  CSP max   are  known. 
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 Paramagnetic  relaxation  enhancement  (PRE). 
PRE  experiments  provide  distance  restraints  in  a  range  of  ~10–35  Å (Battiste  &  Wagner, 
2000) .  The  method  relies  on  the  distance  dependence  of  the  effect  that  a  paramagnetic 
group  has  on  the  nuclei  observed  in  the  NMR.  Initially  the  method  was  applied  to  proteins 
that  are  able  to  bind  paramagnetic  metals;  nowadays  a  selection  of  different  paramagnetic 
tags  is  available  that  can  be  coupled  to  a  position  of  interest  specifically  engineered  in  the 
biomolecule.  In  this  study,  I  use 3-(2-iodoacetoamido)-PROXYL  as  paramagnetic  tag  (also 
called  spin-label),  which  can  react  via  its  iodine  group  with  the  thiol  group  of  a 
solvent-accessible  cysteine  (Fig.  1.5.2).  The  protein  to  be  spin-labelled  must  contain  only 
one  solvent  accessible  cysteine  to  ensure  that  the  paramagnetic  tag  is  located  at  one 
specific  position:  this  can  be  achieved  by  mutagenesis,  whereby  all  undesired  solvent 
accessible  cysteine  residues  are  substituted  by  serine  and  one  cysteine  is  engineered  at  the 
desired  position. 
The  design  of  the  PRE  experiment  used  in  this  work  is  shown  in  Fig.  1.5.2. 
 
Figure  1.5.2.  Scheme  of  a  PRE  experiment.  A. A  paramagnetic  tag  is  covalently  attached  to  one 
component  of  the  complex  at  a  precise  position  on  one  of  the  molecules  of  the  complex.  The  tagged 
(or  spin-labelled)  protein  is  then  added  to  the  NMR  active  partner  and  spectra  are  recorded  with  the 
tag  in  paramagnetic  and  diamagnetic  states. B. In  the  paramagnetic  state,  the  tag  increases  the 
transverse  relaxation  rate  of  the  nuclei  closer  than  approximately  35 Å .  The  corresponding  NMR 
peaks  broaden  and  decrease  in  intensity  in  a  distance-dependent  manner.  This  effect  is  quantified  by 
recording  a  reference  spectrum  where  the  tag  is  in  the  diamagnetic  state  and  thus  no  longer  changes 
the  relaxation  rates  of  the  nuclei  close  to  it.  The  diamagnetic  state  of  the  tag  is  obtained  upon 
reduction  with  ascorbic  acid. 
The  paramagnetic  tag  increases  the  transverse  relaxation  rate  (R 2 )  of  all  nuclei  closer  than 
35  Å  in  a  distance-dependent  manner.  The  mechanisms  through  which  the  paramagnetic 
center  causes  the  increase  in  the  relaxation  rate  of  the  nuclei  are  diverse  and  depend  on  the 
nature  of  the  paramagnetic  center.  For  nitroxide  paramagnetic  groups,  the  main  mechanism 
is  the  electron-nucleus  dipolar  interaction.  The  difference  between  the  transverse  relaxation 
rates  in  the  diamagnetic  and  paramagnetic  states  is  the  PRE  rate  (Γ 2 ),  which  is  defined  by 
the  Solomon-Bloembergen  equation  (Solomon  &  Bloembergen,  1956)  as: 
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2 2 2
B + 1 SB + 3 SB I (10) 
where  γ  is  the  gyromagnetic  ratios  of  the  nuclear  spins,  g  is  the  electron  g-factor,  μ B  is  the  
Bohr  magneton, S  is  the  spin  quantum  number  of  the  electron,  and  J SB  is  the  generalised  
spectral  density  function.  J SB   incorporates  the  distance  dependence  of  the  PRE  rate: 
 
where  r  is  the  distance  between  the  free  electron  of  the  paramagnetic  tag  and  the  nucleus 
observed  in  the  NMR,  and  𝜏 c  is  the  electron-nucleus  correlation  time (Clore  &  Iwahara,  
2009) . 
As  it  can  be  derived  from  equations  (10)  and  (11),  the  distance  can  be  expressed  as: 
 
where  K  is  a  constant  that  contains  the  physical  constants  of  equation  (10)  (γ,  g,  μ B  and  S).  
Therefore,  distances  between  the  tag  and  specific  nuclei  can  be  determined  by  measuring  𝜏 c  
and  Γ 2 .  As  the  PRE  effect  decays  with  the  inverse  sixth  power  of  the  electron-nucleus 
distance,  it  can  be  estimated  that  for  most  of  the  available  tags  the  influence  of  the 
paramagnetic  center  on  the  nuclei  relaxation  rates  can  be  quantified  up  to  a  maximum  of  35 
Å. 
 
Γ 2  can  be  quantified  by  measuring  the  ratio  between  the  intensity  of  the  peaks  in  the  
paramagnetic  and  diamagnetic  states  (Fig.  1.5.3).  In  this  thesis  work,  a  “single-time-point” 
approach  is  used,  in  which  two  HMQC  spectra  are  recorded  for  each  sample,  one  with  the 
tag  in  the  paramagnetic  state  and  one  with  the  tag  in  the  diamagnetic  state.  The  ratio 
between  the  peak  heights  in  the  two  spectra  depends  on  Γ 2   as: 
 
where  R 2 diaH  and  R 2 diaHC  are  the  diamagnetic transverse  relaxation  rates  for  the 1 H   
single-quantum  coherence  and  the 1 H- 13 C  multiple-quantum  coherence,  respectively and 
t hmqc  is  the  coherence  transfer  time  during  which  the  proton  magnetisation  is  in  the  transverse  
plane.  Thus,  to  extract  Γ 2 ,  R 2 diaH  and  R 2 diaHC  must  be  known  for  each  NMR  peak.  These  rates   
are  measured  in  separate  NMR  experiments. 
The  electron-nucleus  correlation  time  𝜏 c  can  be  estimated  from  Γ 2  rates  that  can  be   
correlated  with  known  electron-nucleus  distances.  In  this  work,  as  we  know  the  structure  of 
the  individual  proteins  entering  the  complex,  we  could  measure  intra-molecular  PREs  and 
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 correlate  them  with  the  electron-nucleus  distances  measured  from  the  structure.  In  these 
experiments  the  paramagnetic  tag  is  placed  on  an  NMR  active,  isotope-labelled  protein  with 
a  known  structure.  The  experimental  Γ 2 ,  derived  from  equation  (13)  are  then  used  to  fit  the  Γ 2  
predicted  from  the  distances  between  the  paramagnetic  tag  modelled  on  the  protein 
structure  and  the  corresponding  protein  nuclei.  In  the  fitting  procedure,  both  the 
conformations  of  the  paramagnetic  tag  and  𝜏 c  are  optimised  to  achieve  convergence  
between  the  experimental  and  predicted  Γ 2  (Iwahara et  al ,  2004)  (the  workflow  for  the  
determination  of  𝜏 c   is  shown  in  blue  lines  in  Fig.  1.5.3). 
 
Figure  1.5.3.  A  simplified  scheme  of  the  distance  calculation  protocol  used  in  this  work. First, 
the  diamagnetic  transverse  relaxation  rates  of  each  observed  methyl-group  are  measured.  After  that, 
the  𝜏 c  is  extracted  from  the  intra-molecular  PRE  dataset,  where  the  experimental  Γ 2 rates  are  fit to  the   
Γ 2 rates  calculated  from  the  known distances.  Finally,  the  optimized  𝜏 c  can  be  used  to  calculate  the   
unknown  intermolecular  distances. 
Small-angle  neutron  scattering  (SANS). 
SANS  provides  low  resolution  structural  information  on  particles  in  solution.  Compared  to 
small-angle  X-ray  scattering,  SANS  requires  longer  acquisition  times  and  higher  sample 
concentrations  but  it  has  key  advantages  for  studying  large  biomolecular  complexes:  the 
possibility  of  studying  the  system  in  a  wider  range  of  solvents,  absence  of  radiation  damage, 
and,  most  importantly,  the  ability  to  gain  structural  data  on  individual  components  within  a 
larger  particle. 
The  typical  layout  of  a  SANS  experiment  is  shown  in  Fig.  1.5.4: 
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Fig.  1.5.4.  SANS  experimental  scheme. The  monochromatic  neutron  beam  is  shot  at  the  sample 
and  the  resulting  circularly  symmetric  scattering  pattern  is  detected.  The  scattering  pattern  depends 
on  the  shape  of  the  particle  and  the  scattering  intensity  depends  on  its  size  and  the  concentration. 
 
A  neutron  source  is  used  to  generate  neutrons,  which  are  moderated  to  the  wavelength 
required  for  the  particular  measurement.  SANS  can  be  applied  for  particles  with  sizes 
ranging  from  ~1  nm  up  to  ~500  nm;  the  length  scale  it  probes  (d)  is  proportional  to  the 
neutron  wavelength  (λ),  and  reversely  proportional  to  the  scattering  angle  (2Θ): 
     ≈   d λ2Θ (14) 
The  neutron  wavelength  chosen  for  biological  samples  typically  lies  within  4-7  Å  with  a 
resolution  (Δλ/λ)  of  ~5-10%.  In  the  SANS  experiment,  elastic  coherent  neutron  scattering 
allows  to  obtain  structural  information,  when  the  resulting  neutrons  are  scattered  in  different 
directions  without  energy  transfer.  In  this  case,  the  scattering  intensity  of  a  sample  consisting 
of  identical,  randomly  oriented  particles  depends  on  the  momentum  transfer, q  (the  distance 
of  the  direct  beam  to  the  detector,  Å -1 )  and  can  be  expressed  as: 
where V  is  the  volume  of  the  sample, r  represents  the  coordinates  of  the  individual  scattering 
point,  and  Δϱ  is  the  difference  between  the  scattering  length  densities  of  the  particle  and  the 
solvent  (later  referred  to  as  the  scattering  contrast).  The  scattering  length  density  (SLD) 
depends  on  the  strength  of  the  neutron-nucleus  interaction  and  differs  for  isotopes  of  the 
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 same  element.  The  differences  between  the  SLDs  of 1 H  and 2 H  are  exploited  in  a  method 
called  “contrast  matching”.  The  SLDs  of 1 H  and 2 H  have  different  signs,  and  SLDs  for  various 
biomolecules  typically  have  values  between  those  of  H 2 O  and  D 2 O  (Fig.  1.5.5).  Thus,  it  is 
possible  to  vary  the  concentration  of  D 2 O  in  the  solvent  to  match  the  SLD  of  selected 
biomolecules  and  render  them  “invisible”.  If  a  particle  consists  of  different  biomolecules  (for 
example,  proteins  and  nucleic  acids)  or  biomolecules  with  different  level  of  deuteration  (for 
example 1 H  and 2 H  proteins),  it  is  possible  to  use  a  D 2 O:H 2 O  solvent  mixture  where  a  part  of 
the  particle  is  invisible,  while  another  part  contributes  to  the  scattering  signal  (Jacrot,  1976) . 
 
Fig.  1.5.5.  Contrast  matching  in  SANS.  A. Plot  of  scattering  length  densities  (SLDs)  of  the  solvent 
and  biomolecules  depending  on  the  percentage  of  D 2 O  in  the  solvent.  The  SLDs  of  DNA,  RNA, 
proteins  and  phospholipids  are  between  the  SLDs  of  pure  H 2 O  and  D 2 O.  Thus,  a  contrast  matching 
point  between  the  solvent  and  the  biomolecule  (the  intersection  of  the  solvent  and  the  sample  lines  on 
the  plot)  can  be  reached  by  varying  the  percentage  of  D 2 O:H 2 O.  For  example,  the 1 H  proteins  have  a 
positive  scattering  contrast  in  H 2 O,  are  contrast-matched  by  the  solvent  in  42%  D 2 O  and  have  a 
negative  scattering  contrast  in  100%  D 2 O  (the  scattering  contrast  is  indicated  by  the  red  arrows). B. 
Contrast  matching  labelling  schemes  used  in  this  work. The  panel  ( A )  is  adapted  from (Dunne et  al , 
2017) . 
 
SANS  data  analysis.  The  structural  information  that  can  be  derived  from  the  scattering 
pattern  includes  the  radius  of  gyration  (R g , root  mean  square  distance  of  each  scattering 
center  to  the  center  of  mass ),  an  estimated  molecular  weight  of  the  particle,  and  a 
pair-distance  distribution  function  (P(r),  which  represents  the  probability  distribution  of  all 
pairwise  interatomic  distances  within  the  particle). 
The  Guinier  approximation  postulates  that  at  the  small  angles  ( q R g  ≤  1 –  1.3  depending  on  
the  particle  shape)  the  scattering  depends  linearly  on q 2 on  a  logarithmic  scale (Feigin  & 
Svergun,  1987;  Guinier,  1939) .  The  plot  of  the  logarithm  of  the  scattering  intensity, I ( q ), 
versus  q 2   for  this  q  range  returns  a  straight  line  with  a  slope  of  (R g 2 /3): 
I(q) ≈ ㏑I(0) ㏑ + 3
q R2 g2  (16) 
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 where I (0)  is  the  scattering  intensity  at  the  zero  angle  ( I ( q )  value  at  the  intersection  of  the 
plotted  line  with  the  y-axis).  Apart  from  deriving  R g  and I (0),  the  Guinier  plot  serves  for  the  
analysis  of  the  quality  of  the  sample,  as  deviation  from  the  straight  line  at q  values 
approaching  zero  indicates  interparticle  interactions  such  as  aggregation  or  repulsion  (Fig. 
1.5.6)  (Mertens  &  Svergun,  2010) . 
Figure  1.5.6.  Guinier  plot  reports  on  the  presence  of 
inter-particle  interactions. Deviation  of  the  scattering  plot 
from  the  straight  line  signifies  attraction  (red)  or  repulsion 
(green)  of  the  particles. 
 
 
 
 
 
The  molecular  weight  (M w )  of  the  particle  can  be  derived  from I (0)  and  depends  on  the 
concentration  of  the  sample  ( c ),  the  scattering  contrast  (Δϱ),  and  the  partial  specific  volume 
( ν ),  depends  on  the  type  of  the  biomolecule,  e.g.  protein,  DNA,  RNA);  N A  is  the  Avogadro  
constant: 
 
The  determination  of  the  M w  by  this  method  is  not  very  accurate,  due  to  the  assumptions  on  
the  sample  homogeneity,  the  accuracy  of  the  background  subtraction,  the  precision  of  the 
concentration  measurement  and  the  completeness  of  the  labelling;  however,  it  can  be  used 
to  assess  the  oligomeric  state  of  the  sample.  An  alternative  method  to  determine  M w  is  
based  on  the  volume-of-correlation  parameter  (the  ratio  of I (0)  to  the  total  scattering 
intensity)  and  is  better  suited  for  particles  with  non-spherical  shape  (e.g.  unfolded  proteins; 
the  mass  error  is  ~10%)  (Rambo  &  Tainer,  2013) . 
P(r)  is  the  distribution  of  the  distances  between  the  nuclei  in  the  particle  and  can  be 
calculated  from  the  scattering  intensity  pattern: 
 
As  the  experimental  scattering  data  do  not  reach  from  zero  to  infinite q ,  the  P(r)  is  calculated 
by  an  indirect  Fourier  transformation,  typically  using  the  GNOM  program (Svergun,  1992) . 
For  the  calculation  of  the  P(r)  GNOM  uses  an  estimated  maximal  dimension  of  the  particle 
(D max ,  ranging  from  2R g  to  4R g  in  the  automated  estimation)  and  a  representation  of  the   
scattering  curve  as  a  sum  of  spline  functions  (smoothed  curve).  The  quality  of  the  D max  
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 estimation  can  be  judged  by  the  fitness  of  the  smoothed  scattering  curve  to  the  experimental 
one  and  by  the  behavior  of  the  P(r)  at  the  r=0  and  r=D max   (Fig.  1.5.7). 
Figure  1.5.7.  Pair-distance  distribution. P(r)  represents  the  probability  distribution  of  distances 
between  the  two  scattering  centers  within  the  particle.  The  P(r)  is  for  a  zero  distance  and  approaches 
zero  smoothly  towards  the  D max .  Blue,  P(r)  for  one  scattering  subunit  (Vps75)  within  a 
contrast-matched  protein  complex:  the  D max  of  Vps75  is  95  Å  and  the  most  probable  intramolecular  
distance  is  ~31  Å.  Purple,  the  P(r)  for  two  scattering  subunits  (Vps75  and  Asf1)  within  a 
contrast-matched  protein  complex:  the  P(r)  function  has  a  characteristic  shape  indicating  a 
non-globular  architecture  of  Vps75  and  Asf1  together,  the  D max  of  the  combined  subunits  is  110  Å;  the  
second  maximum  indicates  the  most  probable  intermolecular  distance,  hence  the  distance  between 
the  centers  of  mass  of  the  two  proteins  (in  this  case  ~62  Å). 
 
As  R g  can  also  be  computed  from  the  calculation  of  the  P(r)  by  GNOM,  it  is  important  to  
compare  the  convergence  of  the  R g  values  from  GNOM  and  from  the  Guinier  analysis  to  
ensure  that  both  the  data  and  the  analysis  are  of  high  quality. 
SANS  in  structural  modelling.  The  scattering  curve  can  be  used  either  to  generate  an ab 
initio  low-resolution  structural  envelope  or  to  score  independently  generated  structures  (Fig. 
1.5.8A). 
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Fig.  1.5.8.  Use  of  SANS  data  in  structural  modelling. A.  While  one  structure  corresponds  uniquely 
to  one  scattering  curve,  the  same  scattering  curve  may  generate  from  different  structures.  Thus,  the 
ab  initio  structural  model  obtained  from  the  scattering  data  has  a  low-confidence  level  (top  panel).  On 
the  other  hand,  the  unique  scattering  curve  predicted  from  a  given  structure  can  be  compared  to  the 
experimental  curve  to  evaluate  the  fit  of  this  structure  to  the  SANS  data  (bottom  panel) B .  Due  to  the 
dependence  of  𝜒 2  on  the  experimental  errors,  the  absolute  𝜒 2  values  for  structures  scored  against   
different  experimental  curves  cannot  be  compared  directly  (*the  fitness  of  a  structure  to  the  different 
SAS  datasets  can  be  compared  if  the  visual  fit  and  the  confidence  in  the  𝜒 2  value  are  taken  into  
account.  For  additional  statistical  methods  see  the  review  (Trewhella  et  al ,  2017) ). 
 
A  set  of  programs  for ab  initio  modelling  from  the  SAS  data  has  been  developed  by  the 
Svergun  group (Franke et  al ,  2017) .  The  generation  of  a  dummy  atom  model  can  be  done  by 
DAMMIF,  which  builds  the  model  from  dummy  atoms  based  on  the  agreement  between  the 
theoretical  and  experimental  scattering  curves  and  a  set  of  parameters  such  as  the  model 
connectivity  and  compactness (Franke  &  Svergun,  2009;  Svergun,  1999) .  However,  the 
degeneracy  of  the  SAS  data,  which  arises  from  the  loss  of  the  orientation  and  phase 
information  during  the  data  collection,  severely  limits  the  resolution  and  confidence  of  the ab 
initio  model. 
In  this  work,  the  SANS  data  was  mostly  used  for  evaluation  of  the  structural  models 
generated  by  high-resolution  methods  (X-ray,  NMR)  and  docking.  The  fit  of  the  structural 
model  to  the  experimental  data  is  done  with  CRYSON,  a  program  which  predicts  a 
theoretical  scattering  curve  from  the  structure,  taking  into  account  the  solvent  shell  and 
percentages  of  deuteration  of  the  molecule  and  the  solvent.  The  resulting  theoretical  curve  is 
compared  to  the  experimental  one  and  their  agreement  is  measured  by  the  𝜒 2   parameter: 
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 where N  is  the  number  of  data  points, I exp (q)  is  the  experimental  scattering, I mod (q)  is  the 
theoretical  scattering  curve  back-calculated  from  the  structural  model, c  is  a  scaling  factor  for 
the  theoretical  curve  required  for  the  minimization  of  𝜒 2 , σ (q)  is  the  standard  error  for  each 
data  point (Trewhella et  al ,  2017) .  As  it  can  be  seen  from  this  equation,  the  𝜒 2  value  depends  
on  the  experimental  errors,  as  well  as  the  number  of  data  points  along  the  detector  axis. 
Error  propagation,  in  turn,  depends  on  the  data  reduction  procedure,  which  is  unique  to  each 
instrument,  so  the  final  error  may  be  either  over-  or  underestimated.  Thus,  while  𝜒 2  values  
are  useful  to  compare  the  fits  of  different  models  to  the  same  scattering  curve,  the  absolute 
𝜒 2  values  do  not  unambiguously  report  on  the  fit  quality,  unless  properly  normalized,  and  
should  not  be  directly  compared  between  different  SAS  curves  (Fig.  1.5.8B). 
Multi  angle  light  scattering  (MALS). 
MALS  is  a  technique  for  determination  of  the  molecular  weight  (M w )  and  radius  of  gyration 
(R g )  of  particles  in  solution,  which  in  turn  can  be  used  to  assess  interactions  and  oligomeric 
states  of  the  biomolecules.  Coupling  of  MALS  with  the  size-exclusion  chromatography  (SEC) 
allows  to  define  the  above-mentioned  parameters  for  the  separate  species  present  in  the 
sample,  thus  enabling  the  analysis  of  heterogeneous  samples. 
 
In  a  MALS  experiment,  a  laser  beam  is  shot  at  the  sample  in  solution  and  the  scattering 
intensity  measured  at  several,  2  to  20,  fixed  angles  (Θ)  by  either  a  single  movable  detector 
or  several  fixed  detectors.  The  basic  principle  of  MALS  is  the  proportionality  of  the  resulting 
scattering,  I(Θ),  to  the  M w ,  the  concentration  of  the  sample  (c)  and  to  the  dn/dc  ratio  (Δn/Δc, 
where  Δn  is  the  change  in  the  refractive  index,  Δc  is  the  change  in  the  concentration;  reflects 
the  polarization  difference  between  the  molecules  and  the  solvent  in  a  concentration 
dependent  manner). 
The  reduced  Zimm  equation (Zimm,  1948)  describes  the  amount  of  the  scattered  light  in  a 
M w -  and  concentration-dependent  way: 
 
where  R(Θ,c)  is  excess  Rayleigh  ratio  (the  difference  of  the  scattered  light  from  the  solution 
over  the  scattered  light  from  solvent),  P(Θ)  is  the  angular  dependence  of  the  scattered  light 
(includes  R g  component),  A 2  is  the  second  virial  coefficient  describing  the  solubility  of  the   
biomolecule  in  solution,  and  K  is  a  constant  that  contains  the  dn/dc: 
π (dn dc) n N λ  K = 4 2 / 2 20/ A 4 (21) 
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 where  n 0  is  the  refraction  index  of  the  solvent,  N A  is  the  Avogadro  number  and  λ  is  the   
vacuum  wave-lengths  of  the  laser  beam. 
Due  to  the  low  sample  concentration  in  each  elution  volume  slice,  the  2A 2 c  component  of  the 
equation  (20)  can  be  neglected  (Johnson,  2005) . 
 
While  the  dn/dc  value  can  be  measured  with  the  refractive  index  (RI)  detectors,  its  values  for 
different  proteins  vary  very  slightly  and  often  the  default  value  ( 0.185  mL/g )  is  used  instead 
(recommended  by  Wyatt  Technology).  R(Θ,c),  P(Θ)  and  the  concentration  are  measured 
directly  during  the  experiment,  and  the  M w  determination  in  SEC-MALS  can  be  done  via  a  
Zimm  plot,  where  the  scattering  data  from  each  elution  volume  slice  is  extrapolated  to  zero 
angle  and  zero  concentration. 
The  R g  determination  by  SEC-MALS  has  a  size  limit  of  ~10  nm,  as  R g  is  extracted  from  the   
anisotropic  light  scattering  detected  at  different  angles,  and  the  angular  dependence  P(Θ)  for 
smaller  molecules  is  often  undetectable. 
 
Overall,  SEC-MALS  provides  absolute  mass  determination,  which  does  not  depend  on  the 
elution  time  or  the  shape  of  the  molecule.  An  example  of  the  SEC-MALS  profile  of  the 
molecular  mass  of  the  eluted  species  can  be  seen  in  the  Fig.  4.1.3. 
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 2.  Aims  of  the  thesis  work 
Previous  studies  have  highlighted  a  unique  feature  of  Rtt109:  the  dependence  of  its  activity 
on  the  associated  chaperones,  Asf1  and  Vps75.  While  the  structures  of  Rtt109  and  an 
Rtt109–Vps75  complex  have  been  reported,  these  have  given  little  information  on  the 
chaperone-dependent  differences  in  the  enzyme  activity  and  specificity;  instead  they  posed 
a  question  on  the  stoichiometry  of  the  Rtt109–Vps75  complex.  It  remained  unclear  why 
Rtt109  requires  two  distinct  histone  chaperones  to  acetylate  sites  in  the  unfolded  H3 
N-terminal  tail,  while  acetylation  of  H3  K56  requires  only  Asf1  in  vivo . 
Elucidating  the  mechanism  by  which  Asf1  and  Vps75  regulate  Rtt109  activity  could  shed 
light  on  how  enzyme  binding  partners  can  switch  its  specificity  and  how  the  acetylation  of 
unfolded  substrates  can  be  promoted. 
In  order  to  answer  these  questions,  the  following  objectives  have  been  set  in  this  thesis 
work: 
1. To  reconstitute  the  functional  complex  of  Rtt109  with  the  chaperones  and  the 
substrate  H3:H4  histones  in  vitro  and  determine  its  stoichiometry. 
2. To  explain  the  roles  of  Asf1  and  Vps75  in  Rtt109-dependent  H3  acetylation  by: 
- Solving  the  structural  model  of  the  complex  by  an  integrative  structural 
biology  protocol  combining  NMR  and  SANS  data. 
- Exploring  the  dynamics  of  the  complex  by  molecular  dynamics  simulations 
(MD). 
- Defining  the  determinants  of  Rtt109  activity  regulation  by in  vitro  activity 
assays  with  proteins  containing  mutations  designed  under  the  guidance  of  the 
structural  model. 
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 3.  Methods 
The  text  of  the  sections  3.1  –  3.9  has  been  partially  taken  from  the  published  manuscript 
(Danilenko  et  al ,  2019) ,  and  has  been  originally  written  entirely  by  myself. 
3.1.  Protein  expression  and  purification. 
Plasmids  for Xenopus  laevis histone  H3  (UniProtKb  accession  code  P84233)  and  H4 
(P62799), S.  cerevisiae Vps75  (P53853)  and S.  cerevisiae Asf1  (P32447)  were  obtained 
from  the  Luger  laboratory  (University  of  Colorado  Boulder).  The S.  cerevisiae  Rtt109 
sequence  (Q07794),  codon-optimised  for  expression  in E.  coli ,  was  purchased  from 
Geneart. 
Xenopus  laevis  histones  were  used  due  to  the  better  expression  level  in E.  coli  and  high 
sequence  identity  to  the  S.  cerevisiae  H3  and  H4  (Fig.  3.1.1). 
 
Figure  3.1.1.  Comparison  of  the Xenopus  laevis  and S.  cerevisiae  histones  H3  and  H4. Left, 
sequence  alignment  of Xenopus  laevis H3/H4  (Xen),  histones  used  in  this  study  (Xen#)  and S. 
cerevisiae H3/H4  (Sc).  Fully  conserved,  strongly  similar  and  weakly  similar  residues  are  marked  as 
asterisk,  colon  and  dot,  respectively.  Right,  Xen#  H3/H4  residues  different  from  the Sc  H3/H4 
sequence  are  shown  as  sticks  and  colored  in  magenta  on  the  Rtt109 –Vps75 2 – Asf1 –H3:H4  structure 
(PDB  entry  6o22).  The  interfaces  between  Rtt109,  Vps75  and  the  histones  involve  almost  exclusively 
fully-conserved  H3/H4  residues. 
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 Asf1 2–169 ,  Rtt109  and  Vps75  were  cloned  into  pETM11  vector  (EMBL  collection);  the  Vps75 
sequence  was  also  cloned  into  pACYC184  (addgene)  and  in  araBAD  (EMBL  collection) 
vectors  for  co-expression  with  Rtt109.  pET3d  plasmids  (Luger  laboratory)  were  used  for  H3 
and  H4  expression. 
 
Asf1,  Vps75,  and  Rtt109  were  expressed  in E.  coli BL21(DE3)  cells.  Cells  were  grown  at  37 
°C,  expression  was  induced  by  addition  of  0.5  mM  IPTG  at  OD 600  =  0.6–0.8  and  continued  
for  14  –  16  hours  at  16  °C  in  LB  media  or  at  25  °C  in  99%  D 2 O  M9  minimal  media.  Cells 
were  then  harvested  by  centrifugation  for  30  minutes  at  4000g  at  4  °C  and  lysed  by 
sonication  in  25  mM  Tris–HCl  pH  7.5,  500  mM  NaCl,  5  mM β-mercaptoethanol  ( BME)  with 
the  addition  of  1×  protease  inhibitors  cocktail  (Roche),  0.25  mg/ml  lysozyme,  and  1  µg/ml 
DNase  I. 
 
Vps75  was  purified  by  immobilized-metal-ion  affinity  chromatography  (IMAC)  with  a  HisTrap 
HP  5  ml  column  (GE  Healthcare).  The  column  was  equilibrated  and  washed  with  the  HisTrap 
wash  buffer  (25  mM  Tris–HCl  pH  7.5,  500  mM  NaCl,  5  mM  BME,  20  mM  imidazole)  and 
Vps75  was  eluted  with  a  0  –  100%  gradient  of  the  elution  buffer  (25  mM  Tris–HCl  pH  7.5, 
500  mM  NaCl,  5  mM  BME,  400  mM  imidazole)  over  20  column  volumes  (CVs).  The  tagged 
protein  was  incubated  with  TEV  protease  (added  in  1:50  protease:protein  ratio)  overnight  at 
4  °C.  The  cleaved  protein  was  isolated  by  affinity  purification  with  a  Histrap  HP  column. 
Cleaved  Vps75  was  further  purified  by  ion-exchange  with  a  Hi-trap  Q  5  ml  column  (GE 
Healthcare)  in  25  mM  Tris–HCl  pH  7.5,  5  mM  BME  with  a  gradient  from  0.15  to  1  M  NaCl 
over  20  CV  and  size-exclusion  chromatography  (SEC)  with  a  Superdex  S200  16/60  column 
in  25  mM  Tris–HCl  pH  7.5,  500  mM  NaCl,  5  mM  BME.  Asf1  was  purified  identically  to  Vps75, 
except  for  a  different  imidazole  gradient  (10  mM  –  500  mM  over  15  CV).  Rtt109  was  purified 
identically  to  Vps75,  except  for  the  ion-exchange  step,  which  was  performed  with  a  Heparin 
HP  5  ml  column  (GE  Healthcare)  in  25  mM  Tris–HCl  pH  7.5,  5  mM  BME,  gradient  from  0.3  to 
1  M  NaCl  over  15  CV. 
 
Expression  and  purification  of  histones  H3  and  H4  was  customised  based  on  the  protocols 
from (Luger et  al ,  1999)  and (Klinker et  al ,  2014) ,  which  rely  on  expression  in  inclusion 
bodies  and  refolding.  The  pET3d  plasmid  containing  either  H3  or  H4  was  transformed  into  E. 
coli BL21(DE3)pLysS  cells.  Expression  was  induced  at  OD 600  =  0.6  with  addition  of  0.2  mM  
IPTG  and  continued  at  37  °C  for  the  next  2.5  hours  in  LB  media  or  for  the  next  6  –  8  hours  in 
99%  D 2 O  minimal  media.  Cells  expressing  either  H3  or  H4  were  harvested  by  centrifugation 
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 for  30  min  at  4000g  at  4  °C,  resuspended  in  wash  buffer  (50  mM  Tris-HCl,  pH  7.5,  100  mM 
NaC1,  1  mM  Na-EDTA,  5  mM  BME)  and  lysed  by  sonication  on  ice.  Pellets  containing 
inclusion  bodies  were  washed  twice  with  Triton  wash  buffer  (50  mM  Tris-HCl,  pH  7.5,  100 
mM  NaC1,  1  mM  Na-EDTA,  5  mM  BME  1%  volume/volume  Triton  X-100)  and  twice  with 
wash  buffer.  Pellets  were  then  solubilized  in  the  unfolding  buffer  (7  M  guanidinium 
hydrochloride,  20  mM  Tris-HCl,  pH  7.5,  10  mM  DTT).  Solubilized  histones  were 
buffer-exchanged  into  SAU-200  buffer  (7  M  deionized  urea,  20  mM  sodium  acetate,  pH  5.2, 
5  mM  BME,  1  mM  Na-EDTA,  200  mM  NaCl)  using  a HiPrep  26/10  desalting  column,  which 
was  followed  b y  an  ion-exchange  step  with  HiTrap  Q  5ml  column  in  SAU-200.  The 
ion-exchange  flow-through  was  collected  and  loaded  onto  a  HiTrap  SP  HP,  where  it  was 
purified  with  a  gradient  from  SAU-200  wash  buffer  to  SAU-1000  elution  buffer  (7  M  deionized 
urea,  20  mM  sodium  acetate,  pH  5.2,  5  mM  BME,  1  mM  Na-EDTA,  1  M  NaCl).  H3  was 
eluted  with  the  following  gradient  of  the  SAU-1000  buffer:  0  –  15%  over  2  CV,  followed  by 
15%  of  SAU-1000  for  3  CV,  then  15  –  100%  over  8  CV.  The  gradient  steps  for  H4  were  the 
same,  except  15%  of  SAU-1000  was  changed  to  30%.  All  purification  steps  in  the  buffers 
containing  urea  were  done  at  4  °C  in  order  to  avoid  carbamylation.  Purified  histones  were 
either  used  for  reconstitution  immediately  or  flash-frozen  and  stored  at  –80  °C. 
 
Perdeuterated  and  70%  deuterated  proteins  for  SANS  measurements  were  expressed  in 
100%  D 2 O  M9  minimal  medium  supplemented  with 2 H-glycerol  or 1 H-glucose,  respectively. 
1 H, 15 N-labeled  proteins  were  produced  in  H 2 O  M9  minimal  medium  supplemented  with 
15 NH 4 Cl.  Isoleucine,  Leucine  and  Valine  (ILV)  methyl-labeled  proteins  were  expressed  in 
100%  D 2 O  M9  minimal  medium  supplemented  with  60  mg/L  of α- ketobutyric  acid  sodium  salt 
(Sigma)  and  120  mg/L  of α- ketoisovaleric  acid  sodium  salt  (Sigma),  added  40  minutes 
before  the  induction.  Pro-S  LV  methyl  labeling  was  achieved  with  the  NMR-Bio  precursor 
(DLAM-LV proS  kit).  Labeled  proteins  were  purified  identically  to  the  unlabelled  ones  with  an  
exception  for  Rtt109.  Perdeuterated  or  70%  deuterated  full-length  Rtt109  was  co-expressed 
with  Vps75  in  order  to  increase  the  stability  of  Rtt109  and  reduce  the  amount  of  required 
minimal  media  and  precursors. E.  coli BL21(DE3)  cells  were  transformed  with  both  pETM11 
and  pACYC184  vectors  carrying  Rtt109  and  Vps75,  respectively.  Expression  and  cell  lysis 
were  performed  as  described  above.  Both  histidine-tagged  proteins  were  purified  with 
HisTrap,  after  which  Rtt109  was  separated  from  Vps75  with  a  Heparin  column  (25  mM 
Tris–HCl  pH  7.5,  5  mM  BME,  gradient  from  0.3  to  1  M  NaCl  over  15  CV).  The  C-terminally 
truncated  Rtt109  (Rtt109 1-424 )  could  not  be  separated  from  Vps75  by  ion-exchange 
chromatography.  Thus,  Rtt109 1-424  was  expressed  and  purified  without  Vps75,  independent  
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 of  the  labelling  scheme.  The  expression  and  purification  protocol  for  Rtt109 1-424  was  identical  
for  the  full-length  unlabelled  Rtt109. 
 
Final  protein  concentrations  were  determined  by  UV  absorption  using  the  following  molar 
extinction  coefficients  ( ε molar ,  in  M -1  cm -1 ) : 4470  for  H3;  5960  for  H4;  43890  for Vps75;  21430  
for  Asf1;  49850  for  Rtt109. 
3.2.  Reconstitution  of  the  Asf1–H3:H4–Rtt109–Vps75 2  
complex. 
 
The  complex  reconstitution  consisted  of  three  main  steps,  involving  a  preparation  of  the 
H3:H4  dimer  and  the  reconstitution  of  the  Asf1–H3:H4  sub-complex  at  high  salt 
concentration,  and  a  final  step  consisting  of  mixing  the  Asf1–H3:H4  and  the  Rtt109–Vps75 2  
sub-complexes  at  lower  salt  concentration  (150  mM  NaCl)  in  order  to  allow  for  the  formation 
of  the  full  complex.  The  best  results  were  obtained  when  the  Asf1–H3:H4  sub-complex  was 
kept  in  high  salt  (>  0.5  M  NaCl)  and  at  4  °C  until  mixed  with  the  Rtt109–Vps75 2  by  fast  
pipetting  in  the  NMR/SANS  buffer  (50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM 
BME).  Subsequent  addition  of  first  Vps75 2  and  then  Rtt109  to  the  Asf1–H3:H4  sub-complex  
lead  to  the  same  result  as  addition  of  the  Rtt109–Vps75 2   sub-complex. 
Histones  H3  and  H4  were  mixed  in  equimolar  ratio  in  7  M  urea,  10  mM  Tris–HCl  pH  7.5,  1  M 
NaCl,  1  mM  Na-EDTA,  5  mM  BME  and  dialysed  at  4  °C  into  the  refolding  buffer  (10  mM 
Tris–HCl  pH  7.5,  2  M  NaCl,  1  mM  Na-EDTA,  5  mM  BME).  The  H3:H4  dimer  was  then 
separated  by  SEC  in  refolding  buffer.  The  Asf1–H3:H4  sub-complex  was  prepared  by  mixing 
the  H3:H4  dimer  with  Asf1  at  a  1:1.1  molar  ratio  in  50  mM  Tris–HCl  pH  7.5,  0.5  M  NaCl,  5 
mM  BME  followed  by  SEC. 
The  Rtt109–Vps75 2  sub-complex  was  reconstituted  with  a  1.1:1  Rtt109:Vps75 2  ratio  in  the   
NMR/SANS  buffer  and  subsequently  purified  by  SEC. 
The  full  complex  was  assembled  by  mixing  the  two  sub-complexes  in  a  1:1  ratio  followed  by 
a  SEC  in  the  NMR/SANS  buffer.  All  size-exclusion  chromatography  runs  were  performed 
with  a  Superdex  S200  10/300  column  (GE  Healthcare). 
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 3.3.  Size  exclusion  chromatography  -  multi  angle  light 
scattering  (SEC-MALS)  experiments. 
The  molecular  weights  of  the Rtt109–Vps75  and  Asf1–H3:H4–Rtt109–Vps75 2 complexes 
were  verified  by  SEC-MALS.  The  experiments  were  performed  on  an  AKTA  Pure  system  at 
room  temperature  (25 °C) using  a Superdex  S200  10/300  column  (GE  Healthcare)  in-line 
with  the  refractive  index  detector  Optilab  T-rEX  and  the  miniDAWN  TREOS  MALS  detector 
(WYATT  technology) .  The  data  was  collected  and  analyzed  using  the ASTRA  7.1.4  software 
(WYATT  technology). 
 
All  samples  were  run  in the  NMR/SANS  buffer.  The  Asf1–H3:H4–Rtt109–Vps75 2 sample  was 
obtained  by  mixing Rtt109–Vps75 2  and Asf1–H3:H4  sub-complexes  in  a  1:1  molar  ratio,  the  
sample  concentration  was  6.5  mg/mL.  The Rtt109 2 –Vps75 2  sample  was  prepared  by  mixing  
Rtt109  and  Vps75  in  a  2:2  molar  ratio  in  the  NMR/SANS  buffer,  the  sample  concentration 
was  4.3  mg/mL.  Before  each  experiment  the  delay  volume  was  calibrated  with  bovine  serum 
albumin  (BSA). The  refractive  index  and  viscosity  of  the  NMR/SANS  buffer  were  defined  as 
1.331  and 1.05 cP .  The  dn/dc  (refractive  index  increment  value)  was  set  to  0.185  mL/g 
(default  value  for  protein  samples). 
3.4.  NMR  assignment  of  methyl  groups  and  backbone. 
Assignment  experiments  for  Vps75  were  performed  on 2 H, 13 C, 15 N-ILV-methyl-protonated 
Vps75 1–225  at  0.8  mM  protein  concentration  in  20  mM  Tris–HCl  pH  7.5,  200  mM  NaCl,  1  mM  
DTT  at  300  K.  The  assignment  strategy  is  described  below  and  schematically  shown  in  Fig. 
3.4.1. 
Backbone  amide  resonances  were  assigned  using  TROSY-HNCA,  TROSY-HNCO, 
TROSY-HN(CA)CO,  TROSY-HN(CO)CA  and  TROSY-HNCACB  experiments (Salzmann et 
al ,  1998) .  A  subset  of  the  ILV  methyl  resonances  (I28,  I54,  I60,  I127,  I138,  I155,  I160,  I179, 
V121,  L16  &  L223)  were  assigned  through  Ile,Leu-(HM)CM(CGCBCA)NH  and 
Val-(HM)CM(CBCA)NH  experiments (Tugarinov  &  Kay,  2003) .  Methyl  resonances  of  I28,  I54, 
I72,  I127,  V25,  V32,  V61,  V124,  V213  &  L188  were  assigned  or  verified  via  point  mutations. 
The  remaining  methyl  resonances  were  assigned  using  a  4D  HCCH  HMQC-NOESY-HMQC 
spectrum  recorded  with  non-uniform  sampling  (NUS) (Vuister et  al ,  1993)  in  combination 
with  the  predicted  NOEs  from  the  PDB  entry  2zd7 (Vuister et  al ,  1993;  Park et  al ,  2008) . 
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 Stereospecific  assignment  of  the  L  and  V  methyl  resonances  was  achieved  using  pro-S 
LV-labeling.  Identification  of  the  prochiral  methyl-groups  of  L/V  residues  was  performed  with 
a  3D  experiment  designed  by  Dr.  J.  Kirkpatrick,  in  which  the 1 H  and 13 C  resonances  of  the 
methyl  groups  were  correlated  with  the 13 C  resonances  of  Cγ  and  Cβ  of  leucines  and 
valines,  respectively. 
 
Figure  3.4.1.  Workflow  chart  for  the  assignment  of  the  ILV  methyl  resonances  of  Vps75 1–225 . 
 
The  ILV  methyl-group  assignments  were  then  transferred  from  Vps75 1–225  to  the  free  
full-length  Vps75  in  the  NMR/SANS  buffer  and  then  to  the  Vps75  in  the  full  complex 
following  the  CSPs  in  Vps75  titrations  with  Asf1–H3:H4  or  Rtt109  (Figure  4.7.1). 
 
The  backbone  amide  resonances  of  the  Vps75  C-terminal  acidic  domain  (CTAD,  residues 
226–264)  were  assigned  using  HNCO,  HNCACB  and  HN(CO)CACB  experiments (Grzesiek 
&  Bax,  1992;  Wittekind  &  Mueller,  1993;  Ikura et  al ,  1990a)  recorded  on 1 H, 13 C, 15 N-labeled 
full-length  Vps75  at  0.6  mM  in  the  NMR/SANS  buffer. 
 
Isoleucine  methyl  resonances  of  Rtt109  were  assigned  with  a  3D  (H)CCH 
HMQC-NOESY-HMQC  spectrum  recorded  on  perdeuterated, 13 C, 1 H-methyl-I-labeled  Rtt109 
at  ~0.6  mM  in  complex  with  perdeuterated  Vps75  in  100%  D 2 O  NMR/SANS  buffer. 
Experimental  NOEs  were  compared  to  those  predicted  from  PDB  entry  3q66 (Tang et  al , 
2011) .  Prediction  of  NOEs  expected  from  the  structure  was  done  by  selection  of  pairs  of  Ile, 
Leu  and  Val  methyl  groups  which  are  closer  than  6.5  Å  to  each  other. 
 
Assignment  experiments  for  the  histones  were  recorded  on  0.66  mM 
13 C, 1 H-methyl-ILV-labeled  H3:H4  in  complex  with  perdeuterated  Asf1  in  20  mM  Tris–HCl  pH 
7.5,  1  M  NaCl,  1  mM  Na-EDTA,  5  mM  BME  in  100%  D 2 O.  The  methyl  groups  were  assigned 
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 with  3D  (H)CCH-HMQC-NOESY-HMQC  and  3D  HCH  HMQC-NOESY (Ikura et  al ,  1990b; 
Zuiderweg et  al ,  1990)  spectra  in  combination  with  the  NOEs  predicted  from  PDB  entry  2hue 
(English et  al ,  2006) .  To  facilitate  the  assignment,  methyl  resonances  belonging  to  H4  were 
identified  from  a 13 C-HMQC  spectrum  of  ILV  methyl-labeled  H4  in  the  context  of  the 
Asf1–H3:H4  complex. 
 
The  Asf1  assignment  was  performed  by  Dr.  L.  Lercher  and  described  in (Lercher et  al , 
2018) . 
 
Chemical  shift  perturbations  (CSPs)  were  calculated  according  to: 
 
Where  δ H  is  the  distance  between 1 H  chemical  shifts,  δ C is  the  distance  between 13 C  
chemical  shifts,  δ N  is  the  distance  between  15N  chemical  shifts;  0.3  and  0.15  are  the  scaling  
factors  applied  to  weight  δ C   and  δ N   respectively  (Williamson,  2013) . 
3.5.  Paramagnetic  relaxation  enhancement  (PRE)  experiments 
and  generation  of  the  M3  distance  restraints. 
PRE  datasets  were  acquired  for  eight  paramagnetic  tags  located  at  different  positions  on  the 
H3:H4  dimer  to  measure  distance-restraints  to  Vps75-  or  Rtt109-methyl  groups  in  the 
Asf1–H3:H4–Rtt109–Vps75 2  complex  (H3  R63C,  H3  Q76C,  H4T30C,  H4  R45C,  H4  T82C,  
H4  Q93C  to  Vps75;  H3  K115C  and  H4  Y98C  to  Rtt109). 
 
Single-cysteine  mutations  were  introduced  in  H4  or  in  H3-C110A,  where  the  wild-type 
cysteine  was  substituted  by  alanine.  Mutated  histones  were  then  purified  and  refolded  as  the 
wild-type  proteins,  followed  by  SEC  in  the  refolding  buffer  without  reducing  agent  (10  mM 
Tris–HCl  pH  7.5,  2  M  NaCl).  The  paramagnetic  agent  (3-(2-iodoacetoamido)-PROXYL 
radical  (Sigma-Aldrich,  cat.  no.  253421)  was  added  to  the  H3(C110A):H4  dimer  containing 
the  single  cysteine  mutation  immediately  after  the  SEC  step.  The  coupling  between  the 
paramagnetic  agent  and  the  free  cysteine  was  allowed  to  proceed  overnight  at  4  °C  in  the 
dark.  The  unreacted  paramagnetic  agent  was  removed  during  an  additional  SEC  step  in  10 
mM  Tris–HCl  pH  7.5,  2  M  NaCl,  after  which  H3(C110A):H4  dimers,  containing  the 
paramagnetic  tag,  were  used  for  reconstitution  of  the  complex.  Prior  to  complex 
reconstitution,  performed  as  described  in  section  3.2,  Rtt109,  Vps75,  and  Asf1  were 
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 exchanged  into  the  NMR/SANS  buffer  with  no  reducing  agent  using  a  HiPrep  26/10 
desalting  column  (GE  Healthcare).  The  complexes  were  measured  in  99%  D 2 O  NMR/SANS 
buffer  without  BME on  a  Bruker  Avance  III  850  MHz  spectrometer  equipped  with  a  TCI 
cryoprobe  at  298  K .  Sample  concentrations  varied  between  30  and  90  µ M. 
 
1 H- 13 C  HMQC  spectra  were  acquired  for  the  paramagnetic  and  diamagnetic  (reduced  with  2 
mM  ascorbic  acid)  states  of  the  complexes.  In  order  to  derive  the  peak  intensity  in  the 
paramagnetic  ( I para )  and  the  diamagnetic  ( I dia )  states,  the  peaks  were  fitted  with  FuDA 
(Hansen  Laboratory, https://www.ucl.ac.uk/hansen-lab/fuda/ )  assuming  Lorentzian 
line-shapes  (spectra  were  processed  using  exponential  apodization  in  both  dimensions). 
Overlapped  peaks  were  fitted  as  groups. 
 
The  fitted  volumes  and  line-widths  from  FuDA  were  converted  into  peak-heights  using: 
 I = V
Lw LwH C
  (23) 
where I  is  the  peak  height, V  is  the  peak  volume  and LW H and LW C are  the  fitted  line-widths  
in  the 1 H  and 13 C  dimensions,  respectively.  The  peak-height  ratios  (I para /I dia )  were  calculated 
for  each  data  set  and  the  experimental  errors  for  each  I para /I dia  ratio  were  derived  by  the  error  
propagation  rules  from  the  standard  deviation  of  the  noise  in  the  HMQC  spectra. 
 
In  case  of  Vps75  only  well-resolved  peaks  unambiguously  corresponding  to  Vps75(A)  or 
Vps75(B)  were  used  to  quantify  distances  between  H3:H4  and  ILV  methyl-labeled  Vps75. 
Additional  peaks  were  fitted  for  the  data-sets  recorded  with  H3-Q76C  and  H4-T82C,  where 
preliminary  structural  calculations,  as  well  as  the  intensity  ratios  obtained  for  the 
well-resolved  peaks  of  Vps75(B),  indicated  that  the  paramagnetic  tags  are  far  away  from  the 
Vps75(B)  earmuff  domain  (>  40 Å) .  This  allowed  the  selection  of  five  additional  peaks,  for 
which  only  one  of  the  two  overlapped  resonances  of  Vps75(A)  and  Vps75(B)  was  assumed 
to  be  affected  by  the  paramagnetic  tag.  Hence,  the  ( I para / I dia )  height  ratio  of  the  portion  of  the 
peak  corresponding  to  Vps75(B)  was  presumed  to  be  equal  to  1  and  resulting  restraints 
were  set  unambiguously  to  Vps75(A)  and  Vps75(B).  In  addition,  the  peaks  for  L159  were 
fitted  for  all  datasets  despite  the  overlap:  the  distance  between  the  methyl  groups  of  L159  in 
Vps75(A)  and  Vps75(B)  was  sufficient  to  assume  that  only  one  of  these  residues  could  be 
affected  by  the  paramagnetic  tag  regardless  of  the  tag  position.  In  this  case,  the I para / I dia  
ratios  were  calculated  as  described  above,  but  the  resulting  restraints  were  assigned 
ambiguously  to  either  Vps75(A)  or  Vps75(B). 
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 Diamagnetic  transverse  relaxation  rates  for  the 1 H  single-quantum  coherence  ( R 2 diaH )  and  the 
1 H- 13 C  double-quantum  coherence  ( R 2 diaHC )  were  quantified  using  the  pulse  schemes 
reported  in (Korzhnev et  al ,  2004;  Tugarinov  &  Kay,  2006,  2013) .  Relaxation  delays  for  the 
quantification  of R 2 diaHC  of  both  Vps75  and  Rtt109  methyl  resonances  were  0,  2,  4,  7,  10,  13  
&  20  ms.  Relaxation  delays  for  the  quantification  of R 2 diaH  were  0,  2,  4,  6,  8,  10,  13  &  16  ms  
for  Vps75  resonances,  and  0,  3,  6,  9,  12,  16  &  20  ms  for  Rtt109  resonances.  The 
peak-heights  were  fitted  to  a  mono-exponential  decay  function  to  extract  R 2 diaH   and  R 2 diaHC . 
 
The  resulting  R 2 diaH ,  R 2 diaHC   and  the  I para / I dia   values  were  used  to  calculate  the  transverse  PRE 
rates  ( Γ 2 )  according  to  equation  (13),  section  1.5: 
 
where t hmqc ,  equal  to  7.7  ms,  is  the  total  duration  of  the  constant-time  delays  in  the 
13 C-HMQC  pulse-sequence  during  which  the  magnetization  is  transverse  on 1 H.  The  PRE 
rates  were  converted  into  distances  using  equation  (12),  section  1.5: 
 
where K  is  a  constant  (1.233×10 –23  cm 6 s -2 ),  ω  is  the  proton  Larmor  frequency  and 𝜏 c  is  the   
correlation  time  of  the  electron–nucleus  vector  (81  ns).  The  correlation  time  was  estimated 
by  measuring  the  PRE  values  of  Vps75  methyl  groups  in  the  presence  of  a  paramagnetic  tag 
on  Vps75-E56C  as  part  of  the  full  complex.  The  measured  PRE  values  were  used  as 
restraints  for  the  simultaneous  optimization  of  the  tag  conformations  and 𝜏 c via  the  PRE 
potential  function  in  Xplor-NIH  developed  by (Iwahara et  al ,  2004)  using  a  protocol  written  by 
Nick  Anthis. The  minimization  was  run  for  20  structures  with  the  “obsig”  setting  for 
error-weighting  of  the  PREs,  which  yielded  a  𝜏 c   of  81±7  ns. 
The  above-described  protocol  to  derive  the  distances  from  the  PRE  measurements  was 
developed  in  our  group  by  Dr.  J.  Kirkpatrick,  who  also  kindly  provided  the  scripts  for  the 
extraction  of  the  peak  heights,  PRE  rates  and  𝜏 c . 
 
The  resulting  distances  were  converted  into  M3  restraints  as  follows:  the  restraints  were  set 
between  the  Cβ  of  the  tagged  residues  and  the  corresponding  methyl  groups;  in  order  to 
account  for  the  tag  length  and  flexibility,  an  error  of  ±  6  Å  was  added  to  the  experimental 
error.  For I para / I dia  ratios  below  0.2  the  distance  was  set  between  2.0  and  18.0  Å;  for I para / I dia  
ratios  above  0.8  the  distance  was  set  between  24.0  and  99.0  Å.  The  distances 
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 corresponding  to  the I para / I dia  ratios  below  0.2  and  above  0.8  were  estimated  from  the  
Vps75-E56C  dataset. 
3.6.  Small-angle  neutron  scattering. 
SANS  experiments  were  performed  on  complexes  reconstituted  with  different  combinations 
of  uniformly  perdeuterated,  70%  deuterated  and  protonated  proteins  were  measured  in  the 
SANS  buffer  containing  0%,  42%  or  100%  D 2 O. The  complex  concentrations  varied  between 
11,5  and  36  μM  (1.9  mg/mL  and  6  mg/mL  concentration  of  both  scattering  and 
contrast-matched  proteins)  (Appendix  1). 
 
Seven  measurements  were  carried  out  at  the  KWS-1  beamline (Frielinghaus et  al ,  2015)  at 
the  Juelich  Centre  for  Neutron  Sciences  (JCNS  outstation  at  MLZ,  Garching,  Germany).  Two 
detector  configurations  of  1.5  m  and  4  m  were  used  for  each  sample  with  a  collimation 
length  of  4  m  and  a  neutron  wavelength  of  5  Å.  The  remaining  experiments  were  performed 
at  the  D22  instrument  at  the  Institut  Laue-Langevin  (ILL,  Grenoble,  France)  with  a 
sample-detector  distance  of  4  m,  collimation  length  of  4  m  and  a  neutron  wavelength  of  6  Å. 
 
All  samples  were  measured  at  298  K.  Data  reduction  and  radial  integration  were  carried  out 
according  to  the  standard  procedures  with  ILL  and  JCNS  specific  software.  Buffer 
subtraction  was  done  with  PRIMUS (Konarev et  al ,  2003) .  Fits  of  the  experimental  data  to 
the  models  were  performed  with  CRYSON  (Svergun  et  al ,  1998)  . 
 
The ab  initio  models  of  the  Rtt109−Vps75 2 −Asf1−H3:H4,  Rtt109−Vps75 2 1–225 −Asf1−H3:H4 
and  Rtt109−Vps75 2 1–225 −Asf1−H3 35–135 :H4  complexes  were  generated  with  DAMMIF (Franke 
&  Svergun,  2009) .  20  independent ab  initio  models  were  calculated  for  each  complex  and 
averaged  with  DAMAVER.  The  averaged  ab  initio  models  were  then  filtered  with  DAMFILT. 
3.7.  Structure  calculation. 
The  structural  models  of  Rtt109−Vps75 2 −Asf1−H3:H4  complexes  were  calculated  with  the 
M3  protocol  (Karaca  et  al ,  2017)  employing  HADDOCK  2.2. 
The  building  blocks  were  defined  as  Asf1−H3:H4  and  Rtt109−Vps75 2  sub-complexes.  The  
structure  for  the  Asf1–H3:H4  building  block  was  extracted  from  the  PDB  entry  2hue  (the 
structure  included  Asf1 1-164 ,  H3 60-134 ,  H4 20-101 ).  The  second  building  block  was  comprised  of  an 
ensemble  of  ten  Rtt109–Vps75 2  structures  (all  structures  included  Rtt109 1-418 ,  Vps75(A) 9-225 ,  
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 Vps75(B) 2-231 ).  The  Rtt109–Vps75 2  conformers  were  generated  by  a  400-ns  MD  simulation  
(described  in  section  3.8)  and  selected  with  respect  to  the  normalized consensus  𝜒 2 between  
the  calculated  and  experimental  SANS  curves  of  the  complexes  containing 2 H-Vps75 1–225  
and  2 H-Rtt109/ 2 H-Vps75 1–225 .  The  normalized  𝜒 2   was  calculated  as:  
 
where 𝜒 2 norm  is  the  normalized 𝜒 2 , 𝜒 2 min  and 𝜒 2 max  are  the  minimal  and  maximal 𝜒 2  for  the     
dataset,  respectively. 
 
The  M3  docking  was  driven  by  145  unique  PRE-derived  distance  restraints  between 
Vps75/Rtt109  and  H3/H4  (described  in  section  3.5).  An  additional  restraint  was  added  to 
loosely  limit  the  distance  between  the  Rtt109  C-terminus  and  Asf1  to  ensure  that  the  Rtt109 
C-terminal  tail  can  interact  with  Asf1  as  reported  in (Lercher et  al ,  2018) .  The  complete 
restraint  table  can  be  found  in  the  appendi x  2. 
 
The  rigid  body  docking  stage  (it0)  was  performed  with  the  default  HADDOCK  parameters, 
sampling  of  180°-rotated  molecules  was  disabled.  As  standard  in  HADDOCK,  all  residues 
were  kept  rigid  at  this  stage.  The  resulting  5,000  structures,  corresponding  to  50,000 
sampled  conformers,  were  ranked  using  a  restraint  energy-based  scoring.  The E exp  violation  
energy  represents  the  agreement  between  the  experimental  and  back-calculated  distance 
restraints.  Only  15  structures  with  significantly  lower  ln( E exp )  values  were  identified  as  outliers 
in  box-and-whisker  plots  with  a  whisker  length  of  two  times  the  interquartile  range.  Each  of 
these  15  structures  was  submitted  to  ten  independent  runs  of  flexible  docking  (it1).  The 
following  parameters  were  changed  to  allow  an  extended  search  during  it1:  the  temperature 
of  the  rigid-body  torsion-angle-dynamics  (TAD)  search  was  increased  to  5,000  K;  the 
number  of  steps  was  increased  to  20,000;  the  number  of  rigid-body  cooling  steps  was 
increased  to  20,000;  the  factor  time  step  of  annealing  was  decreased  to  4.  During  this  stage 
side-chains  of  residues  at  the  interfaces,  defined  by  HADDOCK  based  on  the  analysis  of 
intermolecular  contacts  within  a  5-Å  cut-off,  were  flexible. 
 
The  resulting  150  structures  were  scored  against  the  6  SANS  datasets  using  CRYSON.  The 
𝜒 2  values  for  different  datasets  were  individually  normalized  using  rank-preserving  
normalization  (equation  5). The  fitness  parameter  represented  the  sum  of  six 𝜒 2 norm  values  
corresponding  to  the  structure  and  evaluated  the  overall  fit  of  the  structures  to  the  SANS 
data.  The  structures  were  then  clustered  by  orientational  RMSD  (o-RMSD),  which  was 
56 
 calculated  using  the  scripts  adapted  from https://github.com/ezgikaraca/ISD-files (Karaca et 
al ,  2017) .  The  cluster  containing  the  structure  with  the  best  fitness  to  the  SANS  data  was 
defined  as  the  best  cluster  (green  in  Fig.  4.4.6).  33  members  were  selected  from  this  cluster 
to  represent  the  final  ensemble;  the  selected  structures  had  better  fitness  than  any  member 
of  the  second  best  cluster.  The  structure  with  the  lowest  average  backbone 
root-mean-square  deviation  (RMSD)  to  the  33  selected  structures  was  chosen  for  further 
minimization  in  water  (described  in  section  3.8)  and  subsequent  deposition  to  the  PDB  (entry 
6o22). 
3.8.  Molecular  dynamics  simulations. 
MD  simulations  for  the  selection  of  the  Rtt109–Vps75 2  building  blocks  were  set  up  by  Dr.  L.  
Lercher  and  described  in (Danilenko et  al ,  2019) .  The  PDB  entry  3q66  was  selected  as  a 
starting  structure.  The  simulation  was  performed  at  298  K  with  Gromacs  5.1.1  and  the 
AMBER99SB-ILDN  force-field (Abraham et  al ,  2015;  Lindorff-Larsen et  al ,  2010;  Price  & 
Brooks,  2004) .  The  system  consisted  of  a  dodecahedral  box,  filled with  explicit  TIP3P  water 
( (Abraham et  al ,  2015;  Lindorff-Larsen et  al ,  2010;  Price  &  Brooks,  2004) ).  The Na +  and  Cl –   
ions  were  added  to  neutralize  the  total  charge.  The  system  was  minimized  with  the  steepest 
descent  method  and  then  subjected  to  a  two-phase  solvent  equilibration  step:  as  a  canonical 
ensemble  (NVT)  and  as  a  isothermal-isobaric  ensemble  (NPT)  for  1  ns  each.  The 
unrestrained  MD  simulation  was  then  allowed  to  proceed  for  400  ns.  The  Rtt109–Vps75 2  
conformers  were  extracted  from  each  1  ns  frame,  resulting  in  400  structures. 
 
The  MD  simulation  for  the  water  refinement  of  the  Rtt109−Vps75 2 −Asf1−H3:H4  complex  was 
performed  at  300  K  using  AMBER  2018  with  the  AMBER14SB  force-field  (Maier et  al ,  2015; 
Case et  al ,  2018).  The  experimental  structure  of  the  complex,  calculated  as  described  in 
section  3.7,  was  used  as  a  starting  conformation.  The  system  was  simulated  in  explicit 
TIP3P  water  and  consisted  of  a  cubic  box  with  dimensions  of  138.22,  134.21  and  117.14  Å. 
The  box  encompassed  a  water-layer  of  14  Å  thickness  to  account  for  instabilities  in  the 
electrostatic  potential.  The  total  charge  was  neutralized  by  addition  of  Na +  and  Cl –  ions,   
additional  ions  were  also  included  to  match  the  experimental  NaCl  concentration  (150  mM). 
The  system  minimization  was  done  in  two  stages.  First,  the  solvent  was  equilibrated  for 
20,000  steps  with  NPT  and  heated  to  300  K  with  NVT.  Next,  the  complete  system  was 
minimized  for  20,000  steps,  and  heated  to  300  K  with  the  same  procedure.  Finally,  the 
system  was  relaxed  with  restraints  on  the  protein  heavy  atoms  with  NPT  for  0.5  ns  at  300K. 
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 The  system  was  subjected  to  an  additional  10  ns  MD  equilibration  run  and  the  resulting 
structure  was  deposited  as  PDB  entry  6o22. 
 
MD  simulations  to  explore  the  dynamics  of  the  H3 35–59  tail  within  the  
Rtt109−Vps75 2 −Asf1−H3:H4  complex  consisted  of  three  stages:  system  minimization, 
equilibration  and  production  run.  The  system  minimization  and  equilibration  were  performed 
as  described  above  for  the  Rtt109−Vps75 2 −Asf1−H3:H4  complex.  The  starting  structure  was 
modified  by  the  covalent  addition  of  the  H3 35–59  tail  with  Chimera  Modeller (Pettersen et  al ,  
2004) ,  by  K290  acetylation  and  by  the  non-covalent  addition  of  acetyl  coenzyme  A  (acCoA) 
with  PYMOL  (Schroedinger et  al ,  2015).  The  latter  modification  was  achieved  by  alignment 
of  the  Rtt109  molecule  from  the  complex  model  to  the  Rtt109  structure  from  PDB  entry  3q35 
and  subsequent  replacement  of  the  coordinates.  The  replaced  coordinates  included  residues 
191–213,  corresponding  to  the  acCoA  binding  loop,  and  addition  of  acCoA.  Partial  charges 
and  specific  improper  angles  of  acCoA  and  acetylated  lysine  were  generated  according 
to (Papamokos et  al ,  2012) .  The  complex  structure  with  H3-K56  placed  in  the  Rtt109  catalytic 
pocket  was  obtained  via  a  100  ns  MD  production  run  with  center-of-mass  restraints  on  each 
protein  and  a  restraint  between  H3-K56  and  acCoA.  Two  resulting  complex  structures  (with 
the  extended  H3 35–59  conformation  or  the  H3 35–59  conformation  with  H3-K56  in  the  Rtt109   
active  center)  were  then  subjected  to  100  ns  MD  production  runs  with  center-of-mass 
restraints  on  the  proteins.  These  production  runs  were  analyzed  to  study  the  conformational 
preference  of  the  H3  N-terminal  region  and  its  dependence  on  the  starting  conformation. 
 
Analysis  of  the  trajectories  was  performed  with  CPPTRAJ  and  VMD  v  1.9.4a29 (Humphrey 
et  al ,  1996) . 
The  set  up  of  the  system  (choice  of  the  force-field,  including  parameters  for  the  acetylated  K 
and  acCoA,  optimisation  of  the  system  minimization  and  equilibration  parameters)  was  done 
by  Dr.  L.  Codutti. 
3.9.  Activity  assays. 
Acetylation  activity  of  Rtt109  was  quantified  using  the  dot-blot  technique.  The  Asf1–H3:H4 
and  Rtt109–Vps75 2  sub-complexes  were  reconstituted by  mixing  the  individual  components  
followed  by  SEC  (Superdex  S200  10/300;  10  mM  HEPES,  pH  8.0,  0.1  M  NaCl,  5  mM  BME 
for Rtt109–Vps75 2 ;  10  mM  HEPES,  pH  8.0,  0.5  M  NaCl,  5  mM  BME  for  Asf1−H3:H4) . 
Acetylation  reactions  were  performed  using  0.2 µ M  Rtt109–Vps75 2  sub-complexes,  0.2 µ M  
Asf1–H3:H4  and  2 µ M  Ac-CoA  in  10  mM  HEPES  pH  8.0,  100  mM  NaCl.  Reactions  were 
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 stopped  with  0.5  M  sodium  acetate,  pH  5.5;  1.6 µ L  of  the  reaction  mixtures  were  spotted  on 
a  nitrocellulose  membrane.  Membranes  were  air-dried  for  ca.  30  min,  blocked  for  30  min  in 
5%  nonfat  dry  milk–TBST  buffer  (20  mM  Tris–HCl  pH  7.5,  150  mM  NaCl,  0.05%  Tween-20), 
and  subsequently  incubated  for  1  h  in  a  1:2000  dilution  of  primary  antibody  in  TBST:  rabbit 
anti-histone  H3  (acetyl  K9)  (ab4441  Abcam,  lot  no.  lot  no.  GR304381-1  for  the  experiments 
in  Fig.  4.3.4,  GR3229436-1  for  the  remaining  experiments)  or  rabbit  anti-histone  H3  (acetyl 
K56)  (SAB5600015  Sigma,  lot  no.  P1100739).  The  membranes  were  then  washed  three 
times  with  TBST  buffer  and  incubated  for  1  h  with  the  secondary  antibody,  anti-rabbit  IgG 
(whole  molecule)  alkaline  phosphatase  (A3687  Sigma,  lot  no.  SLBK3154V),  1:10000 
solution  in  TBST.  After  three  washes  with  TBST  buffer,  the  blots  were  developed  with 
BCIP®/NBT  Liquid  Substrate  System  (B1911  Sigma,  lot  no.  SLBS4876). 
 
The  intensities  of  the  dots  were  quantified  with  ImageJ.  After  background  subtraction  the 
measured  intensities  were  normalised  relative  to  the  negative  control  (reaction  without 
Rtt109–Vps75 2 ).  For  the  blots  obtained  with  H3  (acetyl  K9)  lot  no.  GR304381-1  the 
intensities  were  normalised  to  the  control  reaction  with  0.2 µ M  Asf1–H3:H4.  For  the 
remaining  experiments  (antibodies  H3  (acetyl  K9)  lot  no.  GR3229436-1;  H3  (acetyl  K56)  lot 
no.  P1100739)  the  control  reaction  with  0.2 µ M  Asf1–H3:H4  did  not  give  any  signal  above 
the  background.  An  additional  negative  control  with  6 µ M  Asf1–H3:H4,  which corresponds  to 
column  “c”  in  the  blots  of  Figs.  4.5.4,  4.6.3,  4.6.4, was  used  for  the  normalization  of  the  dot 
density  and  comparison  of  the  experimental  repeats. 
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4.  Results 
4.1.  Rtt109–Vps75  stoichiometry:  the  Vps75  dimer  accepts  one 
copy  of  Rtt109. 
The  available  crystal  structures  of  the  Rtt109–Vps75  complex (Kolonko et  al ,  2010;  Tang et 
al ,  2011;  Su et  al ,  2011)  display  two  different  stoichiometries,  1:2  and  2:2.  In  order  to  resolve 
this  controversy  and  determine  the  correct  stoichiometry  of  Rtt109:Vps75  in  the  full  catalytic 
complex,  I  reconstituted  the  Rtt109–Vps75  complex in  vitro from  individual  components 
expressed  in  E.  coli  (see  section  3.1)  and  studied  it  in  solution  with  NMR  and  SEC-MALS. 
First,  I  attempted  to  reconstitute  both  1:2  and  2:2  Rtt109–Vps75  complexes in  vitro  by  mixing 
Vps75 2  with  either  one  or  two  molar  equivalent  of  Rtt109.  While  the  1:2  complex  could  be  
isolated  by  SEC,  addition  of  more  than  one  equivalent  of  Rtt109  to  Vps75 2  resulted  in  either  
precipitation  of  excess  Rtt109  or  its  elution  in  an  unbound  state,  suggesting  that  only  the  1:2 
complex  was  formed  under  these  conditions  ( 20  mM  Tris –HCl,  300  mM  NaCl,  1mM  DTT) 
(Fig.  4.1.1). 
As  X-ray  structures  were  obtained  from  co-expression  and  co-purification  of  Rtt109  and 
Vps75,  I  also  checked  whether  both  1:2  and  2:2  complexes  (denoted  as  Rtt109–Vps75 2 and 
Rtt109 2 –Vps75 2 )  could  be  assembled  directly  in E. coli .  Rtt109  with  a  His 6 -tag  was 
co-expressed  with  untagged  Vps75,  to  allow  the  enrichment  of  the  purified  material  with 
either  Rtt109  or  any  natively  formed  Rtt109–Vps75  complex.  After  co-purification  by  affinity 
chromatography  (HisTrap),  the  sample  eluted  from  the  size-exclusion  column  as  three 
species:  high  molecular  weight  aggregates,  one  peak  containing  both  Rtt109  and  Vps75  and 
one  peak  containing  free  Rtt109.  The  fractions  containing  the  Rtt109–Vps75  complex  were 
then  loaded  onto  an  analytical  SEC  column,  where  they  eluted  as  a  single  peak  with  a 
retention  time  corresponding  to  the  Rtt109–Vps75 2  complex  reconstituted in  vitro  (Fig.  
4.1.1A).  This  result  indicates  that  also  in  E.coli  Rtt109  binds  Vps75  with  a  1:2  stoichiometry. 
Next,  I  monitored  the  formation  of  the  Rtt109 – Vps75  complex  by  NMR.  In 1 H- 13 C  HMQC 
spectra  of  ILV-labelled  Vps75 2  only  one  set  of  peaks  for  the  methyl  groups  of  chain  A  and  B  
could  be  observed,  meaning  that  Vps75  homodimer  (Vps75 2 )  is  symmetric  (Fig.  4.1.1B). 
Addition  of  1  equivalent  of  Rtt109  to  Vps75 2  resulted  in  the  splitting  of  some  peaks  into  2  
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 sets  of  peaks:  the  peaks  of  the  first  set  conserved  the  chemical  shifts  displayed  in  the 
absence  of  Rtt109,  while  the  peaks  of  the  second  set  adopted  new  chemical  shifts.  These 
chemical  shift  perturbations  (CSPs)  were  assigned  to  the  methyl  groups  of  Vps75  located  at 
the  Rtt109  binding  interface.  Therefore,  upon  addition  of  one  equivalent  of  Rtt109  to  the 
Vps75  dimer,  one  Vps75  monomer,  Vps75(A),  remains  equivalent  to  the  free  form,  while  the 
other  one,  Vps75(B) ,  binds  Rtt109. 2
 
Figure  4.1.1. Vps75  forms  a  tight  2:1  complex  with  Rtt109. A . Size  exclusion  chromatography  of 
Rtt109  (yellow),  Vps75  (blue),  Rtt109  mixed  with  Vps75  in  a  1.2:2  molar  ratio  (light  grey)  and 
co-expressed  Rtt109  and  Vps75  (dark  grey)  in  20  mM  Tris –HCl,  300  mM  NaCl,  1mM  DTT.  In  the  1.2:2 
Rtt109:Vps75  mixture  excess  of  Rtt109  elutes  in  the  free  form.  The  Rtt109 – Vps75  complex  obtained 
from  co-expression  of  the  proteins  elutes  at  the  same  volume  as  the  Rtt109 – Vps75 2  complex. B .  
Overlay  of 1 H- 13 C  HMQC spectra  of  125 μM  ILV  methyl-labelled  Vps75 2 in  isolation  (blue)  and  upon  
addition  of  1  molar  equivalent  of  Rtt109  (2:1  Vps75:Rtt109  molar  ratio;  grey).  In  isolated  Vps75 2 , 
methyl  groups  of  Vps75(A)  and  Vps75(B)  have  identical  chemical  shifts.  In  the  Rtt109 – Vps75 2  
complex,  Vps75(A)  remains  unaffected,  while  Rtt109-bound  Vps75(B)  displays  CSPs.  Schematic 
representations  of  the  models  of  Vps75 2  and  Rtt109 – Vps75 2  compatible  with  the  NMR  data  are   
displayed  on  the  right.  The  spectra  were  recorded  in 25  mM  Tris–HCl  pH  7.5,  250  mM  NaCl,  1  mM 
DTT  at  298  K  and  850  MHz . 
Upon  addition  of  the  second  equivalent  of  Rtt109,  however,  the  NMR  sample  precipitated. 
The  investigation  of  the  2:2  complex  formation  in  these  conditions  was  hindered  by  Rtt109 
instability:  Rtt109  is  prone  to  degradation  and  aggregation  due  to  the  presence  of  the  long 
unstructured α 2 β 5  loop,  which  can  be  stabilised  by  the  interaction  with  Vps75.  The 
precipitation  of  the  sample  upon  addition  of  the  second  equivalent  of  Rtt109  could  thus  have 
two  reasons:  (i)  Vps75 2  accommodates  only  one  Rtt109  copy  and  the  excess  of  unbound  
Rtt109  precipitates  at  the  concentration  required  for  NMR  experiments,  (ii)  added  Rtt109 
2 Vps75(A)  and  Vps75(B),  together  forming  the  Vps75  dimer,  are  identical  structurally  and  functionally.  
Rtt109  can  bind  on  either  side  of  the  Vps75  dimer,  interacting  with  the  earmuff  domain  of  one  chain 
and  the  N-terminal  part  of  the  dimerization  helix  of  the  other  chain.  For  convenience,  the  Vps75 
monomer  that  is  engaged  by  Rtt109  via  its  earmuff  domain  is  always  referred  to  as  Vps75(B)  or 
Rtt109-bound. 
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 precipitates  before  it  can  form  a  stable  complex  with  the  Vps75 2 – Rtt109  pre-formed 
complex. 
To  enable  experiments  with  Rtt109  in  isolation  as  well  as  the  study  of  the 
“potentially-existing”  2:2  complex  with  Vps75,  Dr.  L.  Lercher  performed  the  thermofluor 
assays  on  Rtt109 (Kozak et  al ,  2016) .  The  results  revealed  that  Rtt109  has  the  highest 
stability  at  acidic  pH  (<  8.0)  and  at  high  concentration  of  NaCl  (increase  of  the  NaCl 
concentration  up  to  1  M  correlated  with  the  increase  in  the  protein  stability).  However,  we 
decided  to  exclude  buffers  with  high  ionic  strength,  as  they  are  detrimental  both  for  the 
interaction  between  Vps75  and  histones (Bowman et  al ,  2011)  and  for  the  performance  of 
the  NMR  experiments.  Thus,  we  selected  the  following  buffers:  citrate  (50  mM  sodium  citrate 
pH  5.5-pH  6.5,  150  mM  NaCl,  5  mM  BME),  phosphate  (25  mM  phosphate  pH  6.5,  200  mM 
NaCl,  5  mM  BME)  and  HEPES  (20  mM  HEPES  pH  7.5,  200-400  mM  NaCl,  5  mM  BME). 
Notably,  the  stability  of  Rtt109  in  the  citrate  buffer  depended  less  on  the  overall  ionic  strength 
than  in  the  other  buffers,  allowing  the  reduction  of  the  NaCl  concentration  to  150  mM  nearly 
without  any  impact  on  the  protein  melting  temperature. 
NMR  titration  experiments  with  ILV-labelled  Vps75  in  the  selected  buffers  demonstrated  that 
in  all  cases  addition  of  1  molar  equivalent  of  Rtt109  to Vps75 2  lead  to  the  same  CSPs  as  
observed  before  (in  Fig.  4.1.1B),  indicating  the  formation  of  the Vps75 2 – Rtt109  complex. 
However,  the  addition  of  the  second  equivalent  of  Rtt109  lead  to  different  results  depending 
on  the  conditions.  In  the  phosphate  buffer  Rtt109  was  not  stable  enough  at  the concentration 
of  100 μM  required  to  reach  2  molar  equivalents.  Thus,  in  this  buffer  I  monitored  ILV-labelled 
Rtt109  at  a  concentration  of  50 μM;  Addition  of  1  equivalent  of  Vps75  (2:2  Rtt109:Vps75 
ratio)  lead  to  two  observable  states  of  Rtt109,  Vps75-bound  and  free  (Fig.  4.1.2A).  Upon 
titration  of  the  second  Vps75  equivalent,  the  peaks  of  Rtt109  corresponding  to  the  free  state 
of  the  protein  disappeared,  indicating  the  formation  of  the  Rtt109–Vps75 2 . In  the  HEPES 
buffer,  addition  of  the  second  molar  equivalent  of  Rtt109  to  the  Rtt109 –Vps75 2  preformed  
complex  yielded  no  changes  in  the  spectrum  of  ILV-labelled  Vps75,  suggesting  that  only  one 
Rtt109  can  be  bound  by  the  Vps75  dimer  in  this  condition  (Fig.  4.1.2B).  Thus,  in  HEPES  and 
phosphate  buffers,  only  the  formation  of  the  Rtt109–Vps75 2   complex  was  observed. 
Differently,  in  citrate  buffer  addition  of  the  second  copy  of  Rtt109  caused  broadening  of  the 
Vps75(A)  peaks  (which  are  unaltered  in  the  Rtt109–Vps75 2  complex),  while  the  peaks  of  the  
Vps75(B)  (which  binds  Rtt109  in  the  Rtt109–Vps75 2  complex)  increased  in  intensity  (Fig.  
4.1.2C).  This  suggested  that  in  citrate  buffer  the  Rtt109 2 –Vps75 2  complex  may  exist  in  
equilibrium  with  the  Rtt109–Vps75 2 ,  while  complete  conversion  of  Rtt109–Vps75 2  into  the  
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 Rtt109 2 –Vps75 2  can  be  excluded  based  on  the  persistence  of  asymmetry  in  the  spectrum  of  
the  Vps75(A)–Vps75(B)  dimer. 
 
Figure  4.1.2. The  formation  of  the  Rtt109 2 – Vps75 2  complex  is  observed  only  in  the  citrate  
buffer . A .  Overlay  of 1 H- 13 C  HMQC spectra  of  ILV  methyl-labelled  Rtt109 in  isolation and  upon  addition    
of  1  or  2  molar  equivalents  of  Vps75  in  25  mM  phosphate  pH  6.5,  200  mM  NaCl,  5  mM  BME  at  50 μM 
Rtt109.  Addition  of  1  equivalent  of  Vps75  (or  0.5  equivalent  of  Vps75 2 ,  green)  leads  to  binding  of  only 
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 50%  of  the  available  Rtt109  to  Vps75.  Upon  addition  of  2  Vps75  equivalents  (black)  Rtt109  is  fully 
bound.  Arrows  indicate  the  peaks  which  are  in  slow  exchange  between  the  free  Rtt109  and  the 
Rtt109 –Vps75 2  complex  states .  The  dashed  box  shows  the  peaks  located  in  the  Rtt109  loop  that  
becomes  structured  upon  interaction  with  Vps75. B-C .  Overlay  of 1 H- 13 C  HMQC spectra  of  ILV  
methyl-labelled  Vps75 2 in  isolation and  upon  addition  of  1  or  2  molar  equivalents  of  Rtt109  in  ( B )  20  
mM  HEPES  pH  8.0  (pH  7.5  for  the  2:2  complex),  150  mM  NaCl  (300  mM  NaCl  for  the  2:2  complex),  5 
mM  BME  at  50 –70 μM  Vps75 2  ( C )  50  mM  sodium  citrate  pH  6.5  (pH  5.6  for  the  2:2  complex),  150  mM  
NaCl,  5  mM  BME  at  50 μM  Vps75 2 .  Addition  of  the  second  Rtt109  equivalent  does  not  affect 
Vps75(A)  in  ( B ),  while  in  ( C )  the  Vps75(A)  peaks  indicated  with  an  arrow  broaden  or  disappear, 
suggesting  that  both  Vps75  chains  may  bind  to  Rtt109.  Spectra  in  ( A )  were  recorded  at  300K  and  800 
MHz.  Spectra  in  ( B - C )  were  recorded  at  298  K  and  850  MHz.  Schematic  representations  of  the 
complexes  observed  at  each  titration  point  are  shown  on  the  right  ( A - C ).  The  data  was  produced 
jointly  with  Dr.  L.  Lercher. 
To  unambiguously  determine  the  stoichiometry  of  the  complex  between  Rtt109  and  Vps75  in 
the  citrate  buffer,  I  performed  SEC-MALS  on  the  2:2  complex  (Fig.  4.1.3).  SEC  coupled  with 
MALS  allows  the  determination  of  the  molecular  weights  of  the  eluted  species  independent 
on  their  shape  and  retention  time.  The  Rtt109 –Vps75  mixture,  loaded  in  a  2:2  molar  ratio, 
eluted  as  two  peaks  with  the  average  molecular  weights  of  111,6  kDa  and  54,4  kDa, 
matching  the  theoretical  masses  of  115,4  kDa  and  50,1  kDa  expected  for  the  Rtt109 –Vps75 2  
complex  and  Rtt109  alone,  respectively.  The  two  peaks  contained  72%  and  20%  of  the 
overall  injected  mass,  which  is  close  to  the  expected  distribution  for  the  Rtt109 –Vps75 2  
complex  and  one  free  equivalent  of  Rtt109  (~70%  and  ~30%) .  The  Rtt109 2 –Vps75 2  complex  
could  not  be  detected,  indicating  that  this  complex  is  too  transient  to  be  isolated  by  SEC. 
Figure  4.1.3. SEC-MALS  analysis  of  the 
Rtt109 –Vps75  2:2  mixture  reveals  the 
formation  of  the  1:2  complex 
exclusively . A .  SEC-MALS  analysis  of  the 
Rtt109 – Vps75  2:2  mixture  at  50  μM  Rtt109 
in  50  mM  sodium  citrate  pH  6.5,  150  mM 
NaCl,  5  mM  BME.  Red,  molecular  mass 
over  the  elution  profile;  the  dashed  grey 
lines  indicate  the  theoretical  masses  of  the 
corresponding  complexes. B .  Analysis  of 
the  peaks  #1  and  #2  of  ( A ).  Panel  ( A )  is 
adapted  from  Danilenko et  al ,  2019  and 
originally  produced  by  myself. 
 
 
In  summary,  the  data  suggest  that,  although  some  amount  of  Rtt109 2 –Vps75 2  complex  can  
be  observed  in  solution  by  NMR  under  certain  conditions  (citrate  buffer,  pH  5.6),  this 
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 complex  is  far  less  stable  than  the  Rtt109–Vps75 2   complex. 
4.2.  Vps75 2  assembles  an  asymmetric  complex  with  Rtt109  and  
Asf1 – H3:H4. 
After  determining  that  Rtt109  binds  Vps75  in  a  1:2  ratio,  I  set  out  to  determine  with  which 
stoichiometry  Rtt109 – Vps75 2  binds  histones.  To  reveal  how  the  substrate  H3:H4  histones  
interact  with  the  enzyme  and  Vps75  I  used  both  NMR  and  SEC-MALS. 
In  vivo,  the  Rtt109 – Vps75 2  sub-complex  is  thought  to  accept  Asf1-bound  histones  as  a  
substrate (Hammond et  al ,  2016) . In  vitro ,  the  addition  of  the  Asf1 –H3:H4  complex  t o 
Rtt109 – Vps75 2  leads  to  the  formation  of  a  stable  complex  composed  of  all  five  proteins,  
which  could  be  isolated  by  SEC (Fig.  4.2.1) . To  verify  the  stoichiometry  of  the  complex,  the 
mixture  of  Rtt109,  Vps75,  Asf1  and  H3:H4  in  a  1:2:1:1  Rtt109:Vps75:Asf1:(H3:H4)  ratio  was 
loaded  onto  the  SEC  column  coupled  with  MALS.  The  injected  material  formed  a 
well-defined  complex  with  a  molecular  mass  of  a  154  kDa;  this  value  is  similar  to  the 
molecular  weight  of  161  kDa  calculated  for  the  hexameric  Rtt109 – Vps75 2 – Asf1 –H3:H4 
complex  (later  referred  to  as  RVAH  complex,  by  the  first  letters  of  the  names  of  the  proteins). 
The  SDS-PAGE  analysis  of  the  peak  confirmed  that  it  contained  all  five  proteins. 
Figure  4.2.1. Rtt109  forms  a  stable  complex 
with  the  histones  and  both  chaperones.  A. 
SEC-MALS  analysis  of  the 
Rtt109:Vps75:Asf1:(H3:H4)  mixture  at  40  μM 
Rtt109  in  50  mM  sodium  citrate  pH  6.5,  150 
mM  NaCl,  5  mM  BME.  Red,  molecular  mass 
over  the  elution  profile;  the  dashed  grey  line 
indicates  the  theoretical  molecular  mass  of  the 
RVAH  complex. B .  SDS-PAGE  analysis  of  the 
fraction  indicated  in  ( A )  as  “S”.  Panel  ( A )  is 
adapted  from  Danilenko et  al ,  2019  and 
originally  produced  by  myself. 
 
In  the 1 H- 13 C  HMQC  spectra  of  ILV-labelled  Vps75,  Vps75(B),  displays  the  same  chemical 
shifts  indicative  of  Rtt109-binding  as  in  the  Rtt109–Vps75 2  sub-complex,  while  Vps75(A),  
which  remained  unbound  in  the  Rtt109–Vps75 2  sub-complex,  displays  new  chemical  shifts,  
indicative  of  binding  to  the  substrate  Asf1–H3:H4  (Fig.  4.2.2).  I  concluded  that  the 
Rtt109:Vps75  1:2  stoichiometry  is  maintained  upon  addition  of  the  Asf1–H3:H4;  furthermore, 
additional 1 H- 13 C  spectra  demonstrated  that  the  formation  of  the  RVAH complex  is  not  
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 dependent  on  the  order  in  which  the  protein  are  mixed  and  is  not  disrupted  by  the  addition  of 
Rtt109  in  excess. 
Figure  4.2.2.  In  the  hexameric  RVAH  complex,  Vps75(A)  binds  the  substrate  while  Vps75(B) 
binds  the  enzymatic  module . A .  Overlay  of 1 H- 13 C  HMQC  spectra  of  ILV  methyl-labelled  Vps75 
homodimer  in  isolation  (blue);  upon  addition  of  Rtt109,  Vps75(A)  remains  unaffected,  while  Vps75(B) 
is  bound  by  Rtt109  (yellow)  forming  the  Vps75 2 –Rtt109  sub-complex;  upon  addition  of  Asf1–H3:H4  to 
the  Rtt109–Vps75 2  sub-complex,  the  Vps75(B)  peaks  remain  in  their  Rtt109-bound  positions,  while  a  
subset  of  the  Vps75(A)  peaks  either  disappears  or  shows  noticeable  CSPs,  indicative  of  binding  to 
Asf1–H3:H4  (green). B .  Overlay  of 1 H- 13 C  HMQC  spectra  of  the  Vps75  homodimer  in  isolation  (blue, 
assignments  are  the  same  as  in  ( A ));  addition  of  Asf1–H3:H4  results  in  the  formation  of  a  transient 
complex  with  Asf1–H3:H4,  where  the  substrates  exchange  rapidly  between  Vps75(A)  and  Vps75(B) 
(orange);  upon  addition  of  Rtt109  to  the  Vps75 2 –Asf1–H3:H4,  a  spectrum  identical  to  the  one  in  ( A , 
right)  is  observed  (green).  All  spectra  were  acquired  with  60  μM  Vps75 2  in  50  mM  sodium  citrate  pH  
6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K.  Panel  ( A )  is  adapted  from  Danilenko et  al , 
2019  and  originally  produced  by  myself. 
In  order  to  better  understand  the  interactions  between  the  components  of  the  complex  and 
the  function  of  both  chaperones  Asf1  and  Vps75  in  Rtt109  activation,  I  attempted  to 
reconstitute  several  sub-complexes.  In  particular,  I  investigated  whether  Rtt109  can  interact 
with  histones  in  the  presence  of  either  Vps75  or  Asf1. 
Rtt109 – Vps75 2 –H3:H4  sub-complex . Previous  studies  of  the  interaction  of  histones  with 
Vps75  and  Rtt109  in  the  absence  of  Asf1  were  plagued  by  aggregation (Bowman et  al ,  2014; 
Albaugh et  al ,  2010) .  Our  attempts  to  study  the  interaction  between  Vps75 2  or  Rtt109  or  
Rtt109–Vps75 2  and  H3:H4  suffered  from  the  same  problem,  with  complexes  without  Rtt109  
showing  better  solubility.  To  determine  how  histones  interact  with  Vps75 2  I  performed  a  
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 series  of  NMR  titrations.  Addition  of  one  H3:H4  equivalent  to  the  ILV  methyl-labelled  Vps75 2  
yielded 1 H- 13 C  HMQC  spectra  with  sufficiently  good  signal-to-noise  ratio  (Fig.  4.2.3A). 
However,  increasing  the  H3:H4  concentration  up  to  a  2:2  Vps75:(H3:H4)  molar  ratio  lead  to 
noticeable  precipitation  and  poor  quality  of  the  spectra.  Nevertheless,  the  observed  CSPs 
could  be  mapped  on  the  inner  surface  of  the  Vps75  dimer,  particularly  on  the  negatively 
charged  surface  of  the  Vps75  earmuff  domain  and  dimerisation  helix. 
This  CSP  pattern  was  very  similar  to  the  one  observed  in  the  above-mentioned  titration  of 
Vps75 2  with  Asf1–H3:H4,  indicating  that  Vps75–(H3:H4)  interaction  is  similar  in  the  presence  
or  absence  of  Asf1  (Fig.  4.2.3B) . 
 
Figure  4.2.3. Vps75  interacts  with  H3:H4  via  its  inner  surface  and  this  interaction  is  compatible 
with  Asf1  presence. A . Overlay  of 1 H- 13 C  HMQC  spectra  of  50  μM  ILV  methyl-labelled Vps75 2  alone  
and  upon  addition  of  1  or  2  molar  equivalents  of (left) H3:H4  in  10  mM  TrisHCl  pH  7.5,  100  mM  NaCl, 
1  mM  DTT;  (right)  Asf1 – H3:H4  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  1  mM  DTT.  All  spectra 
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 were  recorded  at  298  K  and  850  MHz.  Cartoons  below  the  spectra  indicate  the  formed  complexes 
(left,  Vps75  dimer  can  interact  with  H3:H4  dimer,  H3:H4  tetramer  or  two  Vps75  dimers  can  bind  one 
H3:H4  tetramer;  right,  Asf1  prevents  H3:H4  tetramerization,  Vps75  interacts  with  Asf1 – H3:H4). B . 
CSPs  observed  in  ( A )  mapped  on  the  Vps75  structure  (PDB  entry  3q66).  The  disappearance  of 
resonance  is  also  indicative  of  a  change  in  chemical  environment  and  dynamics;  as  such,  resonances 
that  disappear  upon  addition  of  H3:H4  ( A,  left )  are  mapped  in  purple.  The  majority  of  CSPs/affected 
methyl  groups  cluster  on  the  inner  surface  and  cavity  of  Vps75 2 ,  while  the  opposite  side  remains 
unaffected. C .  Surface  charge  representation  of  Vps75 2  with  positive,  neutral  and  negative  
electrostatic  potential  indicated  in  blue,  white  and  red,  respectively.  The  Rtt109-binding  surface  of 
Vps75 2  is  indicated  by  the  dashed  line.  CSPs  mapped  in  ( B )  correspond  to  the  negatively  charged  
part  of  the  earmuff  domain  (encircled)  and  the  bottom  of  the  acidic  cavity. 
Vps75  and  Asf1  do  not  interact  in  the  absence  of  the  histones,  as  indicated  by  the  lack  of 
CSPs  upon  addition  of  the  unlabelled  Asf1  to  the  ILV-labelled  Vps75  and vice  versa  (Fig. 
4.2.4,  Lercher et  al. ,  2018).  This  supports  the  idea  that  the CSPs  shown  in  Fig.  4.2.3B  are  a 
consequence  of  the  Vps75-histone  interaction. 
Figure  4.2.4.  Vps75  does  not 
interact  with  Asf1  in  the  absence 
of  H3:H4. Overlay  of 1 H- 13 C  HMQC 
spectra  of  60  μM  ILV  methyl-labelled 
Vps75 2  alone  and  upon  addition  of  1  
molar  equivalent  of  Asf1.  All  spectra 
were  recorded  in  50  mM  sodium 
citrate  pH  6.5,  150  mM  NaCl,  1  mM 
DTT  at  298  K  and  850  MHz. 
 
 
 
 
 
The  spectra  corresponding  to  the  titration  of  Vps75 2  with  either  H3:H4  or  the  Asf1–H3:H4  
complex  show  CSPs  for  the  same  residues;  nevertheless  the  spectra  are  different.  This  can 
be  explained  by  the  inhomogeneity  of  the  Vps75 2 –H3:H4  complex,  as  Vps75 2  has  been  
reported  to  bind  both  H3:H4  dimers  and  tetramers  as  well  as  to  form  Vps75 
tetramers (Bowman et  al ,  2014;  Hammond et  al ,  2016) .  The  presence  of  mixed  species  (for 
example:  Vps75 4 ,  Vps75 2 –H3:H4,  Vps75 2 –(H3:H4) 2 ,  Vps75 4 –(H3:H4) 2 )  would  lead  to 
aggregation  and  less  clear  CSP  patterns.  On  the  other  hand,  Asf1  is  known  to  prevent  the 
formation  of  the  (H3:H4) 2  tetramer  by  interacting  with  the  C-terminal  region  of  H3 (English et  
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 al ,  2006)  and  therefore  promotes  the  formation  of  only  one,  better  defined, 
Vps75 2 –Asf1–H3:H4  complex. 
Given  the  similarity  of  the  CSPs  of  the  Vps75  ILV-methyl  groups  in  the  Vps75 2 –H3:H4  and 
Vps75 2 –Asf1–H3:H4  complexes  as  well  as  the  absence  of  a  direct  interaction  between 
Vps75  and  Asf1,  it  is  plausible  that the  engagement  of  Asf1  with  the  H3:H4  tetramerization 
interface  does  not  affect  the  Vps75–(H3:H4)  interaction.  In  parallel  to  this  work,  the  formation 
of  the Vps75 2 –Asf1–H3:H4 complex  was  reported  by  Hammond et  al  (Hammond et  al , 
2016),  together  with  a  low  resolution  model  of  the  complex.  Although  the  structural  model 
was  based  on  only  five  distance  restraints,  it  suggested  very  few  contacts  between  Asf1  and 
Vps75,  which  instead  were  modelled  to  interact  with  the  opposite  ends  of  H3:H4.  The 
compatibility  of  the  Asf1–H3:H4  and  Vps75 2 –H3:H4  interaction  surfaces  allows  more  links  in 
the  histone  handover  pathway  during  nucleosome  assembly  and  further  indicates  that 
Asf1–H3:H4  is  a  likely  substrate  for  Rtt109–Vps75 2   in  vivo . 
Rtt109 – Asf1 –H3:H4  sub-complex. While  acetylation  of  H3  N-terminal  lysines  is  carried  out 
by  the  RVAH  complex,  the  necessity  of  Vps75  for  H3  K56  acetylation  remained 
questionable.  Investigation  of  the  interaction  of  Asf1-bound  histones  with S.  cerevisiae 
Rtt109  in  the  absence  of  Vps75 2  could  shed  a  light  on  the  role  of  each  chaperone  as  well  as  
on  the  interaction  between  Rtt109  and  Asf1,  which  remained  elusive.  Recently,  the  Rtt109 
from  the  pathogenic  fungus A.  fumigatus  ( Af Rtt109)  was  shown  to  form  a  functional  complex 
with  Asf1–H3:H4  in  vitro  (later  referred  to  as  Af  RAH  complex)  (Zhang  et  al ,  2018) . 
In  order  to  characterise  interaction  of  Rtt109  with  Asf1–H3:H4,  Dr.  L.  Lercher  tried  to  3
assemble  the S.  cerevisiae  RAH  complex  by  mixing  Rtt109  and  Asf1–H3:H4  in  a  1:1  ratio  in 
the  citrate  buffer.  Both  Rtt109  and  Asf1–H3:H4  remained  soluble;  however,  the  complex  was 
not  stable  enough  to  allow  for  isolation  by  SEC;  a  SEC  run  of  the  mixture  resulted  in 
Asf1–H3:H4  and  Rtt109  eluting  separately.  I  then  attempted  the  reconstitution  of  the 
Rtt109–Asf1–H3:H4  complex  with  the  protocol  reported  for  the  preparation  of  the Af  RAH 
complex (Zhang et  al ,  2018) ,  but  this  protocol  lead  to  a  complete  precipitation  of  the S. 
cerevisiae  ( Sc )  proteins.  The  difference  in  the  biophysical  properties  of  the  RAH  complex  in 
Af  and Sc  can  be  explained  by  the  differences  in  the  secondary  structure  of Sc Rtt109  and  4
Af Rtt109: Af Rtt109  lacks  the α 2 β 5  loop  necessary  for  Vps75  binding  and  has  a  short  loop 
inserted  between  the α 6  and α 7  helices,  absent  in Sc Rtt109  (Fig.  4.2.5).  In  addition,  the 
3  Work  on  the  Rtt109  interaction  with  Asf1–H3:H4  was  done  in  the  Carlomagno  group  by  Dr.  L.  
Lercher  and  myself. 
4 S.  cerevisiae  Rtt109  is  referred  to  as  “Rtt109”  throughout  the  thesis.  However,  to  avoid  any  
confusion,  in  this  paragraph  and  in  the  Fig.  4.2.5  is  it  named  “ Sc Rtt109”. 
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 surface  charge  of  the  two  enzymes  is  different: Sc Rtt109  has  positively  charged  areas, 
which  are  engaged  in  the  interaction  with  Vps75 2 .  This  surface  charge  distribution  is  not 
conserved  in Af Rtt109.  The  difference  in  the  isoelectric  point  of Sc Rtt109  and Af Rtt109  (9.41 
and  6.05,  respectively)  might  explain  the  solubility  of Sc Rtt109  in  citrate  buffer,  as  opposed 
to  the  Tris-HCl  buffer  at  pH  8.0  used  for  reconstitution  of  the Af RAH  complex.  The 
uncharacterised Af Vps75  homologue  ( Af Vps75)  in  turn  does  not  interact  with  the Af Rtt109 
in  vitro  and  has  an  insertion  in  the  region  corresponding  to  the  Vps75 α 5  helix,  suggesting  a 
possible  structural  similarity  to  Nap1  instead.  Altogether,  these  differences  question  the 
similarity  of  the  H3  acetylation  mechanisms  in  A.  fumigatus  and  S.  cerevisiae . 
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Figure  4.2.5.  Comparison  of  Rtt109  from S.  cerevisiae  and A.  fumigatus .  A,  B. Sequence 
alignments  of  Rtt109  ( A )  and  Vps75  ( B )  in  several  fungal  species  ( Sc:  S.  cerevisiae;  Af:  A.  fumigatus; 
Sp: Schizosaccharomyces  pombe ; Ca: Candida  albicans ; Cp: Candida  parapsilosis ).  Dots,  colons  and 
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 asterisks  indicate  weakly  similar,  strongly  similar  and  fully  conserved  residues,  respectively. 
Secondary  structure  elements  of Sc proteins  are  mapped  above  the  alignments.  The  loops  of 
Af Rtt109  are  named  according  to  the  secondary  structure  of Af Rtt109,  which  differs  from Sc Rtt109. C. 
Comparison  of  the  structures  of  Rtt109  from S.  cerevisiae  and A.  fumigatus . Red: Af Rtt109  structure 
(PDB  entry  5zba);  yellow: Sc Rtt109  structure  in  complex  with  Vps75 2  (PDB  entry  3q66);  grey:  
Sc Vps75  structure  from  3q66  (only  Vps75(A)  is  shown).  The  positions  of  amino  acid  insertions  in  the 
Af Vps75  sequence  are  indicated  in  blue  on  the  Vps75  structure  from  PDB  entry  3q66.  The  lack  of  the 
α2β5  loop  in Af Rtt109,  which  in Sc is  essential  for  interaction  with  Vps75,  and  the  presence  of 
insertions  in  both Af Rtt109  and Af Vps75  that  map  to  the  histone-binding  surface  of  the Sc  proteins, 
suggests  that  the  acetylation  of  histones  in Af  may  be  regulated  by  a  mechanism  different  to  that  in 
other  fungi. D,  E. Surface  charge  representations  of Sc Rtt109  ( D )  and Af Rtt109  ( E )  with  positive, 
neutral  and  negative  electrostatic  potential  indicated  in  blue,  white  and  red,  respectively.  The 
positively  charged  patch  present  in  Sc Rtt109  is  not  conserved  in  Af Rtt109. 
Due  to  the  absence  of  a  stable  complex  between  Rtt109  and  Asf1–H3:H4,  we  chose  to  study 
this  by  NMR,  which  is  able  to  capture  transient  interactions.  Comparison  of 1 H- 13 C  HMQC 
spectra  of  ILV  methyl-labelled  Rtt109  alone  and  upon  addition  of  Asf1–H3:H4  yielded  small 
CSPs,  which  were  confined  to  the  Rtt109  unfolded  region  (Fig.  4.2.6A).  A  reverse  NMR 
titration  with  ILV  methyl-labelled  H3:H4  in  complex  with  Asf1  revealed  no  changes  in  the 
spectrum  upon  addition  of  Rtt109.  The  experiment  did  not  reveal  any  interaction  between 
Rtt109  and  H3:H4,  suggesting  that  the  small  CSPs  seen  in  Fig  4.2.6A  arise  from  an 
interaction  between  Rtt109  and  Asf1.  Interestingly,  analogous  experiments  in  the  presence 
of  Vps75 2  caused  noticeable  CSPs,  indicative  of  interactions  between  the  Rtt109  globular  
domain  and  the  histones  in  the  context  of  the  RVAH  complex  (Fig.  4.2.6B,  Fig.  4.5.3B). 
 
Fig.  4.2.6.  Interaction  of  Rtt109  with  Asf1–H3:H4  is  altered/weaker  in  the  absence  of  Vps75.  A. 
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 Overlay  of 1 H- 13 C  HMQC  spectra  of 20  μM ILVM  methyl-labelled  Rtt109  in  isolation  and  upon  addition 
of  Asf1–H3:H4.  The  IM  and  LV  regions  of  the  spectra  are  shown  in  the  top  and  bottom  panels, 
respectively.  CSPs  are  observed  for  the  Rtt109  C-terminus,  while  no  CSPs  are  visible  for  the  globular 
domain.  The  isoleucine  residues  indicated  by  the  boxes  with  dashed  borders  belong  to  the  Rtt109 
globular  domain  and  display  CSPs  upon  addition  of  Asf1–H3:H4  to  the  ILV  methyl-labelled  Rtt109  in 
complex  with  Vps75 2  (Fig.  4.5.3). B . 1 H- 13 C  HMQC  spectra  of 50  μM  ILV  methyl-labelled  H3:H4  in  
complex  with  unlabelled  Asf1  upon  addition  of  either  Rtt109  or  both  Vps75 2  and  Rtt109.  No  CSPs  are  
observed  upon  addition  of  Rtt109  in  the  absence  of  Vps75 2 ,  suggesting  that  Rtt109  interacts  tightly 
with  histones  only  in  the  RVAH  complex.The  spectra  were  recorded  in  50  mM  sodium  citrate  pH  6.5, 
150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K. 
Thus,  Asf1  carrying  the  H3:H4  dimer  can  be  directly  bound  by  Vps75 2 .  The  Vps75 
homodimer  can  then  act  as  an  assembly  platform  for  the  full  RVAH  complex,  binding  and 
bringing  together  the  enzyme  and  the  substrate  and  facilitating  their  interaction.  On  the  other 
hand,  individual  sub-complexes  of  Vps75 2 –H3:H4  or  Asf1–H3:H4  do  not  provide  a  viable 
pathway  for  the  binding  of  the  substrate  to  Rtt109  in  vitro . 
4.3.  The  Rtt109  C-terminal  tail  interacts  with  Asf1,  releasing  the 
H3  N-terminal  tail  for  acetylation. 
The  NMR  data  detailed  in  section  4.2  hinted  at  the  interaction  between  the  unfolded  region 
of  Rtt109  and  Asf1  (Fig  4.2.6).  Fittingly,  a  previous in  vivo  study  showed  the  importance  of 
the  unfolded  Rtt109  -terminal  region  (residues  424-436)  for  Asf1-dependent  acetylation  of 
H3 (Radovani et  al ,  2013) .  Dr.  L.  Lercher  hypothesized  that  the  CSPs  observed  in  Rtt109 
titrations  with  Asf1–H3:H4  are  the  result  of  the  interaction  between  the  Rtt109  C-terminal  tail 
and  Asf1.  Using  NMR  and  Isothermal  Titration  Calorimetry  (ITC)  experiments,  we 
demonstrated  that  the  interaction  between  Rtt109  and  Asf1  is  confined  to  the  short  basic 
sequence  at  the  C-terminus  of  Rtt109  (Rtt109 419–433 )  and  solved  the  NMR  structure  of  the 
Rtt109 419–433  in  complex  with  Asf1  (deposited  as  PDB  entry  6f0y).  The  investigation  of  the  
Rtt109 419-433  interaction  with  Asf1  as  well  as  the  structure  determination  were  done  by  Dr.  L.  
Lercher  and  are  described  in  detail  in  (Lercher  et  al ,  2018) . 
The  Asf1-Rtt109 419–433  structure  revealed  that  the  Rtt109  peptide  (419-433)  interacts  with  the  
Asf1  surface  on  the  opposite  side  of  the  histone-binding  interface  (Fig.  4.3.1),  and  that  the 
Rtt109–Asf1  interaction  is  compatible  with  Asf1  binding  H3:H4  (Lercher  et  al ,  2018). 
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Fig.  4.3.1.  Asf1  interaction  with  the  Rtt109  C-terminus.  A. Overlay  of  the  Asf1-Rtt109 419–433  
structure  (PDB  entry  6f0y)  and  Asf1–H3:H4  structure  (PDB  entry  2hue).  Rtt109  C-terminus  binds  to 
Asf1  at  the  surface  opposite  to  its  histone-binding  site  and  does  not  significantly  alter  Asf1 
conformation. B. 90  degree  rotation  of  the  overlaid  structures  as  in  (A);  Asf1  is  shown  in  surface 
charge  representation.  Data  used  in  the  figure  was  produced  by  Dr.  L.  Lercher. 
After  the  determination  of  the  Asf1-Rtt109 419–433  structure,  we  addressed  the  question  of  
whether  this  interaction  is  preserved  in  the  RVAH  complex  and  investigated  its  functional 
significance. 
In  order  to  characterise  the  Asf1–Rtt109  interaction  in  the  context  of  the  RVAH  complex,  we 
performed  NMR  titration  experiments  with  ILV  methyl-labelled  Asf1.  This  allowed  us  to 
compare  CSPs  observed  upon  addition  of  Rtt109  to  free  Asf1  and  to  Asf1–H3:H4–Vps75 2 . 
The  Asf1  methyl  groups  affected  by  the  addition  of  Rtt109  were  identical  in  the  two  cases, 
indicating  that  the  Rtt109 419–433 –Asf1  interaction  is  preserved  in  the  presence  of  histone  and 
Vps75 2   (Lercher  et  al ,  2018). 
To  obtain  the  Vps75 2 –Asf1–H3:H4  sub-complex  for  this  experiment,  we  first  titrated 
unlabelled  Vps75 2  to  the  ILV  methyl-labelled  Asf1  in  complex  with  H3:H4.  This  yielded  
unexpected  CSPs  for  the  Asf1  residues  mapping  on  the  binding  surface  of  the  Rtt109 
C-terminal  tail,  even  prior  to  addition  of  Rtt109  (Fig.  4.3.2).  As  discussed  previously,  Vps75 
and  Asf1  do  not  interact  directly  (Fig.  4.2.4). 
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Figure  4.3.2.  Asf1  binds  H3  N-terminal  tail  via  its  Rtt109  C-terminus  interaction  interface.  A. 
Overlay  of 1 H- 13 C  HMQC  spectra  of 50  μM ILV  methyl-labelled  Asf1  alone  (grey);  upon  titration  of 
H3:H4  (green);  upon  titration  of  H3:H4  and  Vps75 2  (green);  upon  titration  of  H3Δ28:H4  (red).  Asf1  
residues  V65  and  L38  are  located  at  the  Rtt109  C-terminus  binding  site,  while  residue  L6  is  located  at 
the  H3:H4  dimer  interaction  interface.  While  V65  and  L38  are  reverted  to  the  state  identical  to  the  free 
Asf1  upon  addition  of  Vps75 2  to  Asf1–H3:H4,  L6  remains  H3:H4-bound. The  cartoon  schemes  on  the  
right  represent  the  changes  observed  in  Asf1  in  each  titration.  “Bound”  and  “free”  refer  to  the  Asf1 
surfaces  that  interact  with  Rtt109  C-terminus/H3  N-terminus  (top  part)  and  with  the  H3:H4 
tetramerization  interface  (bottom  part). B.  CSPs  plots  for  the  spectra  in  ( A )  (top)  and  for  the  spectra  of 
free  Asf1  vs.  Asf1  in  complex  with  the  Rtt109  C-terminus  (bottom).  The  same  residues  of  Asf1  that 
are  involved  in  the  interaction  with  Rtt109  C-terminus  (indicated  by  the  dashed  box)  are  affected  by 
the  addition  of  Vps75 2  to  Asf1–H3:H4 . Figure  is  adapted  from  Lercher et  al ,  2018  and  originally  
produced  jointly  by  Dr.  L.  Lercher  and  myself;  data  was  produced  jointly  by  Dr.  L.  Lercher  and  myself. 
 
The  Asf1  peaks  displaying  CSPs  after  the  addition  of  Vps75 2  to  Asf1–H3:H4,  shifted  to  the  
positions  characteristic  of  free  Asf1  (Fig  4.3.2A).  At  the  same  time,  the  peaks  corresponding 
to  the  Asf1  residues  involved  in  the  interaction  with  the  H3:H4  tetramerization  interface 
remained  in  the  histone-bound  state.  Altogether,  this  data  suggests  that  Vps75  influences 
the  interaction  between  Asf1  and  histone  regions  other  than  the  core,  for  example  the  long 
unstructured  N-terminal  tail  of  H3. 
To  test  this  hypothesis,  we  prepared  a  histone  H3  protein  carrying  a  28-residue  N-terminal 
deletion  (H3Δ28)  and  reconstituted  H3Δ28:H4  dimers.  Spectra  of  Asf1-H3Δ28:H4  revealed 
that,  although  interaction  between  Asf1  and  the  H3:H4  tetramerization  interface  is  retained, 
the  Rtt109  binding  surface  of  Asf1  had  chemical  shifts  similar  to  those  of  free  Asf1  or  of 
Vps75 2 –Asf1–H3:H4  (Fig.  4.3.2).  This  data  suggested  that  in  the  Asf1–H3:H4  sub-complex 
residues  1-28  of  the  H3  N-terminal  tail  are  bound  by  the  same  Asf1  surface  that  interacts 
with  Rtt109 419-433 ,  and  that  the  addition  of  Vps75 2  to  Asf1–H3:H4  results  in  the  release  of  the  
H3  tail  from  Asf1. 
To  further  test  this  idea,  we  monitored  the  H3  N-terminal  tail  by  NMR.  We  reconstituted 
full-length  H3:H4  dimers  with 15 N  labelled  H3  and  titrated  Asf1,  Asf1  and  Vps75 2 ,  or  Asf1  and 
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 Rtt109  onto  H3:H4  (Fig.  4.3.3).  Indeed,  upon  addition  of  Asf1  we  observed  CSPs  for  H3 
residues  19-26,  confirming  the  interaction  between  the  H3  tail  and  Asf1.  This  interaction  can 
be  outcompeted  either  by  binding  of  the  Rtt109  C-terminal  tail  to  the  same  Asf1  site,  or  by 
interaction  of  Vps75 2   with  the  H3  N-terminal  tail. 
 
Figure  4.3.3.  Rtt109  and  Vps75 2  are  able  to  prevent  the  interaction  of  the  H3  N-terminal  tail  with  
Asf1.  A. Overlay  of 1 H- 15 N  HSQC  spectra  of 50  μM 15 N-labelled  H3  in  the  H3:H4  complex  (green),  in 
the  Asf1–H3:H4  complex  (grey)  and  in  the  Asf1–H3:H4  complex  upon  addition  of  Rtt109  (yellow).  In 
Asf1–H3:H4,  peaks  assigned  to  H3  19-26  display  strong  CSPs  indicating  binding  of  those  residues  by 
Asf1.  Upon  addition  of  Rtt109,  peaks  belonging  to  H3  19-26  are  located  between  the  Asf1-bound  and 
free  form,  indicating  that  Rtt109  can  outcompete  the  H3  tail  for  the  interaction  with  Asf1. B. Overlay  of 
1 H- 15 N  HSQC  spectra  of 50  μM 15 N-labelled  H3  in  the  H3:H4  complex  (green),  in  the  Asf1–H3:H4 
complex  (grey)  and  in  the  Asf1–H3:H4  complex  upon  addition  of  Vps75 2  (blue).  Upon  addition  of  
Vps75 2 ,  peaks  belonging  to  H3  15-32  appear  to  be  in  neither  in  the  Asf1-bound  state,  nor  in  the  free 
state,  indicating  that  Vps75 2  both  releases  the  H3  tail  from  Asf1  and  interacts  with  it.  The  figure  is  
adapted  from  Lercher et  al ,  2018,  Danilenko et  al ,  2019  and  originally  produced  by  myself;  the  data 
was  produced  jointly  with  Dr.  L.  Lercher. 
Next,  to  test  the  functional  relevance  of  the  Asf1–  Rtt109 419-433  interaction,  I  used in  vitro dot  
blot  assays  to  monitor  the  acetylation  of  K9  and  K56  by  Rtt109  and  Rtt109 1-424 ,  a  truncated 
version  of  Rtt109  lacking  the  C-terminal  residues  crucial  for  the  interaction  with  Asf1  (Fig. 
4.3.4). 
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 Figure  4.3.4.  The  C-terminal  tail  of  Rtt109  is  required  for  H3  K9  acetylation  only  in  the  absence 
of  Vps75 2 . A,  B .  Time-course  of  H3  acetylation  in  the  Asf1–H3:H4  sub-complex  by  Rtt109–Vps75 2  
(blue),  Rtt109 1-424 –Vps75 2  (green),  Rtt109  (red),  Rtt109 1-424  (yellow).  Acetylation  reactions  were   
allowed  to  proceed  for  the  indicated  time,  spotted  on  the  membrane  and  stained  with  antibodies 
against  acetylated  H3  K9  ( A )  or  H3  K56  ( B ).  The  dot  blots  (left  panels)  were  quantified  and  the 
intensity  of  the  dots,  representing  the  amount  of  acetylated  H3,  were  plotted  (right  panels).  Reaction 
without  Rtt109  (Asf1–H3:H4,  grey)  is  a  control  for  the  antibody  specificity  towards  acetylated  H3.  The 
experiments  were  repeated  three  times;  the  error  bars  represent  the  standard  deviation.  The  figure  is 
adapted  from  Lercher et  al ,  2018  and  was  originally  produced  by  myself;  the  data  was  produced  by 
myself. 
Fig.  4.3.4A  shows  that  in  the  absence  of  Vps75 2 ,  H3  K9  acetylation  is  significantly  reduced 
when  the  Rtt109  C-terminal  residues  are  eliminated.  However,  we  observed  no  difference  in 
the  acetylation  activity  of  Rtt109  and  Rtt109 1-424  in  complexes  containing  Vps75 2 .  This  data  is  
in  agreement  with  the  results  discussed  in  this  section:  the  interaction  between  the  enzyme 
and  the  Asf1–H3:H4  substrate  relies  on  the  Rtt109  C-terminal  tail,  which  also  releases  the 
H3  N-terminal  tail  from  Asf1,  making  it  available  for  acetylation.  Addition  of  Vps75 2  can  
functionally  compensate  for  the  role  of  Rtt109  C-terminal  tail  in  K9  acetylation,  because  it 
can  both  free  the  H3  tail,  containing  K9,  from  Asf1  and  facilitate  the  interaction  between 
Rtt109  and  the  histones  (Fig.  4.3.5).  For  an  optimal  level  of  K56  acetylation,  however,  the 
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 presence  of  both  Vps75 2   and  Rtt109  C-terminus  are  required. 
 
Figure  4.3.5. Scheme  of  the  described  interactions.  H3  N-terminal  tail  is  bound  and  protected  from 
acetylation  by  Asf1  in  Asf1–H3:H4,  but  is  released  by  Rtt109  C-terminus  via  competition  for  the  same 
Asf1  site  or  by  Vps75 2  via  interaction  with  Vps75 2 .  The  figure  is  adapted  from  Lercher et  al .,  2018  and  
was  originally  produced  by  myself. 
In  summary,  we  found  that  Asf1  binds  the  H3  N-terminal  tail,  for  example  to  protect  it  from 
nonspecific  interactions  or  modifications.  The  Rtt109  C-terminal  tail  and  Vps75 2  are  required  
to  overcome  this  Asf1-H3  interaction  via  different  mechanisms.  The  Rtt109  C-terminal  tail  is 
solely  responsible  for  the  Rtt109  interaction  with  Asf1  (Lercher et  al ,  2018)  and  for  the 
release  of  the  H3  N-terminal  tail  from  Asf1  in  the  absence  of  Vps75. In  vitro  Vps75 2  is  able  to  
fully  replace  the  Rtt109  C-terminal  tail  function  in  K9  acetylation;  however, in  vivo  both 
elements  are  required,  suggesting  the  presence  of  additional  factors  or  interactions 
impacting  K9  acetylation  (Radovani  et  al ,  2013) . 
4.4.  Determination  of  the  Rtt109-Vps75 2 -Asf1-H3:H4  complex 
structural  model. 
To  gain  further  insights  into  the  mechanism  of  Rtt109  activation  by  Asf1  and  Vps75,  I  set  out 
to  solve  the  structure  of  the  RVAH  complex  by  an  integrative  structural  biology  approach, 
combining  in-solution  data  from  NMR  and  SANS. 
Selection  of  the  docking  blocks:  Vps75 2   adopts  a  new  conformation  in 
the  RVAH  complex  to  accommodate  the  enzyme  and  the  histones. 
To  solve  the  structure  of  the  RVAH  complex  I  employed  the  M3  docking  protocol  described  in 
section  3.7  (Fig.  4.4.7).  M3  calculates  complex  structures  from  semi-flexible  subunits 
(building  blocks)  using  distance  restraints  between  them.  A  low  number  of  building  blocks 
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 simplifies  the  calculation  and  requires  fewer  distance  restraints.  The  hexameric 
Rtt109–Vps75 2 –Asf1–H3:H4  complex  can  be  considered  as  a  combination  of  two  building 
blocks  consisting  of  the  X-ray  structure  of S.  cerevisiae  Asf1  in  complex  with  the Xenopus 
laevis  H3:H4  (PDB  entry  2hue)  and  of  the  structure  of S.  cerevisiae  Rtt109–Vps75 2  (PDB  
entry  3q66). 
To  be  able  to  calculate  the  complex  structure  from  the  known  structures  of  the  building 
blocks,  one  needs  to  assume  that  the  building  blocks  do  not  undergo  significant 
conformational  changes  upon  the  formation  of  the  full  complex.  To  test  this  assumption  in  the 
case  of  the  RVAH  complex,  I  used  both  NMR  and  SANS  to  monitor  the  changes  in  the 
Asf1–H3:H4  and  Rtt109–Vps75 2   structures  upon  formation  of  the  RVAH  complex. 
 
As  far  as  the  Asf1–H3:H4  subunit  is  concerned  (PDB  entry  2hue),  NMR  data  demonstrate 
that  the  interaction  interface  between  Asf1  and  H3:H4  is  preserved  in  the  RVAH  complex 
(Fig.  4.4.1).  The  majority  of  the  chemical  shift  differences  observed  between  the  free 
Asf1–H3:H4  and  Asf1–H3:H4  in  the  context  of  the  RVAH  complex  could  be  mapped  to  the 
Asf1  surface  at  the  Rtt109 419-433  binding  site.  As  discussed  in  section  4.3,  this  area  is  on  the  
opposite  side  of  the  Asf1  H3:H4  binding  site,  thus  the  observed  CSPs  are  likely  a  result  of 
the  Asf1  interaction  with  the  Rtt109  C-terminus  and  release  of  the  H3  N-terminal  tail  (absent 
in  the  PDB  entry  2hue).  As  Asf1  residues  engaged  with  the  H3:H4  core  did  not  display 
CSPs,  I  concluded  that  this  interaction  is  preserved  in  the  full  RVAH  complex.  A  further 
argument  in  favor  of  this  conclusion  is  provided  by  the  SANS  data.  The  Asf1–H3:H4 
structure  (PDB  entry  2hue)  fits  well  to  the  SANS  data  reporting  on  the  Asf1–H3:H4  shape  in 
the  context  of  the  RVAH  complex,  further  confirming  that  this  structure  can  be  used  as  a 
docking  block  (Fig.  4.4.1B). 
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 Figure  4.4.1. Asf1–H3:H4  structure  (PDB  entry  2hue)  is  preserved  within  the  RVAH  complex. A . 
Overlay  of 1 H- 13 C  HMQC  spectra  of  50  μM  ILV  methyl-labeled  Asf1  in  complex  with  unlabelled  H3:H4 
or  H3:H4–Rtt109–Vps75 2 .  Residues  displaying  chemical  shift  differences  are  marked.  Spectra  were 
recorded  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K. B . 
Overlay  of  the  experimental  SANS  curve  (black,  dotted)  acquired  for  RVAH  complex  assembled  with 
1 H-Asf1–H3:H4  and 2 H(70%)-Rtt109–Vps75 2  in  100%  D 2 O  buffer  with  the  curve  predicted  from  the  
structure  of  the  RVAH complex  (green)  generated  with  PDB  entry  2hue  as  the  Asf1–H3:H4  building 
block.  The  schematic  representation  shows  the  proteins  contributing  to  the  scattering  intensity 
(Asf1,H3:H4)  in  color,  contrast-matched  proteins  (Rtt109,  Vps75)  in  grey.  Figure  is  adapted  from 
Danilenko  et  al .,  2019  and  originally  produced  by  myself. 
 
On  the  other  hand,  the  fit  of  the  Rtt109–Vps75 2  structure  (PDB  entry  3q66)  to  the  SANS  data  
reporting  on  the  Rtt109–Vps75 2  conformation  in  the  RVAH  complex  was  not  satisfactory  (Fig.  
4.4.2B).  Unlike  the  Asf1–H3:H4  structures,  the  known  structures  of  Rtt109–Vps75 2  
complexes  and  Vps75 2  dimers  suggest  a  large  conformational  flexibility  of  the  Vps75 2  dimer.   
As  it  can  be  seen  from  the  superposition  of  these  structures,  the  conformation  of  Vps75 2  
ranges  from  “open”  to  “closed”,  with  the  degree  of  opening  determined  by  the  extent  of  the 
kink  in  the  dimerisation  helixes  at  residue  P42  (Fig.  4.4.2A). 
 
Figure.  4.4.2.  The  Rtt109–Vps75 2 conformation  in  the  RVAH  complex  differs  from  the  structure 
of  PDB  entry  3q66.  A. The  overlay  of  Rtt109–Vps75 2  and  Vps75 2  structures  aligned  by  Vps75(B)  to   
PDB  entry  3q66  shows  that  the  Vps75 2  dimer  can  adopt  more  closed  or  more  open  conformations.  B.  
Overlay  of  the  experimental  SANS  curve  (black,  dotted)  acquired  for  the  RVAH  complex  assembled 
with 2 H-Rtt109–Vps75 2  and 1 H-Asf1–H3:H4  in  42%  D 2 O  buffer  with  the  curve  predicted  from  the  PDB  
entry  3q66  (green).  The  region  of  the  mismatch  is  marked  by  an  arrow.  The  figure  is  adapted  from 
Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
 
To  determine  the  conformation  adopted  by  Rtt109–Vps75 2  in  the  RVAH  complex  we  used  a  
combination  of  MD  simulations  (see  section  3.8)  and  SANS.  An  unrestrained  400  ns  MD 
simulation,  starting  from  the  Rtt109–Vps75 2  structure  of  PDB  entry  3q66  was  used  by  Dr.  L.  
Lercher  to  explore  the  conformational  space  of  the  Rtt109–Vps75 2  complex.  The  400  
snapshot  structures  resulting  from  the  MD  simulation  were  scored  against  the  SANS  curves 
to  identify  the  structures  with  the  best  fit  to  the  experimental  data.  I  recorded  three  SANS 
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 datasets  reporting  on  the  conformation  of  Rtt109,  Vps75 2  and  Rtt109–Vps75 2  in  the  full   
complex  (the 1 H-Vps75 2 1–225 –Asf1–H3:H4 2 H-Rtt109; 1 H-Rtt109–Asf1–H3:H4 2 H-Vps75 2 1–225  
and 1 H-Asf1–H3:H4 2 H-Rtt109–Vps75 2 1–225  samples,  respectively )  (Fig.  4.4.3A).  The  scoring  5
against  the  first  dataset  yielded  good  fits  and  nearly  identical  𝜒 2  values  between  the  
experimental  and  back-calculated  curves  for  all  400  structures.  This  indicated  that  (i)  the 
shape  of  Rtt109  did  not  get  significantly  altered  during  the  MD  simulations,  (ii)  it  adequately 
describes  the  Rtt109  conformation  in  the  context  of  the  RVAH  complex. 
The  selection  of  the  structure  to  use  as  building  block  was  done  by  scoring  against  the 
curves  reporting  on  the  Vps75 2  and  the  Rtt109–Vps75 2  shapes  ( 1 H-Rtt109–Asf1–H3:H4   
2 H-Vps75 2 1–225  and 1 H-Asf1–H3:H4 2 H-Rtt109–Vps75 2 1–225  samples).  The  𝜒 2  values between    
the  experimental  SANS  data  and  SANS  data  calculated  from  the MD  structures  were 
normalised  from  0  to  1  for  each  of  the  two  datasets.  Subsequently,  the  fitness  parameter, 
represented  by  the  sum  of  the  normalised  𝜒 2  for  each  structure,  was  used  to  rank  
Rtt109–Vps75 2   structures  according  to  their  fitness  to  both  SANS  datasets. 
Based  on  the  fit  to  the  experimental  scattering  curves,  I  selected  an  ensemble  of  10 
top-ranking  Rtt109–Vps75 2  structures  to  represent  the  second  building  block  in  M3.  Fig.  
4.4.3D  shows  that  all  selected  structures,  despite  belonging  to  different  clusters,  display  a 
similar  opening  and  rotation  of  Vps75(A)  relative  to  Rtt109.  This  new  Vps75 2  conformation  
results  in  a  better  accessibility  of  the  Vps75  earmuff  domain,  which  was  previously  identified 
as  a  potential  binding  site  for  Asf1–H3:H4  (section  4.2). 
 
5 Vps75 2 1–225  with  the  truncation  of  the  39  C-terminal  residues  was  used  for  these  experiments  to   
match  the  number  of  Vps75  residues  present  in  the  PDB  entry  3q66.  The  use  of  the  truncated 
proteins  for  SANS  samples  is  discussed  below  in  the  subsection  “Distance  restraints”. 
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 Figure  4.4.3. Selection  of  the  Rtt109–Vps75 2  building  block  for  M3. A .  Schematic  representation  
of  SANS  datasets  used  for  the  selection  of  the  Rtt109–Vps75 2  conformation.  The  colored  proteins  
contribute  to  the  scattering-intensity,  while  the  grey  proteins  are  effectively  invisible  due  to 
contrast-matching  with  the  solvent.  While  the  MD-generated  structures  can  be  discriminated  by  𝜒 2  
values  for  the  datasets  on  the  left,  they  fitted  equally  well  to  the  dataset  reporting  on  the  Rtt109 
conformation  in  the  RVAH  complex. B .  Plot  of  the  normalized  𝜒 2  versus  structural  similarity  
(orientational  root-mean-square  deviation,  o-RMSD)  to  the  PDB  entry  3q66  for  the  MD-generated 
structures  of  the  Rtt109–  Vps75 2 complex.  The  o-RMSD  was  calculated  for  Vps75(A)  relative  to 
Rtt109.  The  normalized  𝜒 2 was  calculated  for  the  two  SANS  curves  used  in  the  selection.  The  
conformers  are  clustered  by  o-RMSD  and  the  clusters  are  shown  in  different  colors.  Ten  structures 
with  lowest  normalized  𝜒 2 ,  which  contain  representatives  from  the  three  best-scoring  clusters,  were 
selected  as  building  blocks  for  M3.  All  selected  structures  have  a  better  fitness  to  the  experimental 
SANS  data  than  the  structure  of  PDB  entry  3q66. C .  Overlay  of  the  experimental  SANS  curves  used 
for  the  selection  (black,  dotted)  with  the  curves  predicted  from  the  structure  of  PDB  entry  3q66  (green 
and  grey)  and  from  the  MD-generated  structure  with  the  best  fitness  to  the  SANS  data  (dark  red,  red). 
D .  Overlay  of  the  structure  of  PDB  entry  3q66  and  ( left )  10  selected  MD  structures;  ( right )  the 
selected  MD  structure  with  the  best  fitness.  All  selected  models  adopt  the  more  open  conformation, 
which  results  in  a  higher  accessibility  of  the  Vps75(A)  earmuff  domain  for  substrate  binding.  The 
figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally  produced  by  myself;  the  data  was 
produced  jointly  with  Dr.  L.  Lercher. 
Distance  restraints. 
To  gain  sufficient  information  for  the  docking  of  the  building  blocks  into  the  complex 
structure,  I  measured  a  number  of  PRE-derived  distance  restraints  as  well  as  a  series  of 
SANS  curves  with  contrast  matching. 
Measurement  of  PRE  restraints.  The  PRE  experiments  were  conducted  on  the  complexes 
reconstituted  with  the  full  length  proteins  as  described  in  section  3.5.  The  distances  between 
the  building  blocks  were  derived  by  placing  paramagnetic  tags  on  H3  or  H4  and  by 
monitoring  the  I/ILV  methyl-groups  of  Rtt109/Vps75.  The  positions  of  the  spin-labels  as  well 
as  the  overall  number  of  extracted  distances  for  each  dataset  are  shown  in  Fig.  4.4.4. 
 
Figure  4.4.4.  PRE-derived  distance  restraints.  8  PRE  datasets  were  recorded  with  the 
paramagnetic  tags  attached  to  H3/H4  (positions  are  indicated  by  blue  or  yellow  spheres);  2  of  the 
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 datasets  reported  on  the  distances  between  the  tag  and  Rtt109  I  methyl  groups  (yellow  markers),  the 
remaining  datasets  reported  on  the  distances  between  the  tag  and  Vps75 2  ILV  methyl  groups  (blue).  
An  additional  restraint  was  added  to  loosely  limit  the  distance  between  Rtt109  and  Asf1  to  guarantee 
the  Rtt109 419-433 -Asf1  interaction. 
 
Ambiguity  in  the  Rtt109  methyl-group  assignment  (discussed  in  section  4.7)  did  not  interfere 
with  the  generation  of  the  PRE-derived  restraints  between  Rtt109  and  the  histones.  All  PRE 
measurements  from  H3/H4  to  the  I  methyl  groups  of  Rtt109  returned  so-called  “negative” 
restraints,  meaning  that  the  paramagnetic  tag  was  located  too  far  from  the  methyl  group  to 
have  an  influence  on  the  NMR  signal.  In  this  case  a  distance  restraint  greater  than  24 Å  was 
given  between  the  methyl  group  and  the Cβ  of  the  tagged  residue.  Because  all  distance 
restraints  were  identical,  they  could  be  assigned  to  the  Rtt109  I  methyl  groups  irrespective  of 
the  assignment.  This  yielded  18  restraints  between  H3/H4  and  Rtt109. 
The  generation  of  distance  restraints  from  the  experiments  with  the  ILV  methyl-labelled 
Vps75 2  was  complicated  by  the  presence  of  two  chains.  Initially,  I  attempted  to  generate  
restraints  using  the  “or”  statement,  where  distances  were  assigned  to  the  methyl  group  of 
Vps75(A)  or  Vps75(B).  Restraints  generated  by  this  approach  proved  to  be  too  ambiguous, 
failing  to  produce  a  convergent  structural  ensemble.  To  solve  this  problem,  I  used  only 
well-resolved  peaks,  which  could  be  unambiguously  assigned  to  either  Vps75(A)  or 
Vps75(B)  methyl  groups.  In  addition,  when  the  distance  between  the  corresponding  methyl 
groups  of  chain  A  and  B  was  two  times  larger  than  the  radius  of  the  sphere  influenced  by  the 
paramagnetic  tag,  I  generated  additional  distance  restraints  assuming  that  0.5  of  the 
methyl-group  peak  intensity  was  influenced  by  the  presence  of  the  paramagnetic  tag  and 
assigning  this  to  the  methyl-group  of  the  chain  A  or  B.  This  approach  allowed  to  generate 
126  distance  restraints  between  H3/H4  and  Vps75 2 . 
 
SANS-derived  restraints.  Vps75,  H3,  H4  and  Rtt109  possess  disordered  tails:  residues 
225-264  in  Vps75  (later  referred  to  as  the  Vps75  C-terminal  acidic  domain,  CTAD),  1-34  in 
H3,  418-436  in  Rtt109,  1-19  in  H4.  These  disordered  sequences  are  absent  in  the  X-ray 
structures  serving  as  the  building  blocks.  Presence  of  these  residues  in  the  SANS  samples 
could  compromise  fitting  of  the  RVAH  complex  structures,  generated  from  the  building 
blocks,  to  the  SANS  data.  The  Rtt109  and  H4  parts  missing  in  the  building  blocks  comprise 
of  only  18  residues  each,  while  the  longer  Vps75  CTAD  and  H3  N-terminal  tail  (1-34)  could 
affect  the  fitting  to  the  SANS  data  more  significantly.  
To  determine  whether  the  RVAH  complex  could  be  assembled  without  these  disordered  tails, 
I  used  Vps75  and  H3  constructs  with  truncated  tails  (Vps75 1–225  and H3 35–135 )  for   
reconstitution  of  the  RVAH  complex.  I  then  monitored  the  complex  assembly  using 1 H- 13 C 
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 HMQC  spectra  of  ILV  methyl-labelled  Vps75 2  or  Vps75 2 1–225  (Fig.  4.4.5).  The  CSPs  for   
full-length  and  truncated  Vps75 2  upon  subsequent  addition  of  Asf1–H3/(H3 35–135 ):H4  and  
Rtt109  followed  the  same  pattern,  indicating  that  the  truncations  did  not  affect  the 
interactions  between  Vps75  and  the  remaining  complex  components.  Moreover,  I  verified  by 
SANS  that  the  Asf1-Rtt109  conformation  is  preserved  in  the  RVAH  complex  assembled  with 
the  Vps75 1–225  and  H3 35–135 .  SANS  samples  of  RVAH  complexes  reconstituted  with 2 H  
Asf1–Rtt109  and  either 1 H  Vps75 2 1–225 –Asf1–H3 35–135 :H4  or 1 H  Vps75 2 –Asf1–H3:H4  resulted 
in  the  identical  curves.  In  conclusion,  truncation  of  the  Vps75  CTAD  and  H3  N-terminus  did 
not  interfere  with  the  assembly  of  the  complex.  Furthermore,  the  RVAH  complex  assembled 
with  the  truncated  proteins  could  be  isolated  by  SEC  and  the  interactions  between  the 
complex  components  were  preserved. 
 
Figure  4.4.5.  The  assembly  of  the  RVAH  complex  does  not  depend  on  the  Vps75  CTAD  and  H3 
N-terminal  tail  (residues  1-34).  A. Overlay  of 1 H- 13 C  HMQC  spectra  of  60  μM  Vps75 2 in  isolation  and 
upon  subsequent  addition  of  Asf1–H3:H4  and  Rtt109  ( top );  overlay  of 1 H- 13 C  HMQC  spectra  of  60  μM 
Vps75 2 1-225  in  isolation  and  upon  subsequent  addition  of  Asf1–H3 35-135 :H4  and  Rtt109  ( bottom ).  The  
CSPs  of  the  Vps75  follow  the  same  pattern  in  both  Asf1–H3:H4–Rtt109–Vps75 2 and 
Asf1–H3 35-135 :H4–Rtt109–Vps75 2 1-225 . B-C. CSP  analysis  of  the  spectra  in  ( A ).  Spectra  were  recorded 
in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K.  Titration  with 
Vps75 2 was  done  in  a  D 2 O-based  buffer,  while  the  one  for  Vps75 2 1-225  was  done  in  a  H 2 O-based  buffer.  
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 The  differences  in  the  CSPs  values  between  the  spectra  are  caused  by  the  isotopic  effects  induced  by 
the  different  solvents. D .  Overlay  of  the  experimental  SANS  curves  acquired  for  the  RVAH  complex 
assembled  with 2 H-Rtt109–Asf1  and 1 H-H3:H4–Vps75 2  in  42%  D 2 O  (grey); 2 H-Rtt109–Asf1  and  
1 H-H3 35-135 :H4–Vps75 2 1-225  in  42%  D 2 O.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  
originally  produced  by  myself. 
 
Six  SANS  datasets  on  the  RVAH  complexes  reconstituted  with  Vps75 1–225  and  H3 35–135  were   
recorded  to  be  used  in  the  M3  protocol  (Fig.  4.4.6).  The  labelling  schemes  were  chosen  in  a 
way  that  allowed  to  obtain  information  on  the  shapes  of  the  two  docking  blocks  or  their  parts 
in  relation  to  each  other. 
 
Figure  4.4.6.  SANS  restraint  table .  Schematic  representation  of  the  SANS  samples  measured  for 
the  M3  protocol.  The  colored  proteins  contribute  to  the  scattering-intensity  with  either  positive  (+)  or 
negative  (–)  contrast,  while  the  grey  proteins  are  effectively  invisible  due  to  contrast-matching  with  the 
solvent. 
Structure  calculation. 
The  scheme  of  the  M3  protocol  is  shown  in  the  Fig.  4.4.7.  The  PRE-derived  distance 
restraints  were  used  to  drive  the  generation  of  the  RVAH  complex  models. 
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Figure  4.4.7.  Scheme  of  the  M3  calculation  protocol. During  the  it0  stage,  the  building  blocks  are 
treated  as  rigid  bodies  and  their  docking  is  guided  by  the  PRE-derived  distance  restraints.  After  it0,  15 
structures  with  significantly  better  distance  restraint  violation  energy  were  selected  for  the  next  stage 
(it1).  During  the  high  temperature  simulated  annealing  (SA)  in  it1,  the  extended  conformational  search 
was  driven  again  by  the  PRE-derived  distance  restraints;  the side-chains  of  residues  at  the  interaction 
interfaces  were  flexible.  After  it1  the  structures  were  scored  against  the  six  SANS  datasets  and  the 
cluster  with  the  best  fitness  was  selected.  The  protocol  is  described  in  detail  in  section  3.7. 
 
The  150  structures  resulting  from  the  flexible  refinement  round  were  scored  against  the 
above-mentioned  SANS  datasets  and  clustered  by  their  structural  similarity  (o-RMSD)  to  the 
structure  with  the  best  fitness  to  the  SANS  data.  The  best  scoring  cluster  (green  in  Fig. 
4.4.8)  contained  33  structures  with  significantly  better  fitness  to  the  SANS  curves  than  the 
other  structures;  these  structures  were  therefore  selected  as  the  final  ensemble.  T he 
structure  closest  to  the  ensemble  center  (1.4  Å  average  RMSD  to  the  other  structures  in  the 
ensemble)  was  selected  as  the  ensemble  representative.  This  RVAH  complex  structure  was 
refined  in  explicit  water  as  described  in  section  3.8  and  deposited  as  PDB  entry  6o22. 
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Figure  4.4.8.  Cluster  selection. A.  Correlation  between  the  o-RMSD  of  the  RVAH  structural  models 
calculated  by  the  M3  protocol  and  their  agreement  to  the  experimental  SANS  data  (fitness).  The 
o-RMSD  was  calculated  with  respect  to  the  structure  with  the  best  fitness;  the  structures  were 
clustered  by  o-RMSD  and  each  cluster  is  represented  by  one  color.  Members  of  the  cluster  that  best 
fit  the  experimental  data  (green  cluster)  with  the  fitness  value  below  the  indicated  threshold  were 
selected  as  the  final  ensemble  (33  structures). B. Superposition  of  the  33  structures  of  the  final 
ensemble.  The  figure  is  adapted  from  Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
 
The  deposited  structure  (PDB  entry  6o22)  fitted  well  to  the  experimental  data,  including  both 
PRE  measurements  and  SANS  curves  (Fig.  4.4.9,  Fig.  4.4.10). 
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 Figure  4.4.9. Fit  of  the  structural  model  to  the  PRE-derived  restraints. A. The  positions  of  the 
paramagnetic  tags  used  in  the  PRE  measurements  (color  coding  as  in  Fig.  4.4.4). B. Comparison  of 
experimental  (red)  and  back-calculated  (light  blue)  ratios  of  peak  intensities  measured  in  the  presence 
of  the  paramagnetic  ( I para )  or  diamagnetic  ( I dia )  forms  of  the  tags..  The  figure  is  adapted  from  Danilenko 
et  al ,  2019  and  was  originally  produced  by  myself. 
 
Figure  4.4.10. Fits  of  the  curves  predicted  from  the  structure  of  the  RVAH complex  (PDB  entry  6o22) 
to  the  experimental  curves  corresponding  to  the  samples  shown  in  Fig.  4.4.6.  The  experimental  data 
is  shown  as  dots,  curves  back-calculated  from  the  PDB  entry  6o22  are  shown  as  lines.  The  plot  on 
the  right  shows  the  Guinier  region  of  the  curves.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and 
was  originally  produced  by  myself. 
 
4.5.  The  structure  of  the  RVAH  complex  and  its  functional 
annotation. 
The  structural  model  of  the  RVAH  complex  obtained  in  this  work  provides  several  key 
insights  into  the  acetylation  mechanism  of  both  the  H3  N-terminal  tail  and  H3  K56. 
 
Overview  of  the  RVAH  structural  model. The  RVAH  complex  is  characterised  by  a 
bagel-like  shape  with  a  central  cavity  of  approximately  25 Å  in  diameter. The  bottom  half  of 
the  bagel  is  formed  by  the  Vps75 2  dimer,  while  the  top  part  is  composed  of  
Rtt109–Asf1–H3:H4  (Fig.  4.5.1).  As  expected  from  previous  NMR  titration  experiments 
(section  4.2),  Vps75(B)  is  occupied  by  Rtt109  and  Vps75(A)  binds  histones  via  its  earmuff 
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 domain.  In  addition,  the  Vps75(A)  α5  helix  makes  contacts  with  Rtt109,  further  facilitating  the 
Rtt109-(H3:H4)  interaction.  The  Vps75  acidic  cavity  builds  the  floor  of  the  internal  cavity  of 
the  bagel,  while  the  top  part  is  formed  by  the  positively  charged  H3:H4  and  Rtt109  surfaces 
(including  the  Rtt109  active  center). 
 
Figure  4.5.1.  The  RVAH  complex  adopts  a  bagel-like  shape.  A. The  structure  of  the  RVAH 
complex  (PDB  entry  6o22).  The  flat  ribbon  (yellow)  connecting  the  Rtt109  core  and  the  Rtt109 418-433  
region  replaces  the  part  of  the  Rtt109  C-terminal  tail  for  which  no  structural  information  is  available. B. 
Electrostatic  surface  representation  of  the  inner  surface  of  the  complex.  D225  and  G231  are  the  last 
structured  amino  acids  of  Vps75 2 ;  L60  is  the  first  amino  acid  of  the  H3  core;  the  Vps75- 206 EE 207  dyad  
is  at  the  center  of  an  acidic  patch  of  the  Vps75  earmuff  domains.  The  figure  is  adapted  from 
Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
 
The  Vps75  CTADs  (residues  226-264)  and  the  H3  N-terminal  tail  (residues  1-59)  are  not 
present  in  the  structural  model.  The  Vps75(A)  and  Vps75(B)  CTADs  start  next  to  the  basic 
surfaces  of  H3:H4  and  Rtt109  respectively.  The  C-terminal  end  of  the  H3  N-terminal  tail  (H3 
L60)  faces  the  inner  cavity  of  the  complex  and  is  located  in  the  vicinity  of  the  Rtt109  active 
center.  The  distance  between  H3  L60  and  acCoA  in  our  model  is  nearly  identical  to  the  one 
in  the Af  RAH  structure,  confirming  that  H3  K56  can  reach  into  the  Rtt109  active  center  in 
the  RVAH  complex  (Fig.  4.5.2). 
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Figure  4.5.2.  The  RVAH  structural  model  is  compatible  with  Asf1  and  Vps75  promoting  H3  K56 
acetylation. The  distance  between  H3  L60  and  the  catalytic  center  of  Rtt109  in  the  solution  structure 
of the  RVAH  complex  (PDB  entry  6o22;  left)  is  consistent  with  the  corresponding  distance  in  the  5zba 
crystal  structure  of  the S.  cerevisiae H3:H4  in  complex  with Af Asf1  and Af Rtt109  (PDB  entry  5zba; 
right). 
 
Intermolecular  contacts  within  the  RVAH  complex. The  contacts  between  Rtt109  and 
both  histones  are  similar  to  the  ones  observed  in  the Af RAH  structure  (PDB  entry  5zba).  In 
particular,  Rtt109  makes  contacts  with  the  long  α2  helix  of  H3  via  a  salt  bridge  between 
Rtt109  R318  (R292)  and  H3  E94,  as  well  as  between  Rtt109  K323  and  H3  E105  (Fig.  4.5.3,  6
Fig.  4.5.4).  The  H3  E94-Rtt109  R318  (R292)  interaction  is  formed  by  residues  that  are 
conserved  in  various  fungi  (Fig.  4.2.5).  In  agreement  with  this,  the  H3  E94C  mutation  with 
the  subsequent  attachment  of  the  paramagnetic  tag  severely  disturbed  the  complex 
formation  (Fig.  4.5.3B). In  vivo  data  on S.  cerevisiae  also  demonstrates  the  importance  of 
the  H3  E94  for  H3  acetylation (Zhang et  al ,  2018) .  Residues  299E,  300E,  301D  of  Rtt109  are 
engaged  in  electrostatic  interactions  and  hydrogen  bonds  with  both  Vps75(A)  and  H3. 
Rtt109  299E  and  301D  interact  with  positively  charged  residues  of  the  Vps75(A)  α5  helix, 
while  the  conserved  Rtt109  E300  interacts  with  H3  S85  and  S86.  These  observations  are 
supported  by in  vivo  data,  where  Rtt109 299 EED 301  mutation  to 299 KKK 301  was  demonstrated  to   
reduce  H3  K9  and  K27  acetylation  (Kolonko  et  al ,  2010) . 
6  A  hydrogen  bond  between  Rtt109  R292  and  H3  E94  is  observed  in  some  of  the  structures  from  the  
final  ensemble,  but  not  in  the  PDB  entry  6o22. 
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Figure  4.5.3.  The  contact  between  H3  E94  and  Rtt109  is  essential  for  the  formation  of  the  RVAH 
complex.  A .  Electrostatic  contacts  between  Rtt109,  H3  and  Vps75(A)  in  the  RVAH  complex. B . 
Overlay  of 1 H- 13 C  HMQC  spectra  of  65  μM  I-labelled  Rtt109  in  complex  with  unlabelled  Vps75 2 (blue); 
upon  titration  of  Asf1–H3:H4  (pink);  or  Asf1–H3(E94C-tag):H4  (orange).  H3(E94C-tag)  contains  E94C 
mutation  followed  by  the  attachment  of  paramagnetic  tag  coupled  with  the  94C  residue.  The  peaks 
indicated  by  dashed  boxes  and  arrows  display  noticeable  CSPs  upon  addition  of  wild-type 
Asf1–H3:H4,  but  not  Asf1–H3(E94C-tag):H4.  The  spectra  were  recorded  in  50  mM  sodium  citrate  pH 
6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K.  The  figure  is  adapted  from  Danilenko et  al , 
2019  and  originally  was  produced  by  myself. 
 
In  addition,  Rtt109  interacts  with  the  C-terminus  of  H4,  where  H4  R95  is  engaged  in  a 
hydrogen  bond  with  Rtt109  E317  (Fig.  4.5.4A).  Interaction  of  the  last  residues  of  the  H4 
C-terminus  with  Rtt109  is  supported  by  the 1 H- 15 N  HSQC  spectra  of  H4:  the  C-terminal  H4 
G102  is  not  affected  by  the  interaction  of  Asf1–H3:H4  with  Vps75 2 ,  but  disappears  upon 
addition  of  Rtt109  to  the  Asf1–H3:H4–Vps75 2  complex. In  vitro ,  deletion  of  the  H4  
C-terminus  (95-102)  reduced  H3  K56  acetylation  nearly  2-fold,  while  H3  K9  acetylation  was 
unaffected. 
Deletion  of  the  Rtt109  C-terminus,  responsible  for  interaction  with  Asf1  and  release  of  the  H3 
N-terminal  tail  in  absence  of  Vps75 2 ,  had  a  similar,  albeit  less  dramatic  effect  on  H3  K56 
acetylation  by  the  RVAH  complex,  while  H3  K9  acetylation  was  less  perturbed  (Fig  4.3.4, 
section  4.3;  Fig.  4.5.4). 
The  difference  in  the  influence  of  these  mutations  on  the  acetylation  of  the  different  H3  sites 
may  be  explained  by  considering  the  position  of  these  sites  in  the  structure  of  the  complex. 
H3  K56,  as  shown  in  the  Fig.  4.5.2,  is  located  near  the  folded  core  of  H3:H4  and  is  able  to  fit 
into  the  Rtt109  active  center  only  if  the  stretch  between  H3  L60  and  K56  is  unfolded.  Any 
mutations  influencing  the  interaction  between  Asf1–H3:H4  and  Rtt109  might  result  in  a 
change  in  the  distance  between  the  Rtt109  active  center  and  H3  K56,  physically  limiting  the 
access.  On  the  other  hand,  acetylation  of  H3  K9,  located  towards  the  end  of  the  long 
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 unfolded  H3  N-terminal  tail,  can  tolerate  a  less  close  contact  between  Rtt109  and 
Asf1–H3:H4. 
 
Fig.  4.5.4.  The  H4  C-terminus  is  required  for  H3  K56,  but  not  H3  K9  acetylation. A .  Contacts 
between  Rtt109,  the  H4  C-terminus  and  H3  in  the  RVAH  complex. B .  Overlay  of 1 H- 15 N  HSQC  spectra 
of  50  μM 15 N-labelled  H4  in  the  Asf1–H3:H4  complex  (grey)  upon  titration  of  Vps75 2  (blue)  and  Rtt109  
(yellow).  Peaks  missing  in  the  spectra  of 15 N-labelled  H4 1–94  in  the  Asf1–H3:H4 1–94  complex  (red)   
belong  to  the  C-terminus  of  H4  (residues  95-102).  Only  peaks  corresponding  to  the  unfolded  residues 
are  visible  due  to  the  labelling  scheme  and  the  size  of  the  complexes.  The  H4  G102  peak  is  not 
affected  by  Vps75,  but  disappears  upon  addition  of  Rtt109  indicating  that  it  is  no  longer  in  the 
unbound  unfolded  state.  The  spectra  were  recorded  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5 
mM  BME  at  600  MHz  and  298  K. C .  Time-course  of  H3  K56  (top)  and  H3  K9  (bottom)  acetylation.  The 
dot  blots  (right  panels)  were  quantified  and  the  intensity  of  the  dots,  representing  the  amount  of 
acetylated  H3,  were  plotted  (left  panels).  The  reaction  without  Rtt109  (Asf1–H3:H4,  white)  is  a  control 
for  the  antibody  specificity  towards  acetylated  H3.  The  experiments  were  repeated  four  times;  the 
error  bars  represent  the  standard  error  of  the  mean.  The  figure  is  adapted  from  Danilenko et  al ,  2019 
and  was  originally  produced  by  myself. 
 
In  addition  to  the  Vps75(A)  α5  helix  (Fig  4.5.3),  histones  H3:H4  interact  with  the  Vps75(A) 
earmuff  domain:  H3  R69  is  engaged  in  the  stacking  interaction  with  Vps75  F77,  while  H3 
L65  and  H4  L22  fit  into  the  two  hydrophobic  pockets  formed  by  either  Vps75  residues  70-73 
or  Vps75  Q64  and  A219,  respectively  (Fig.  4.5.5).  Accordingly,  the  double  H3  R69E,R72E 
mutation  weakened  the  interaction  of  Vps75  with  the  histones. 
92 
  
Figure  4.5.5.  Interaction  of  Vps75(A)  with  H3:H4.  A. Contacts  between  Vps75(A)  and  H3:H4  in  the 
RVAH  complex. B.  Overlay  of 1 H- 13 C  HMQC  spectra  of  60  μM  ILV-methyl  labelled  Vps75 2  in  the  
presence  of  Asf1–H3:H4  or  Asf1–H3(R69E,R72E):H4.  The  H3  R69E,R72E  mutation  reduces  the 
interaction  between  Vps75  and  the  histones,  as  evident  by  the  reduction  in  CSPs.  The  spectra  were 
recorded  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K. C.  CSP 
plots  for  the  spectra  shown  in  ( B ).  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally 
produced  by  myself. 
 
The  Vps75  CTAD  shields  the  DNA-binding  surface  of  H3:H4. Although  the  Vps75  CTAD 
is  not  necessary  for  the  RVAH  complex  formation  (section  4.4),  it  was  speculated  that  the 
Vps75  CTAD  may  contribute  to  H3  acetylation in  vivo ,  independently  of  its  nuclear 
localization  signal  (Keck  &  Pemberton,  2011;  Park  et  al ,  2008) . 
To  investigate  the  function  of  the  Vps75  CTAD  and  its  potential  interactions  with  the  RVAH 
complex  components,  I  recorded  a  set  of  NMR  titration  experiments.  The  Vps75  CTAD  is 
unfolded,  thus  I  could  monitor  it  in 1 H- 15 N  HSQC  spectra  of 15 N-labelled  protonated  Vps75. 
93 
 Fig.  4.5.6  shows  that  the  Vps75  CTAD  undergoes  noticeable  CSPs  upon  addition  of  Rtt109 
and  Asf1–H3:H4;  however,  the  chemical  shift  dispersion  indicates  that  the  CTAD  remains 
unfolded  in  all  cases.  The  interaction  with  Rtt109  is  confined  to  the  last  ten  residues  of  the 
Vps75  CTAD,  while  the  negatively  charged  part  of  the  CTAD  engages  in  interactions  with 
Asf1–H3:H4. 
 
Figure  4.5.6.  The  Vps75  CTAD  interacts  with  Asf1–H3:H4  but  remains  disordered.  A. Overlay  of 
1 H- 15 N  HSQC  spectra  of 15 N-labeled  50  μM  Vps75 2  in  isolation  (grey),  in  complex  with  Rtt109  (purple)  
or  Asf1–H3:H4  (orange).  Only  peaks  corresponding  to  the  unfolded  residues  of  Vps75  are  visible  due 
to  the  labelling  scheme  and  the  size  of  the  complexes.  The  chemical  shift  dispersion  of  the  Vps75 
226–264  stretch  remains  very  narrow  indicating  that  the  Vps75  CTAD  stays  disordered  in  all 
complexes.  Spectra  were  recorded  in  50  mM  sodium  citrate  pH  5.5,  150  mM  NaCl,  5  mM  BME  at  600 
MHz  and  298  K. B. CSP  analysis  demonstrates  that  the  interaction  between  the  Vps75 2  CTADs  and  
Asf1–H3:H4  mostly  affects  residues  227-242;  these  residues  are  not  affected  by  the  interaction  with 
Rtt109. C.  Chemical  shift  analysis  of  Vps75  (226–264)  in  the  context  of  isolated  Vps75 2  by  TALOS-N  
demonstrates  that  the  Vps75  tail  is  disordered.  The  chemical  shift  dispersion  of  Vps75  CTAD  remains 
narrow  in  the  RVAH  complex.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally 
produced  by  myself. 
 
Despite  its  disordered  nature,  the  Vps75  CTAD  interacts  with  a  specific  surface  of  the 
Asf1–H3:H4  sub-complex,  as  demonstrated  by  comparison  of  the  titrations  of  the  ILV-methyl 
labelled  H3:H4  with  full-length  and  C-terminally  truncated  Vps75 2 (Vps75 2 1-225 )  (Fig.  4.5.7). 
Upon  addition  of  full-length  Vps75 2  to  Asf1–H3:H4,  The  CSPs  of  ILV-methyl  labelled  H3:H4  
mapped  on  the  H3:H4  surface  involved  in  the  interaction  with  the  earmuff  domain  (according 
to  the  structure  of  the  RVAH  complex)  and  on  the  H3:H4  DNA-binding  surface,  which  in  the 
RVAH  complex  is  located  near  the  start  of  the  Vps75  CTAD.  Truncated  Vps75 2 1-225  could  still  
bind  H3:H4  via  the  earmuff  domain,  but  did  not  interact  with  the  H3:H4  DNA-binding  surface 
(Fig.  4.5.7). 
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Figure  4.5.7.  Vps75  CTAD  H3:H4  DNA-binding.  A. 1 H- 13 C  HMQC  spectra  of  60  μM  ILV-labelled 
H3:H4  as  part  of  the  Asf1–H3:H4  sub-complex  in  the  presence  of  0.5  and  1.1  equivalents  of  Vps75 2  
(left)  or  Vps75 2 1–225 (right).  The  spectra  were  recorded  with  in  50  mM  sodium  citrate  pH  6.5,  150  mM 
NaCl,  5  mM  BME  at  850  MHz  and  298  K. B. CSPs  of  the  spectra  in  ( A )  mapped  on  the  Asf1–H3:H4 
structure  (PDB  entry  2hue;  Asf1,  H3  and  H4  are  shown  in  red,  green  and  grey,  respectively).  The 
differences  in  CSPs  between  titration  with  the  full-length  Vps75 2  (left)  and  Vps75 2 1–225 (middle)  are  
marked  by  a  rectangle.  The  CSPs  for  the  H3:H4  surface  that  interacts  with  the  Vps75 2  earmuff  
domain  (Vps75 2  folded  core)  are  similar  in  both  cases.  The  right  panel  shows  the  CSPs  of  
Asf1–H3:H4  in  the  RVAH  complex;  the  interaction  with  Vps75 2  (including  the  CTAD)  is  preserved. C.  
Electrostatic  surface  representation  of  Asf1–H3:H4.  The  surface  bound  by  the  Vps75  CTAD  is 
indicated  by  a  rectangle.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally 
produced  by  myself. 
 
These  data  suggested  that  the  Vps75  CTAD  covers  the  H3:H4  DNA-binding  surface. 
Interestingly,  the  Vps75  CTAD  does  not  appear  to  become  structured  in  this  interaction.  The 
Vps75  CTAD  lacks  the  motif  (an  acidic  stretch  with  one  or  more  aromatic  residues,  most 
often  Y)  identified  previously  as  characteristic  for  the  disordered  domains  of  chaperons  that 
wrap  around  the  DNA-binding  surface  of  histone  dimers  or  octamers (Chen et  al ,  2015; 
Huang et  al ,  2015;  Warren et  al ,  2017) .  This  interaction  of  the  Vps75  CTAD  with  H3:H4  could 
act  both  (i)  to  shield  H3:H4  from  nonspecific  interactions,  including  spurious  interaction  with 
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 DNA,  (ii)  to  reduce  the  positive  charge  of  the  inner  cavity  of  the  RVAH  complex  in  order  to 
attract  the  H3  N-terminal  tail  to  the  Rtt109  active  center. 
 
In  summary,  the  structural  model  of  the  RVAH  complex  revealed  that  both  chaperones 
facilitate  formation  of  a  complex  with  an  inner  cavity,  in  which  the  Rtt109  active  center  and 
H3  K56  are  placed  next  to  each  other.  H3  K56  acetylation  is  promoted  by  Asf1  and  Vps75 
via  a  substrate  presentation  mechanism,  where  Vps75  aids  the  formation  of  the  RVAH 
complex,  while  Asf1  interacts  with  Rtt109  C-terminus,  and  facilitates  the  interaction  between 
Rtt109  and  the  H4  C-terminus.  Both  of  these  contacts  were  found  to  be  important  for  the  H3 
K56  acetylation.  However,  the  question  remains  open  of  how  the  RVAH  complex  promotes 
acetylation  of  H3  K9,  K23  and  K27  located  in  the  long  disordered  and  positively  charged  H3 
N-terminal  tail. 
4.6.  Vps75  promotes  H3  N-terminal  tail  acetylation  via  two 
acidic  structural  elements. 
Previous in  vivo  data  as  well  as  NMR  data  from  this  work  identified  two  regions  of  Vps75  that 
could  play  a  role  in  the  H3  N-terminal  tail  acetylation:  1.  The  acidic  patch  composed  of  two 
conserved  E  (Vps75  E206,  E207;  later  referred  to  as 206 EE 207 ),  which  contributes  to  the 
negatively  charged  part  of  the  RVAH  complex  cavity  (Fig.  4.5.1);  2.  The  Vps75  CTAD. 
A  triple  mutation  of  the 205 SEE 207  to 205 AAA 207  decreases  H3  K9  acetylation  by  10% in  vivo ,   7
but  does  not  affect  the  histone  binding  affinity  of  Vps75 (Berndsen et  al ,  2008) .  In  agreement 
with  this,  in  the  RVAH  structure  this  acidic  patch  is  not  involved  in  the  interaction  with  the 
H3:H4  folded  core.  However,  ILV  residues  next  to  it  (I208,  L203,  L200)  display  CSPs  upon 
addition  of  the  Asf1–H3:H4,  indicating  a  potential  interaction  with  the  H3  N-terminal  tail. 
As  discussed  in  section  4.5,  one  of  the  two  Vps75  CTADs  of  the  Vps75  dimer  interacts  with 
the  DNA-binding  surface  of  H3:H4.  However,  it  remains  unfolded  and  potentially  available  for 
the  interaction  with  the  H3  N-terminal  tail. 
To  test  whether  any  of  these  structural  elements  are  involved  in  the  interaction  with  the  H3 
N-terminal  tail,  I  used  full-length  Vps75 2 ,  Vps75 2 1–225 ,  and  a  Vps75 2  construct  with  E206  and  
E207  mutated  to  alanines  ( AA Vps75 2 )  in  NMR  titration  experiments  with 15 N  labelled  H3  (Fig. 
4.6.1). 
 
7 In S.  cerevisiae  H3  K9  acetylation  is  carried  out  by  both  Rtt109  and  Gcn5.  In  the  cited  study,  the  
influence  of  the  Vps75  mutation  on  H3  K9  acetylation  was  monitored  in  a  strain  containing  wild-type 
Gcn5,  which  may  have  masked  the  effect  of  the  mutation  on  the  Rtt109-dependent  acetylation. 
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Figure  4.6.1. The  Vps75 206 EE 207  motif  and  the  CTAD  are  required  for  the  chaperoning  of  the  H3  
N-terminal  tail. A.  Overlay  of 1 H- 15 N  HSQC  spectra  of  60  μM  H3  in  the  H3:H4  dimer,  in  the 
Asf1–H3:H4  sub-complex,  and  in  the  Asf1–H3:H4  sub-complex  upon  addition  of  Vps75 2 ,  Vps75 2 1–225  
or AA Vps75 2 . B.  CSP  plots  for  the  spectra  in  ( A ).  Top  panel,  comparison  of  the  CSPs  between  the  free 
H3:H4  and  the  sub-complexes  with  Asf1  and  Asf1  and  Vps75  together.  Bottom  panel,  comparison  of 
the  CSPs  between  the  Asf1–H3:H4  and  the  sub-complexes  with  Vps75.  The  residues  in  the  H3 
N-terminal  tail  are  in  the  free,  unfolded  state  in  the  H3:H4  dimer;  upon  addition  of  Asf1  residues  19-28 
interact  with  Asf1  in  the  Asf1–H3:H4  sub-complex;  upon  addition  of  Vps75 2 residues  15-32  are 
released  from  Asf1  and  interact  with  Vps75  in  the  Asf1–H3:H4–Vps75 2  sub-complex.  In  the  
sub-complexes  with AA Vps75 2  and  Vps75 2 1–225 ,  the  mutant  forms  of  Vps75  appear  to  be  unable  to  bind  
the  histone  tail  like  the  wild-type  Vps75.  The  spectra  were  recorded  with  in  50  mM  sodium  citrate  pH 
6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K. 
 
Vps75  is  able  to  release  the  H3  N-terminal  tail  from  Asf1  and  bind  it  (Fig.  4.3.2,  4.3.3). 
However,  neither  one  of  the  Vps75  mutants  is  able  to  bind  the  H3  N-terminal  tail  like  the 
wild-type  chaperone  (Fig.  4.6.1B).  In  the  Asf1–H3:H4–Vps75 2 1–225  sub-complex,  the  chemical  
shifts  of  the  H3  N-terminal  tail  and  the  intensity  of  the  peaks  are  very  similar  to  the  ones 
observed  in  the  spectrum  for  the  free  H3:H4.  This  suggests  that  although  Vps75 2 1–225  is  able  
to  release  the  H3  N-terminal  tail  from  Asf1,  it  fails  to  engage  the  H3  residues  15-32.  In  the 
Asf1–H3:H4– AA Vps75 2  sub-complex,  the  resonances  of  the  H3  N-terminal  tail  appear  to  be  
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 only  partially  bound  to  Vps75.  Taken  together,  the  mutant  data  indicates  that  both  the  Vps75 
CTAD  and  the  206 EE 207  region  play  a  role  in  H3  N-terminal  tail  acetylation. 
In  agreement  with  these  data,  both  Vps75  mutants  were  unable  to  fully  release  the  H3  tail 
from  Asf1  (Fig.  4.6.2).  The  CSPs  of  the  ILV-methyl  groups  of  Asf1  displayed  an  equilibrium 
between  the  H3-bound  and  free  states  upon  addition  of  Vps75 2 1–225   or  AA Vps75 2 . 
 
Figure  4.6.2.  The  Vps75 206 EE 207  and  the  CTAD  are  required  for  the  release  of  the  H3  N-terminal  
tail  from  Asf1.  A. Overlay  of 1 H- 13 C  HMQC  spectra  and  of  60  μM  ILV-methyl  labelled  Asf1  in  the 
Asf1–H3 29-135 :H4  sub-complex,  Asf1–H3:H4  sub-complex  in  isolation  and  Asf1–H3:H4  sub-complex 
upon  addition  of  wild-type  Vps75 2 ,  Vps75 2 1–225  or AA Vps75 2 .  In  the  Asf1–H3 29-135 :H4  sub-complex,  
assembled  with  H3  lacking  the  1-28  residues  of  the  N-terminal  tail,  Asf1  residues  I60  and  V62  are  not 
bound  by  the  H3  N-terminal  tail.  In  the  Asf1–H3:H4  sub-complex,  addition  of  Vps75 2  leads  to  the  
release  of  the  H3  N-terminal  tail;  chemical  shifts  for  I60  and  V62  are  the  same  as  in  the 
Asf1–H3 29-135 :H4  sub-complex.  Addition  of  Vps75 2 1–225  and AA Vps75 2  to  the  Asf1–H3:H4  sub-complex   
leads  to  a  partial  release  of  the  H3  N-terminal  tail;  chemical  shifts  for  I60  and  V62  are  between  the  H3 
N-terminus  bound  state  and  free  state. B.  CSP  plots  for  the  spectra  in  ( A ).  Vps75 2 1–225  and AA Vps75 2   
are  able  to  only  partially  release  the  H3  N-terminal  tail  from  Asf1,  as  indicated  by  lower  CSPs  for  the 
Asf1  residues  60-69  (in  comparison  to  the  wild-type  Vps75 2 ). 
 
The  inability  of  Vps75 2 1–225  and AA Vps75 2  to  completely  release  the  H3  tail  from  Asf1  and   
engage  it  in  interactions  demonstrates  that  both  the  acidic  patch 206 EE 207 and  the  CTAD  of 
Vps75  contribute  to  recruiting  the  H3  tail  away  from  Asf1  towards  the  central  cavity  of  the 
RVAH  complex. 
The  difference  in  the  Vps75 2 1–225  and AA Vps75 2  interactions  with  the  H3  N-terminus   
suggested  that  Vps75  CTAD  is  essential  for  binding  the  H3  N-terminal  tail,  while  the  acidic 
patch 206 EE 207  could  play  a  role  in  the  release  of  the  H3  N-terminal  tail  without  a  direct  
interaction  (Fig.  4.6.1,  H3  N-terminal  tail  residues  15-32  are  bound  by AA Vps75 2 ,  but  not  by 
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 Vps75 2 1–225 ).  As  the  acidic  patch  is  located  near  the  start  of  the  H3  N-terminal  tail  (L60)  in  the 
RVAH  complex  (Fig.  4.5.1),  I  hypothesised  that  it  may  engage  in  the  interaction  with  the  H3 
residues  35-59,  not  visible  in  the 1 H- 15 N  HSQC  spectra  of  the  15N  labelled  H3.  Through  this 
interaction,  the  H3  N-terminal  tail  could  be  pulled  into  the  Vps75 2  acidic  cavity,  disrupting  its  
interaction  with  Asf1. 
The  role  of  the  acidic  patch  was  further  investigated  by  molecular  dynamics  simulations  of 
the  RVAH  complex.  In  the  simulations,  H3  residues  35-59  were  modelled  either  in  a  random 
conformation  or  in  a  conformation  where  H3  K56  was  placed  directly  into  the  Rtt109  active 
center  (Fig.  4.6.3).  Independently  of  the  starting  conformation,  the  H3  N-terminal  tail 
engaged  in  a  stable  interaction  with  the 206 EE 207  acidic  patches  on  both  Vps75  chains  via  H3  
R52  and  H3  R53.  H3  R52  was  predominantly  bound  by  the  Vps75(A)  E207,  while  H3  R53 
formed  a  hydrogen  bond  with  the  Vps75(B)  E207.  These  interactions  locked  H3  K56  away 
from  the  active  center  of  the  enzyme.  In  agreement  with  this,  H3  K56  acetylation  was 
increased  by  1.3-fold  in  the  RVAH  complex  reconstituted  with AA Vps75,  while  H3  K9 
acetylation  was  unaffected. 
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Figure  4.6.3.  The  Vps75  acidic  patch  captures  H3  R52  and  R53  and  keeps  H3  K56  away  from 
the  Rtt109  active  center.  A-B. Snapshots  from  the  MD  simulation  trajectories  at  0  and  100  ns.  Left, 
starting  conformation  of  the  RVAH  complex  with  H3  residues  35-59.  Right,  final  conformation  at  100 
ns.  Residues  H3  35-59  were  modelled  without  any  restrains  ( A )  or  with  H3  K56  placed  into  the  Rtt109 
active  center  in  the  starting  conformation  ( B ). C-D. Analysis  of  hydrogen  bonds  present  between  H3 
R52,  R53  and  Vps75  E206,  E207  in  the  100  ns  MD  simulations  of the  RVAH  complex  from  (A)  and 
(B),  respectively. Both  MD  simulations  result  in  the  formation  of  stable  hydrogen-bonds  (H-bonds) 
between  H3  R52  and  Vps75(A)  E207  and  between  H3  R53  and  Vps75(B)  E207,  which  are 
incompatible  with  H3  K56 reaching  the  Rtt109  catalytic  center. E.  Time-course  of  H3  acetylation  in 
Asf1–H3:H4  by  Rtt109–Vps75 2  (blue)  or  Rtt109– AA Vps75 2  (orange).  Acetylation  reactions  were   
allowed  to  proceed  for  the  indicated  time,  spotted  on  the  membrane  and  stained  with  antibodies 
against  acetylated  H3  K56  (left)  or  H3  K9  (right).  The  dot  blots  were  quantified  and  the  intensity  of  the 
dots,  representing  the  amount  of  acetylated  H3,  were  plotted.  The  reaction  without  Rtt109 
(Asf1–H3:H4,  white)  is  a  control  for  the  antibody  specificity  towards  the  acetylated  H3.  The 
experiments  were  repeated  four  times;  the  error  bars  represent  the  standard  error  of  the  mean.  The 
figure  is  adapted  from  Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
 
I  then  investigated  further  the  role  of  the  Vps75  CTAD  and  its  interaction  with  the  H3 
N-terminal  tail.  While  this  interaction  is  preserved  in  the  RVAH  complex,  the  intensity  of 
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 peaks  of  the  H3  tail  backbone  amide  resonances  decreased  in  comparison  to  the  spectra  of 
the  Vps75 2 –Asf1–H3:H4  sub-complex  (Fig.  4.6.4).  This  difference  suggests  that  the  H3 
N-terminal  tail  has  a  lower  mobility  in  the  RVAH  complex,  possibly  due  to  its  confinement  in 
the  central  cavity  of  the  complex.  To  test  the  hypothesis  that  the  Vps75  CTAD  interacts  with 
the  H3  N-terminal  tail,  attracting  it  towards  the  RVAH  complex  cavity  and  hence  the  Rtt109 
active  center,  I  calculated  the ab  initio  models  of  the  RVAH  complex  from  the  SANS  datasets 
recorded  on  complexes  reconstituted  with  the  full-length  proteins,  with  Vps75 2 1–225 ,  or  with 
Vps75 2 1–225  and  H3 35–135  (see  section  3.6).  The ab  initio  modelling  of  the  RVAH  complex  with   
Vps75 2 1–225  and  H3 35–135  returned  an  envelope  with  a  large  middle  cavity  of  ~25 Å  in   
diameter ,  similar  to  the  structural  model  of  the  RVAH  complex  (PDB  entry  6o22,  Fig.  4.5.1). 
In  the  envelope  generated  for  the  RVAH  complex  with  both  the  Vps75  CTAD  and  the  H3 
N-terminal  tail,  the  area  corresponding  to  the  central  cavity  was  filled  with  dummy  atoms, 
indicating  that  the  Vps75  CTAD  and  the  H3  N-terminal  tail  occupy  it.  The  fact  that  the ab 
initio  model  for  the  RVAH  complex  containing  Vps75 2 1–225  had  a  cavity  with  dimensions  
identical  to  the  envelope  generated  for  the  complex  containing  Vps75 2 1–225  and  H3 35–135   
demonstrates  that  the  H3  N-terminal  tail  either  does  not  localize  to  the  central  cavity  of  the 
RVAH  complex  in  the  absence  of  the  Vps75  CTAD . 8
8  The  differences  between  the ab  initio  models  could  in  principle  be  due  to  other  factors:  only  Vps75  
CTADs  contribute  to  filling  of  cavity,  hence  their  truncation  has  the  same  effect  as  the  truncation  of 
both  Vps75  CTAD  and  the  H3  N-terminal  tail.  However,  NMR  data  of  Fig.  4.6.4  together  with  the 
identity  of  the  cavity  parameters  in  the  two  models  and  the  influence  of  Vps75  CTAD  on  H3  K9 
acetylation  support  the  model  where  the  Vps75  CTAD  attracts  the  H3  N-terminal  tail  to  the  cavity. 
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Figure  4.6.4.  The  Vps75  CTAD  guides  acetylation  of  the  unfolded  H3  N-terminal  tail.  A. Overlay 
of 1 H- 15 N  HSQC  spectra  of  60  μM  H3  in  the  Asf1–H3:H4–Vps75 2  sub-complex  in  isolation  and  upon  
addition  of  Rtt109.  The  chemical  shift  of  the  H3  residues  1-32  are  unaltered  in  the  RVAH  complex,  but 
the  intensity  of  the  cross-peaks  is  decreased,  suggesting  a  reduced  mobility  of  the  residues.  The 
contour  levels  for  the  spectrum  of  H3  in  the  RVAH  complex  were  lowered  to  make  all  peaks  visible. B. 
SANS-derived ab  initio  envelopes  of  Rtt109–Vps75 2 1–225 –Asf1–H3:H4  (middle)  and 
Rtt109–Vps75 2 1–225 –Asf1–H3 35–135 :H4  (right)  display  an  empty  central  cavity,  which  is  filled  by 
scattering  units  in  the  complex  reconstituted  with  the  full-length  proteins  (left). C.  Overlay  of 1 H- 15 N 
HSQC  spectra  of  60  μM  Vps75 2  in  isolation  (grey)  and  in  the  RVAH  complex  with  either  full-length  H3  
(blue)  or  H3 29-135  (pink).  Only  residues  belonging  to  the  Vps75  CTADs  are  visible  due  to  the  labelling  
schemes  and  the  size  of  the  complex.  CTADs  of  Vps75(A)  and  Vps75(B)  display  different  chemical 
shifts  in  the  RVAH  complex,  causing  the  doubling  of  the  resonances:  the  peaks  of  one  of  the  two 
CTADs  remain  in  the  state  similar  to  the  free  Vps75  CTAD,  while  those  of  the  other  CTAD  move  to 
new  positions.  The  CSPs  for  the  residues  234–256  are  lower  in  the  Rtt109–Vps75 2 –Asf1–H3 29–135 :H4 
complex  (CSP  plot,  bottom),  indicating  that  these  residues  interact  with  H3  1-28.  All  spectra  were 
recorded  with  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K. D. 
Time-course  of  H3  acetylation  (top,  K56;  bottom,  K9)  in  the  Asf1–H3:H4  by  Rtt109–Vps75 2  (blue)  or  
Rtt109–Vps75 2 1–225  (purple).  The  experiments  were  repeated  four  times;  the  error  bars  represent  the  
standard  error  of  the  mean.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally 
produced  by  myself. 
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Finally,  NMR  titration  experiments  with  the 15 N-labelled  protonated  Vps75  demonstrated  that 
the  CTAD  residues  234-256  are  involved  in  the  interaction  with  the  H3  N-terminal  tail  (Fig. 
4.6.4C).  Overall,  regions  of  the  unfolded  Vps75  CTAD  and  the  H3  N-terminal  tail  that  were 
identified  to  interact  with  each  other  are  composed  of  stretches  of  negatively  or  positively 
charged  amino  acids: 
 
suggesting  that  “fuzzy”  electrostatic  interactions  can  occur  between  the  two  without  folding. 
In  agreement  with  the  hypothesis  that  the  Vps75  CTAD  attracts  the  H3  N-terminal  tail 
towards  the  central  cavity  via  weak  electrostatic  interactions,  the  deletion  of  Vps75  CTAD 
reduced  H3  K9  acetylation  2-fold in  vitro .  H3  K56  acetylation  remained  unaffected,  indicating 
that  the  functional  state  of  the  RVAH  complex  was  not  altered  by  the  truncation. 
 
Thus,  this  work  supports  a  model  in  which  Vps75  acts  as  the  Rtt109  acetylation  specificity 
switch  in  a  two-step  mechanism.  The  model  is  summarized  in  the  following  scheme  (Fig. 
4.6.5). 
 
Figure  4.6.5. Vps75  promotes  H3  K9  acetylation  by  a  two-step  mechanism. Left,  H3  K56 
acetylation  is  promoted  by  a  substrate  presentation  mechanism,  where  H3  K56  is  placed  next  to  the 
Rtt109  active  center  by  the  interactions  between  Rtt109  and  Asf1/H4/H3.  Right,  the  positively  charged 
H3  N-terminal  tail  is  confined  in  the  proximity  of  the  enzyme  active  center  by  two  acidic  regions  of 
Vps75 2 :  the  Vps75  acidic  patch  in  the  earmuff  domain  binds  to  H3  R52,  R53;  the  Vps75  CTAD  covers 
the  positively  charged  surface  of  H3:H4  and  engages  in  fuzzy  electrostatic  interactions  with  the  H3 
N-terminal  tail.  The  figure  is  adapted  from  Danilenko et  al ,  2019  and  was  originally  produced  by 
myself. 
 
The  H3  K56  acetylation  is  promoted  by  its  placement  near  the  enzyme  catalytic  pocket,  in  a 
classical  substrate  presentation  mechanism.  Contrarily,  H3  K9,  K23  and  K27  are  located  in 
the  unfolded  and  positively  charged  part  of  the  H3  tail  and  cannot  be  easily  localized  to  the 
active  site  because  of  their  high  mobility.  In  the  absence  of  Vps75 2 ,  these  residues  may 
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 reach  the  Rtt109  active  center  as  the  H3  tail  randomly  samples  the  conformational  space; 
however,  in  this  case  acetylation  is  inefficient.  Contrarily,  Vps75 2  facilitates  acetylation  of  the  
H3  N-terminal  tail  by  using  its  CTAD  to  confine  the  H3  tail  to  the  RVAH  cavity  and  thus  in  the 
proximity  of  the  Rtt109  binding  pocket.  Both  the  H3  tail  and  the  Vps75  CTAD  remain  flexible 
and  thus  preserve  a  large  part  of  their  entropy.  In  addition,  the  flexibility  of  the  H3  tail  allows 
acetylation  of  residues  at  multiple  sites  (H3  K9,  K23  and  K27).  The  process  of  H3  tail 
acetylation  is  aided  by  the  Vps75  acidic  patch,  which  interacts  with H3  R52  and  R53,  
disfavoring  H3  K56  acetylation. 
4.7.  Assignment  of  the  methyl  groups. 
In  order  to  enable  the  above-mentioned  NMR  titration  experiments  as  well  as  the  PRE 
measurements,  I  assigned  Vps75  (backbone  and  ILV-methyl  groups),  Rtt109  (I-methyl 
groups),  H3:H4  (ILV  methyl-groups  and  the  backbone  of  the  H3  N-terminal  tail).  Asf1 
assignments  were  done  by  Dr.  L.  Lercher  and  described  in  Lercher  et  al ,  2018. 
 
Stereospecific  assignment  of  Vps75  ILV-methyl  groups  in  the  free  state  and  in  the 
RVAH  complex.  The  strategy  and  experimental  details  of  the  Vps75  assignment  are 
described  in  section  3.4.  The  Vps75 1–225  construct,  where  the  unfolded  CTAD  of  Vps75  
(residues  226–264)  was  truncated,  was  used  for  the  assignment  experiments  to  reduce  the 
overlap  of  the  cross-peaks.  A  total  of  56%  of  backbone  amide  resonances  were  assigned 
(Fig.  4.7.1).  ILV-methyl  groups  of  Vps75 1–225  were  assigned  by  connecting  them  to  the  
backbone  resonances  (via  Ile,Leu-(HM)CM(CGCBCA)NH  and  Val-(HM)CM(CBCA)NH 
experiments),  point  mutations,  a  4D  NOESY  experiment  (4D  HCCH  HMQC-NOESY-HMQC) 
and  stereospecific  labelling  of  the  pro-S  LV-methyl  groups.  In  total,  17/17  I,  10/13  L,  and 
10/10  V  residues  were  assigned  (Fig.  4.7.2). 
The  ILV-methyl  groups  assignments  were  transferred  from  free  Vps75 1–225  to  the  full-length  
Vps75  and  then  to  the  Vps75  in  the  context  of  the  RVAH  complex  following  the  CSPs  for 
each  peak  in  the  individual  titrations  of  Vps75 2  with Asf1–H3:H4,  Rtt109  and  
Rtt109–Asf1–H3:H4. 
 
104 
  
Figure  4.7.1.  Backbone  assignment  of  free  Vps75 1–225 . 1 H- 15 N  HSQC  spectrum  of  0.8  mM  free 
Vps75 2 1–225  (0.8  mM)  in  20  mM  Tris–HCl  pH  7.5,  200  mM  NaCl,  1  mM  DTT  at  850  MHz  and  300  K.  
The  upper  panel  shows  the  full  spectrum;  the  lower  panel  an  excerpt  thereof. The  figure  is  adapted 
from  Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
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Figure  4.7.2.  Assignment  of  Vps75  ILV-methyl  resonances.  A,B. Overlay  of 1 H- 13 C  HMQC  spectra 
of  ILV-labelled  Vps75 2 1–225  (dark  blue)  in  20  mM  Tris–HCl  pH  7.5,  200  mM  NaCl,  1  mM  DTT  at  850  
MHz  and  300  K,  Vps75 2  (light  blue)  and  Vps75 2  as  part  of  the  Rtt109–Vps75 2 –Asf1–H3:H4  complex   
(purple)  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850  MHz  and  298  K.  ( A )  Ile 
region  ( B ):  Leu/Val  region  with  stereospecific  assignment.  The  assignments  are  shown  for  Vps75 2  and  
Vps75 2  in  the  Rtt109–Vps75 2 –Asf1–H3:H4  complex.  In  the  latter  spectrum,  A  and  B  indicate  the  
Vps75(A)  and  Vps75(B)  chains,  respectively.  The  asterisk  marks  tentative  assignments. The  figure  is 
adapted  from  Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
 
Assignment  of  Rtt109  I-methyl  resonances. Due  to  the  large  size  of  Rtt109  (50  kDa 
versus  the  32  kDa  Vps75)  and  the  poorer  stability  and  solubility  of  the  isolated  protein,  we 
chose  to  assign  the  methyl  groups  without  the  prior  backbone  assignment.  Previously  Dr.  L. 
Lercher  recorded  a  dataset  for  the  ILV-methyl  groups  assignment  on  perdeuterated, 
ILV ProS -methyl  labelled  Rtt109  sample,  which  yielded  an  insufficient  number  of  NOE 
cross-peaks  and  no  cross-peaks  between  I  and  LV.  I  then  recorded  a  second  dataset  on 
perdeuterated,  I-methyl  labelled  Rtt109  in  complex  with  perdeuterated  Vps75,  where  the 
presence  of  Vps75  improved  sample  stability,  while  labelling  of  only  I  residues  allowed  to 
reduce  the  spectral  width. 
In  this  dataset  I  observed  four  groups  of  resonances  (three  groups  included  just  two 
resonances  each, one  group  included  three  ones)  that  gave  NOE  cross-peaks  among  each 
other,  indicating  that  these  methyl  groups  are  located  in  the  vicinity  of  each  other  (up  to  ~6.5 
Å  distance).  I  then  used  the  structure  of  Rtt109  from  PDB  entry  3q66  to  predict  all  isoleucine 
residues  pairs  for  which  the  methyl  groups  are  within  this  distance  from  each  other. 
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 Comparison  of  the  experimental  NOESY  data  with  the  data  expected  from  the  Rtt109 
structure  allowed  me  to  assign  each  of  the  groups  to  a  defined  I  residues  in  Rtt109. 
 
While  I  could  assign  each  group  of  residues  (e.g.  by  characteristic  chemical  shifts,  CSPs  in 
complexes  with  Vps75  and  RVAH),  I  could  not  specifically  assign  I  resonances  within  each 
group.  Thus,  all  resonances  in  the  first  group  from  the  scheme  above  were  assigned  as 
I189/I332/I83  etc.  Further  assignment  was  complicated  by  the  low  expression  and  high 
instability  of  Rtt109  bearing  point  mutations  of  ILV  residues.  In  total,  I  could  assign  9/31 
I-methyl  group  resonances. 
 
Figure  4.7.3.  Assignment  of  Rtt109  I-methyl  resonances. I-methyl  labelled  Rtt109  at  ~0.6  mM  in 
complex  with  perdeuterated  Vps75  in  50  mM  sodium  citrate  pH  6.5,  150  mM  NaCl,  5  mM  BME  at  850 
MHz  and  298  K. 
 
Assignment  of  H3:H4  ILV-methyl  resonances. Assignment  of  H3  and  H4  ILV-methyl 
groups  was  done  similarly  to  Rtt109.  Unambiguous  assignment  was  possible  due  to  a  larger 
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 number  of  unique  combinations  of  residues  that  are  close  to  each  other  in  space,  NMR  data 
on  ILV-methyl  labelled  H4,  which  allowed  to  differentiate  the  H4  residues  from  the  H3  and 
comparison  with  the  previously  reported  assignment  of  H3  and  H4  in  the  context  of  the 
nucleosome (Kato et  al ,  2011) .  In  total,  I  assigned  5/7  I,  4/12  L  and  1/6  V  residues  of  H3  and 
6/6  I,  1/8  L  and  4/9  V  residues  of  H4. 
 
Figure  4.7.4.  Assignment  of  Vps75  ILV-methyl  resonances. 1 H- 13 C  HMQC  spectrum  of  ILV-labelled 
H3:H4  as  part  of  the  Asf1–H3:H4  complex  (0.66  mM)  in  20  mM  Tris–  HCl  pH  7.5,  1  M  NaCl,  1  mM 
Na-EDTA,  5  mM  BME  in  100%  D2O  at  850  MHz  and  298  K.  The  asterisk  marks  tentative 
assignments.  The  figure  is  adapted  from  Danilenko  et  al ,  2019  and  was  originally  produced  by  myself. 
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 5.  Discussion 
5.1.  Asf1  and  Vps75  activate  Rtt109  via  substrate  presentation 
mechanisms.  
The  structure  of  the  RVAH  complex  presented  in  this  work  rationalizes  the in  vivo  activity 
data,  showing  that  both  Asf1  and  Vps75  are  important  for  H3  K9  acetylation,  but  only  Asf1  is 
essential  for  H3  K56  acetylation  (Fig.  1.3.2,  1.4.2).  The  proposed  mechanism  of  how  the 
chaperones  regulate  Rtt109-dependent  acetylation  of  H3  is  summarized  in  Fig.  5.1.1. 
 
Figure  5.1.1.  Regulation  of  Rtt109  activity  by  Asf1  and  Vps75. Asf1  presents  the  H3:H4  dimer  to 
Rtt109  in  a  correct  orientation,  where  the  H3  N-terminal  tail  faces  towards  the  active  center  and  H3 
K56  is  placed  in  the  vicinity  of  the  catalytic  pocket.  Vps75  facilitates  the  formation  of  the  complex  and 
attracts  the  disordered  H3  N-terminal  tail  to  the  Rtt109  active  center  via  both  its  folded  and 
unstructured  domains. 
 
Mutations  of  H3  E94,  which  affect  the  formation  of  the  RVAH  complex,  as  shown  by  NMR 
data  in  Fig.  4.5.3,  decrease  both  H3  K56  and  K9  acetylation in  vivo  (Zhang  et  al,  2018). 
Mutations  that  affect  local  interactions  of  Rtt109  and  the  Asf1-bound  histones,  such  as 
deletion  of  the  H4  C-terminus  (95-102)  or  the  Rtt109  C-terminal  tail,  decrease  the  acetylation 
of  H3  K56  but  don’t  affect,  or  affect  less  significantly  acetylation  of  H3  K9  by  the  RVAH 
complex in  vitro  (Fig.  4.5.4).  On  the  other  hand,  deletion  of  the  Vps75  CTAD  decreases  the 
acetylation  of  K9,  but  not  K56  (Fig.  4.6.4).  These  results,  taken  together  with  the  structure  of 
the  RVAH  complex,  are  consistent  with  a  model  in  which  H3  K56  acetylation  is  promoted  by 
Asf1,  acting  to  position  the  H3  core  with  respect  to  Rtt109  in  such  a  way  that  K56  faces  the 
Rtt109  active  site;  Vop75  aids  the  formation  of  a  stable  complex,  but  does  not  exert  an  active 
function  in  catalysis.  On  the  other  hand,  acetylation  of  H3  K9  is  critically  dependent  on 
Vps75:  the  H3  N-terminal  tail  is  first  released  from  Asf1  by  both  Rtt109  and  Vps75,  and  then 
is  confined  near  the  Rtt109  active  center  by  the  concerted  action  of  both  the  acidic  cavity 
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 and  the  CTAD  of  Vps75.  This  is  shown  by  the  CSP  data  on  the  H3  N-terminal  tail  and  the 
Vps75  CTAD  as  well  as  by  the  low  resolution  SANS  envelopes  (Fig.  4.5.7  and  section  4.6). 
 
The 206 EE 207  acidic  patch  located  in  the  Vps75  cavity  further  aids  H3  N-terminal  tail  
acetylation  by  capturing  R52  and  R53  of  H3  and  mildly  inhibiting  H3  K56  acetylation,  as 
demonstrated  by  molecular  dynamics  simulations  and in  vitro activity  assays  (Fig.  4.6.3). 
The  H3 52 RR 53  is  the  only  double  arginine  patch  in  the  H3  N-terminal  tail,  despite  the  fact  that  
all  of  the  H3  lysine  residues  that  can  be  acetylated  have  an  arginine  residue  in  the  vicinity. 
However,  H3 52 RR 53  might  be  engaged  by  the  Vps75  cavity  more  efficiently  due  to  both  its  
ability  to  make  a  higher  number  of  hydrogen  bonds  and  its  proximity  the 206 EE 207 .  It  is 
important  to  note  that  although  Vps75 206 EE 207  has  a  mild  inhibitory  effect  on  H3  K56ac,  the  
overall  acetylation  of  H3  K56  is  not  inhibited  but  rather  promoted  by  the  presence  of  Vps75 
in  vitro  (Fig.  4.3.4).  This  is  most  likely  due  to  the  role  of  Vps75  in  the  formation  of  the  tight 
complex  between  Rtt109  and  Asf1–H3:H4. 
 
In  vitro ,  CSP  experiments  and  SEC  did  not  detect  a  tight  complex  between  Rtt109  and 
Asf1–H3:H4  in  the  absence  of  Vps75  (Fig.  4.2.6).  However,  Rtt109–Asf1–H3:H4  can 
acetylate  H3  K56  both in  vitro  and in  vivo .  One  explanation  of  this  is  that  a  transient 
short-lived  interaction  between  Rtt109  and  Asf1-bound  histones  is  sufficient  for  the 
acetylation  of  H3  K56;  on  the  other  hand,  efficient  acetylation  of  the  disordered  N-terminal 
tail,  which  is  not  actively  guided  towards  the  active  center  in  the  absence  of  Vps75,  requires 
a  longer  lifetime  of  the  complex.  In  addition  to  this,  the  Rtt109–Asf1–H3:H4  stability  and 
activity in  vivo  might  be  influenced  by  such  factors  as  PTMs  of  H3  and  the  long  CTAD  of 
Asf1. 
Some  Rtt109  homologs  lack  the  ability  to  bind  to  their  corresponding  Vps75 (Chen et  al , 
2019b;  Zhang et  al ,  2018) .  The  conservation  of  the  residues  involved  in  the  interaction 
between  the  Asf1–H3:H4  and  Rtt109  in A.  fumigatus  and S.  cerevisiae  together  with  the  role 
of  characterized  Rtt109  homologs  in  the  DNA  damage  response,  suggest  that  the 
mechanism  of  H3  K56  acetylation  by  Rtt109  is  conserved  throughout  fungi.  The  degree  of 
the  H3  N-terminal  tail  acetylation  by  Rtt109  homologs  as  well  as  the  role  of  Vps75  homologs 
appears  to  be  more  variable. 
 
While  the  structural  model  of  the  RVAH  complex  explains  the  preference  of  Rtt109  for  the 
acetylation  of  H3,  and  how  Vps75  promotes  acetylation  of  the  H3  N-terminal  tail,  it  does  not 
explain  the  selectivity  for  specific  lysine  residues  in  the  H3  tail.  It  appears  that  the  selectivity 
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 of  Rtt109  towards  H3  K9,  H3  K14 ,  K23,  K27  and  K56,  but  not  K18,  K36  or  K37  is 9
determined  by  the  structure  of  the  active  center  of  the  acetyltransferase  rather  than  by 
histone  chaperones.  All  lysine  residues  targeted  by  Rtt109  have  a  similar  surrounding 
amino-acid  sequences  (Fig.  5.1.2A). 
 
Figure  5.1.2.  Residues  following  H3  lysines  determine  the  acetylation  by  Rtt109.  A.  Lysines 
which  are  acetylated  by  Rtt109  are  followed  by  small  residues  (similar  residues  are  highlighted  by  a 
green  background). B,C .  Particular  views  of  the A.  fumigatus  Rtt109–Asf1–H3:H4  structure  (PDB 
entry  5zba).  Rtt109  is  shown  in  beige,  Asf1  in  pink,  H3  in  green  and  H4  in  grey. 
 
As  an  example  of  how  the  neighbouring  amino  acids  influence  lysine  acetylation,  the  H3 
S57Q  mutation  abolishes  K56 in  vivo  without  affecting  K9,  K23  or  K27  (Zhang et  al ,  2018).  In 
the  X-ray  structure  of  the A.  fumigatus  Rtt109–Asf1–H3:H4  from  Zhang et  al ,  H3  S57  is 
engaged  in  a  hydrogen  bond  with  D260  (corresponding  to  D287  in S.  cerevisiae ),  which 
could  explain  its  importance  (Fig.  5.1.2B).  However,  H3  K23  and  K14,  which  can  be 
acetylated  by  Rtt109,  are  followed  by  alanines,  which  are  similar  to  serines  in  size  but 
cannot  form  hydrogen  bonds  with  their  side  chain.  This,  together  with  the  effect  of  the 
mutation  of  a  small  S  to  a  large  Q,  suggests  that  the  size  of  the  neighbouring  amino  acids  is 
the  defining  factor.  From  the  crystal  structure  it  is  unclear  why  a  large  residue  could  not  be 
accommodated  in  this  position. 
 
In  addition  to  the  placement  of  H3  K56  in  the  catalytic  pocket,  the  Zhang et  al  structure 
shows  that  a  part  of  the  H3  tail  (residues  ~45-51)  is  wrapped  around  the  H3:H4  dimer  via 
interactions  with  H4  (residues  44-47)  mediated  mostly  by  the  backbone  atoms  (Fig.  5.1.2C). 
Interestingly,  our  CSP  data  indicates  that  this  H4  surface  is  affected  by  the  presence  of  the 
Vps75  CTAD  (Fig.  4.5.7).  While  I  hypothesize  that  these  CSPs  arise  from  a  direct  interaction 
between  the  Vps75  CTAD  and  H3:H4,  they  may  also  be  caused  by  the  modulation  of  the 
interaction  of  the  H3  tail  with  H3:H4. 
9  Rtt109  is  able  to  acetylate  H3  K14  in  vitro ,  however in  vivo  Gcn5  is  the  major  HAT  responsible  for  
the  H3  K14  acetylation.  It  is  possible  that  H3  K14ac  is  introduced  by  Gcn5  prior  to  the  H3  acetylation 
by  Rtt109. 
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It  would  be  interesting  to  obtain  a  more  detailed  molecular  view  of  the  H3  N-terminal  tail  and 
its  interactions  within  the  complex,  including  the  residues  surrounding  the  catalytic  pocket  of 
Rtt109,  the  Vps75  CTAD  and  the  complex  cavity. 
5.2.  Vps75  dimer  accepts  one  copy  of  Rtt109  to  form  a  functional 
complex. 
This  work  addresses  the  long-standing  debate  on  the  stoichiometry  of  the  Rtt109–Vps75 
complex,  which  originated  from  the  detection  of  1:2  and  2:2  complexes  by  X-ray 
crystallography  (Tang et  al ,  2011;  Su et  al ,  2011).  The  NMR  titration  experiments  and  MALS 
data  of  section  4.1  show  that  the  Rtt109 2 –Vps75 2  complex  is  detectable  in  solution in  vitro  
only  in  certain  buffer  conditions  and  is  less  stable  than  the  Rtt109–Vps75 2 .  Although 
conformational  flexibility  of  the  Vps75  dimer  can  allow  the  formation  of  the  2:2  complex,  from 
our  functional  and  structural  data  it  is  unclear  which  functions  Rtt109 2 –Vps75 2  could  perform  
in  vivo ,  if  this  complex  is  present  in  the  cell. 
 
As  it  can  be  seen  from  the  CSP  and  SEC-MALS  data  (Fig.  4.2.1,  Fig.  4.2.2),  formation  of  the 
complex  of  Rtt109–Vps75  with  the  substrate  Asf1–H3:H4  requires  a  free  earmuff  domain  of 
one  of  the  Vps75  monomers.  It  is  unlikely  that  Rtt109 2 –Vps75 2  could  accept  Asf1–H3:H4  as  
a  substrate,  as  the  surfaces  of  Rtt109  and  Vps75  that  interact  with  the  histones  in  the  RVAH 
complex  are  largely  inaccessible  in  the  Rtt109 2 –Vps75 2  complex.  Thus,  if  Rtt109 2 –Vps75 2   
has  an  acetylation  function,  it  would  most  likely  acetylate  H3  in  a  non-Asf1-bound  state.  In 
disagreement  with  this  hypothesis,  it  has  been  demonstrated  that  Asf1  is  necessary  for  the 
Rtt109-dependent  acetylation  of  both  K9  and  K56 in  vivo  (Fig.  1.4.2).  Thus,  it  is  unlikely  that 
Rtt109 2 –Vps75 2   takes  part  in  H3  acetylation  at  all. 
The  interaction  of  the  Rtt109–Vps75 2  with  a  second  Rtt109  copy  could  potentially  play  a  role  
in  a  storage  of  Rtt109,  which  is  not  stable in  vivo  in  the  absence  of  Vps75.  However, 
expression  of  Rtt109  peaks  during  the  S-phase,  while  Vps75  is  expressed  constantly;  hence, 
it  is  more  conceivable  that  Vps75  is  stored  as  a  self-tetramer  outside  of  the  S-phase,  during 
which  the  requirement  of  the  newly  synthesized  and  acetylated  H3  is  high (Gown et  al ,  1996; 
Bowman  et  al ,  2014) . 
 
In  summary,  data  of  this  thesis  work  suggest  that  acetylation  of  H3 in  vivo  is  performed  by 
Rtt109  bound  to  Vps75  in  a  1:2  stoichiometry,  while  the  2:2  complex  may  have  other  cellular 
functions  or  be  an  artifact  observed  in  vitro . 
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 5.3.  Asf1  regulates  the  accessibility  of  the  H3  N-terminal  tail. 
The  high  conservation  of  both  the  H3  N-terminal  tail  and  the  Asf1  surface  it  engages 
suggests  that  the  mechanism  by  which  Asf1  chaperones  the  N-terminal  tail  might  be 
conserved  throughout  eukaryotes.  In  support  of  this  hypothesis,  the Xenopus  laevis  H3 
N-terminal  tail  interacts  with  the H.  sapiens Asf1b  in  a  similar  manner  as  with Sc  Asf1,  as 
seen  in  NMR  titration  experiments  (Lercher et  al ,  2018).  The  NMR  experiments  in  sections 
4.3  and  4.6  show  that  this  binding  of  the  H3  N-terminal  tail  to  Asf1  can  be  disrupted  by 
different  mechanisms.  One  is  a  competition  for  the  same  Asf1  surface  by  other  binding 
partners.  CSP  data  show  that  the  C-terminal  tail  of  Rtt109  is  able  to  displace  the  H3 
N-terminal  tail;  it  is  conceivable  that  other  Asf1  binding  partners,  such  as  the  HIRA  and 
CAF-1  complexes,  utilize  the  same  mechanism in  vivo.  Alternatively,  the  interaction  between 
Asf1  and  the  H3  N-terminal  tail  can  be  disrupted  by  binding  partners  of  the  tail  itself;  our 
CSP  data  show  that  Vps75  can  engage  different  regions  of  the  H3  N-terminal  tail  by  its 
CTAD  and  its  folded  acidic  cavity,  thereby  releasing  the  H3  tail  from  Asf1. 
 
In  vivo  data  demonstrates  that  both  Rtt109  C-terminal  tail  and  Vps75  are  required  for 
efficient  H3  K9  acetylation (Radovani et  al ,  2013) ; in  vitro ,  however,  Vps75  can  fully  rescue 
the  C-terminally  truncated  Rtt109  (Fig.  4.3.4).  PTMs  of  H3  could  be  one  of  the  factors  which 
contribute  to  this  difference  and  add  additional  complexity  to  the  acetylation  regulation in 
vivo .  In  agreement  with  this  hypothesis,  it  was  recently  shown  that  H3  carrying  the  K14ac 
mark  promotes  the  acetylation  of  H3  K56  over  K9  by  the  RVAH  complex in  vitro  (Cote et  al , 
2019). Sensing  of  the  acetylation  state  of  K14  is  mediated  by  Asf1  E105,  as  demonstrated 
by  the  Asf1  E105A  mutant .  In  addition  to  the  E105  mutation,  mutations  of  residues  located 
on  the  Asf1  surface  that  is  involved  in  binding  of  either  Rtt109 419–433  or  the  H3  N-terminal  tail  
(D37,  E39,  D58),  slightly  alter  the  selectivity  of  Rtt109  acetylation in  vitro  (Cote et  al ,  2019). 
In  particular,  some  of  these  mutations  decrease  the  preference  for  H3  K56ac  promoted  by 
the  presence  of  H3  K14ac.  The  structural  data  presented  in  section  4.3  and  Lercher et  al  are 
consistent  with  the  hypothesis  that  the  underlying  mechanism  of  this  alteration  is  the  change 
in  the  H3  N-terminal  tail-Asf1  interaction:  while  H3  K14ac  might  contribute  to  stabilization  of 
the  Asf1-bound  state  of  the  H3  N-terminal  tail,  mutations  of  the  negatively  charged  Asf1 
residues  engaged  with  H3  ~19-32  could  weaken  this  interaction,  rendering  the  H3  tail  more 
accessible  for  acetylation. 
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 The  chaperoning  of  the  H3  N-terminal  tail  by  Asf1  could  play  a  role  in  contexts  other  than 
Rtt109-dependent  acetylation  of  H3.  Asf1  is  central  to  various  pathways  that  include  H3:H4, 
such  as  replication,  transcription  and  DNA-damage  response.  Thus,  the  Asf1-H3  N-terminal 
tail  interaction,  which  can  be  regulated  by  protein  partners  as  well  as  H3  PTMs,  could 
provide  additional  links  in  the  histone  biogenesis  and  recycling  pathways. 
5.4.  Structurally  disordered  protein-protein  interactions. 
The  majority  of  structurally  characterised  protein-protein  interactions  involve  either  binding  of 
folded  domains  to  each  other,  or  folding  of  unstructured  regions  upon  binding.  Only  recently 
the  term  “fuzzy”  interactions  was  introduced  to  describe  the  interactions  where  disorder  is 
preserved  upon  binding (Tompa  &  Fuxreiter,  2008) .  In  the  electrostatically-driven  interaction 
of  the  H3  N-terminal  tail  with  the  Vps75  CTAD,  both  binding  partners  remain  disordered 
(judging  from  the  secondary  structure  prediction,  Fig.  4.5.6C,  and  the  preservation  of  a 
narrow  chemical  shift  dispersion  for  both  Vps75  CTAD  and  H3  tail  in  the  RVAH  complex). 
This  binding  mode  is  advantageous  for  the  role  of  Vps75  CTAD  in  H3  tail  acetylation,  as  it 
provides  fast  dissociation  rates  and  accessibility  of  all  N-terminal  lysines  of  H3  to  Rtt109; 
furthermore,  this  interaction  mode  is  not  associated  with  a  large  loss  of  conformational 
entropy  which  would  occur  in  a  folding-upon-binding  mechanism. 
 
Histone  chaperones  from  diverse  families,  such  as  NAP,  FACT,  NPM,  ASF  and  CAF,  contain 
intrinsically  disordered  acidic  regions  (acidic  IDRs) (Warren  &  Shechter,  2017) .  For  several 
of  them,  including  Spt16  (FACT),  Chz1,  SWR1,  Npm1  and  Nap1,  the  Vps75  homolog  in S. 
cerevisiae ,  it  was  shown  that  these  acidic  IDRs  shield  the  DNA-binding  surfaces  of  the 
H2A:H2B,  thus  preventing  nonspecific  interactions  and  aggregation (Kemble et  al ,  2015; 
Warren et  al ,  2017) .  The sequence  motif  of  these  IDRs includes  a  variable  negatively 
charged  patch  with  one  or  more  aromatic  residues,  typically  tyrosines,  which  aid  the 
“anchoring”  to  the  histone  surface.  The  disordered  domains  of  MCM2  and  Spt2,  that  wrap 
the  H3:H4,  display  similar  features (Chen et  al ,  2015;  Huang et  al ,  2015) . On  the  other  hand, 
Vps75  CTAD  engages  the  H3:H4  DNA-binding  surface,  despite  the  fact  that  its  sequence 
lacks  a  tyrosine  or  any  other  aromatic  residue. 
 
While  the  sequence  of  the  Vps75  CTAD  is  not  conserved  in  fungi,  fungal  Vps75  CTADs 
share  an  overall  similar  negative  charge  (Fig.  1.3.1),  which  further  suggests  that  the 
interaction  between  the  Vps75  CTAD  and  H3  N-terminal  tail  relies  on  sequence-nonspecific 
electrostatic  contacts  based  on  the  charge  complementarity  between  the  two  disordered 
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 regions.  Recently,  other  examples  of  fuzzy  electrostatic  interactions  between  disordered 
domains  have  been  reported.  In  the  complex  of  chaperone  ProTα  and  H1,  the  complex  is 
highly  mobile  but  the  interaction  between  the  two  proteins  is  tight  (pM  to  sub-μM) (Borgia et 
al ,  2018;  Feng et  al ,  2018) ;  this  aids  the  role  of  ProTα  in  chromatin  remodelling,  allowing  it  to 
access  the  DNA-bound  H1  and  compete  for  the  interaction.  In  the  intra-molecular  interaction 
of  two  oppositely  charged  sequences  within  the  C-terminal  tail  of  the  histone  chaperone 
Npm1  (Warren et  al ,  2017),  the  self-chaperoning  of  the  tail  regulates  the  accessibility  of  the 
acidic  patch  that  engages  the  H2A:H2B  DNA-binding  surface,  as  discussed  above.  In  both 
cases,  the  interaction  is  based  on  charge  complementarity,  and  the  complexes  are  highly 
dynamic,  as  shown  by  the  models  generated  with  FRET,  PRE,  NMR  and  SAS  data  and 
molecular  dynamics  simulations.  Thus,  this  interaction  mode  could  be  an  as  yet  over-looked 
mechanism  by  which  IDRs  interact  with  each  other. 
 
Our  understanding  of  the function  of  IDRs  in  protein-protein  interactions,  and  their  specific 
mode  of  action  remains  poor  despite  these  regions  being widespread  in  eukaryotes,  where 
25-30%  of  all  proteins  are  predicted  to  be  mostly  disordered  and  ~40%  are  expected  to 
contain  disordered  sequences  longer  than  40  amino  acids (Dunker et  al ,  2000;  Oldfield et  al , 
2005) .  IDRs  are  frequently  identified  in  transcription  factors  and  are  reported  to  have  a  role 
in  multiple  diseases (Minezaki et  al ,  2006;  Anbo et  al ,  2019) .  Overall,  this  understudied 
interaction  mode  would  have  wide-ranging  implications  for  our  understanding  of  eukaryotic 
protein-protein  interactions. 
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 Appendix  1.  SANS  data 
The  SANS  data  obtained  during  the  thesis  work.  The  highlighted  entries  contain  the  samples 
used  for  1)  the  scoring  of  the  structural  models  in  M3  (blue,  the  labelling  schemes  are  shown 
in  the  Fig.  4.4.6);  2)  the  selection  of  the  docking  blocks  (red);  3)  for  the  controls  and  for  the 
generation  of  the ab  initio  envelopes  shown  in  the  Fig.  4.6.4  (green).  These  datasets  were 
deposited  to  SASDBD,  the  accession  numbers  are  noted  below  the  sample  name. 
The  proteins  are  denoted  by  the  first  letters  of  their  names  (R  -  Rtt109;  V  -  Vps75 2 ,  VΔ225  - 
Vps75 2 1-225 ;  A  -  Asf1;  H  -  H3:H4,  HΔ35  -  H3 35-135 :H4).  The  concentration  (conc.*)  is  the 
concentration  of  the  scattering  subunits,  which  is  lower  or  equal  to  the  concentration  of  the 
full  RVAH  complex.  “+”  and  “-”  signs  refer  to  the  scattering  contrast  in  case  of  the  different, 
non-zero,  contrasts  of  the  two  parts  of  the  complex. 
 
June  2016,  ILL,  D22. 
November  2016,  ILL,  D22. 
 
March  2017,  MLZ,  KWS-1. 
116 
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May  2018,  ILL,  D22. 
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 Appendix  2.  Restraints  used  for  the  structure 
calculation  by  M3 
The  table  of  unambiguous  restraints  used  in  M3  during  both  it0  and  it1.  The  building  block  A 
is  presented  by  10  Rtt109–Vps75 2  structures,  the  building  block  B  is  the  Asf1–H3:H4  
structure  (PDB  entry  2hue).  The  residues  within  the  building  blocks  were  renumbered  to 
avoid  duplicating  numbers.  In  the  building  block  A  (segid  A)  Vps75(B)  numbering  is 
preserved;  the  Vps75(A)  and  Rtt109  are  renumbered  by  addition  of  1000  or  2000, 
respectively,  to  the  original  residue  number.  In  the  building  block  B  (segid  B)  Asf1  numbering 
is  preserved,  H3  and  H4  are  renumbered  by  addition  of  1000  or  2000,  respectively. 
The  distances  are  in  Å,  the  distance  restraint  boundaries  range  from  [distance1  +  distance3] 
to  [distance1  -  distance2]. 
 
assign  (resid  1063  and  name  CB  and  segid  B)  ((resid   159  or  resid  1159)  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  27.2  7.2  7.9 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1146  and  name   CD1  and  segid  A)  25.4  6.5  6.7 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1018  and  name   CD1  and  segid  A)  25.1  9.6  73.9 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1105  and  name   CD1  and  segid  A)  21.5  8  13 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid   105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  19.2  6.1  6.1 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid   146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  ((resid   159  or  resid  1159)  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  29.8  6.6  6.6 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1146  and  name   CD1  and  segid  A)  25.0  6.6  6.6 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1018  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1105  and  name   CD1  and  segid  A)  22.7  8.4  20.6 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid   105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1066  and  name   CG1  and  segid  A)  19.2  7.5  9.4 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    18  and  name   CD1  and  segid  A)  18.0  16.0  8.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  19.2  6.1  6.2 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid   146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  ((resid   159  or  resid  1159)  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1018  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid   105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
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 assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid   146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  ((resid   159  or  resid  1159)  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid  1018  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid  1066  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    18  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  71  and  name  N  and  segid  B)  (resid  2401  and  name  N  and  segid  A)  50.0  45.0  10.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1179  and  name  CD1  and  segid  A)  18.0  16.0  8.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1155  and  name  CD1  and  segid  A)  21.5  6.1  6.1 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1160  and  name  CD1  and  segid  A)  24.7  8.1  11.5 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1159  and  name  CD2  and  segid  A)  25.6  6.5  6.6 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1112  and  name  CD1  and  segid  A)  18.0  16.0  8.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  179  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  155  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  160  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  159  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  112  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1146  and  name   CD1  and  segid  A)  21.9  6.5  6.5 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid   105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1066  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  24.2  6.1  6.1 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid   146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1179  and  name  CD1  and  segid  A)  23.6  8.4  19.2 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1155  and  name  CD1  and  segid  A)  22.2  6.1  6.1 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1160  and  name  CD1  and  segid  A)  22.6  9.4  76.4 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1159  and  name  CD2  and  segid  A)  26.1  6.7  6.7 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1112  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  179  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  155  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  160  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  159  and  name  CD2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  112  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    66  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    91  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    60  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1018  and  name   CD1  and  segid  A)  26.3  10.3  72.7 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid   105  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1066  and  name   CG1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    18  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1091  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
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 assign  (resid  2082  and  name  CB  and  segid  B)  (resid   208  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    80  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    86  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid   146  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2294  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2282  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2332  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2083  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2189  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2383  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2138  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2150  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1115  and  name  CB  and  segid  B)  (resid  2365  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2294  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2282  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2332  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2083  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2189  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2383  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2138  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2150  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2098  and  name  CB  and  segid  B)  (resid  2365  and  name  CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid   160  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1051  and  name   CD1  and  segid  A)  21.3  6.5  6.7 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    51  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid    88  and  name   CG2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1160  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1063  and  name  CB  and  segid  B)  (resid  1088  and  name   CG2  and  segid  A)  21.5  6.9  7.4 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid   160  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1028  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid    28  and  name   CD1  and  segid  A)  27.6  7  7.2 
assign  (resid  2030  and  name  CB  and  segid  B)  (resid  1160  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid    88  and  name   CG2  and  segid  A)  99.0  75.0  0.0 
assign  (resid  1076  and  name  CB  and  segid  B)  (resid  1088  and  name   CG2  and  segid  A)  25.6  6.7  6.9 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1051  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    51  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1028  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid    28  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid  1127  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2082  and  name  CB  and  segid  B)  (resid   127  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid    88  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2093  and  name  CB  and  segid  B)  (resid  1088  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid    88  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
assign  (resid  2045  and  name  CB  and  segid  B)  (resid  1088  and  name   CD1  and  segid  A)  99.0  75.0  0.0 
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 Appendix  3.  Assignment  of  Vps75  and  H3:H4 
 
Stereospecific  assignment  of  ILV  methyl  groups  of  Vps75  in  the  RVAH  complex.  A  - 
Vps75(A)  chain,  earmuff  domain  of  which  is  histone-bound;  B  -  Vps75(B)  chain,  earmuff 
domain  of  which  is  Rtt109-bound;  (A/B)  -  overlapping  peaks  of  chain  A  and  B.  “?”  mark  is  a 
tentative  assignment. 
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 Assignment  of  ILV  methyl  groups  of  Vps75 1-225  in  isolation.  “?”  mark  is  a  tentative  
assignment. 
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 Assignment  of  ILV  methyl  groups  of  H3:H4  in  the  Asf1-H3:H4  complex.  “?”  mark  is  a 
tentative  assignment.  “A”  marks  the  methyl  groups  of  H3,  “B”  -  of  H4. 
1 H[ppm]             13 C[ppm] Assign  F1 
0.82863 11.30804   B29Ile[45] 
1.04607 13.32840   B34Ile[89] 
0.46452 13.65557   B46Ile[55] 
0.84690 12.82277   A51?Ile[121] 
0.98044 15.33118   A119Ile[20] 
0.50085 9.49224   B50Ile[1] 
0.83126 15.06161   B26Ile[73] 
1.06364 22.38630   B57Val[117] 
1.07553 22.71801   B57Val[24] 
0.91417 26.41810   B58Leu[228] 
0.88004 13.24425   A62?Ile[71] 
0.93803 13.83382   A66Ile[113] 
0.93057 25.39729   A70Leu[107] 
0.78508 22.88351   A71Val[75] 
0.74726 15.15428   A74Ile[129] 
0.59670 24.03360   A103Leu[27] 
0.41416 25.72395   A103Leu[29] 
0.81938 13.32056   A112Ile[99] 
-0.1073              11.86058   A130Ile[79] 
0.77195 24.40702   A82Leu[147] 
0.83721 25.92663   A82Leu[137] 
1.03759 24.26377   A109Leu[159] 
0.71799 13.67572   A124Ile[18] 
0.89656 22.28807   B43Val[22] 
0.72001 22.47330   B43Val[242] 
0.95401 21.59490   B70Val[236] 
1.03053 22.88484   B70Val[238] 
0.44932 20.47260   B81Val[67] 
 
Assignment  of  ILV  methyl  groups  of  H3:H4  in  the  RVAH  complex.  “?”  mark  is  a 
tentative  assignment. 
1 H[ppm]             13 C[ppm] Assign  F1 
0.78685 14.76406   B26Ile[73] 
0.44475 13.22723   B46Ile[55] 
0.75180 12.91389   A51?Ile[230] 
1.07056 22.35116   B57Val[117] 
1.09938 22.89425   B57Val[24] 
0.90704 26.58572   B58Leu[228] 
0.85487 13.48125   A66Ile[113] 
0.81917 22.81807   A71Val[75] 
0.74971 15.14938   A74Ile[129] 
0.62812 23.71233   A103Leu[27] 
0.44070 25.92479   A103Leu[29] 
0.82001 13.28678   A112Ile[99] 
-0.2186 12.04984   A130Ile[231] 
0.84697 25.82752   A82Leu[137] 
0.78348 24.48627   A82Leu[147] 
1.03121 23.98510   A109Leu[159] 
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 0.99001 15.61656   A119Ile[20] 
0.72544 13.84888   A124Ile[18] 
0.91411 22.52512   B43Val[22] 
0.71505 22.44941   B43Val[242] 
0.50591 10.34802   B50Ile[1] 
0.46643 20.36271   B81Val[67] 
 
Assignment  of  Vps75 1-225   in  isolation. 
1 H[ppm] 15 N[ppm]       13 C[ppm]      Assign  F1    Assign  F2    Assign  F3 
8.35395 122.60356   174.49827   4AspH    4AspN    3SerC 
8.35370 122.63640   54.53532    4AspH    4AspN    4AspCa 
8.35358 122.60997   40.28025    4AspH    4AspN    4AspCb 
8.18700 119.98388   176.47474   5GlnH    5GlnN    4AspC 
8.19427 120.00191   55.82693    5GlnH    5GlnN    5GlnCa 
8.19428 120.00150   28.62891    5GlnH    5GlnN    5GlnCb 
8.32203 121.66094   176.36226   6GluH    6GluN    5GlnC 
8.32256 121.67002   56.72429    6GluH    6GluN    6GluCa 
8.32256 121.67075   29.23566    6GluH    6GluN    6GluCb 
8.32229 119.30827   176.57390   7AsnH    7AsnN    6GluC 
8.32856 119.32724   53.24708    7AsnH    7AsnN    7AsnCa 
8.32853 119.32331   38.54847    7AsnH    7AsnN    7AsnCb 
8.35904 121.69037   175.45103   8GluH    8GluN    7AsnC 
8.35939 121.69750   56.74014    8GluH    8GluN    8GluCa 
8.35906 121.69748   29.25769    8GluH    8GluN    8GluCb 
8.36651 119.73006   176.54159   9AsnH    9AsnN    8GluC 
8.36705 119.73310   53.32088    9AsnH    9AsnN    9AsnCa 
8.36744 119.73099   38.40116    9AsnH    9AsnN    9AsnCb 
8.59928 122.49364   176.05809   10GluH   10GluN   9AsnC 
8.60854 122.51886   57.98023    10GluH   10GluN   10GluCa 
8.60882 122.52035   28.73528    10GluH   10GluN   10GluCb 
8.30554 119.46380   177.79480   11HisH   11HisN   10GluC 
8.30851 119.47079   57.02090    11HisH   11HisN   11HisCa 
8.30695 119.45688   29.32778    11HisH   11HisN   11HisCb 
7.95448 122.53173   176.13787   12AlaH   12AlaN   11HisC 
7.96507 122.55996   54.39055    12AlaH   12AlaN   12AlaCa 
7.96541 122.56449   17.77703    12AlaH   12AlaN   12AlaCb 
8.13562 118.54001   180.02809   13LysH   13LysN   12AlaC 
8.13678 118.54426   58.92916    13LysH   13LysN   13LysCa 
8.13756 118.54763   31.25152    13LysH   13LysN   13LysCb 
8.09279 124.13121   179.22546   14AlaH   14AlaN   13LysC 
8.09172 124.13038   54.53786    14AlaH   14AlaN   14AlaCa 
8.09301 124.13178   17.32423    14AlaH   14AlaN   14AlaCb 
8.11903 117.02769   179.16501   15PheH   15PheN   14AlaC 
8.12674 117.03899   60.71253    15PheH   15PheN   15PheCa 
8.12609 117.03709   37.52888    15PheH   15PheN   15PheCb 
7.90029 121.43513   178.63294   16LeuH   16LeuN   15PheC 
7.90057 121.43306   57.41823    16LeuH   16LeuN   16LeuCa 
7.89954 121.44601   40.36715    16LeuH   16LeuN   16LeuCb 
7.52673 108.44402   179.88640   17GlyH   17GlyN   16LeuC 
7.52780 108.44952   45.74329    17GlyH   17GlyN   17GlyCa 
7.88663 122.13916   176.71675   18LeuH   18LeuN   17GlyC 
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 7.88832 122.14259   57.58239    18LeuH   18LeuN   18LeuCa 
7.88615 122.15998   40.05304    18LeuH   18LeuN   18LeuCb 
7.84940 122.58587   179.44397   19AlaH   19AlaN   18LeuC 
7.84966 122.60592   54.71173    19AlaH   19AlaN   19AlaCa 
7.84938 122.59621   16.84821    19AlaH   19AlaN   19AlaCb 
7.75977 119.60322   181.11642   20LysH   20LysN   19AlaC 
7.76209 119.59933   58.21282    20LysH   20LysN   20LysCa 
7.76069 119.60496   30.48526    20LysH   20LysN   20LysCb 
7.99429 118.60056   180.04133   21CysH   21CysN   20LysC 
8.00924 118.59220   63.88797    21CysH   21CysN   21CysCa 
8.00536 118.59725   25.91751    21CysH   21CysN   21CysCb 
7.92899 119.74346   176.74942   22GluH   22GluN   21CysC 
7.93767 119.75781   58.96136    22GluH   22GluN   22GluCa 
7.93621 119.76848   28.69951    22GluH   22GluN   22GluCb 
7.52816 119.63904   179.22918   23GluH   23GluN   22GluC 
7.54080 119.63854   28.71228    23GluH   23GluN   23GluCb 
7.54018 119.65780   58.78389    23GluH   23GluN   23GluCa 
7.87037 121.78010   179.95169   24GluH   24GluN   23GluC 
7.87735 121.80159   59.39022    24GluH   24GluN   24GluCa 
7.87644 121.77114   28.69042    24GluH   24GluN   24GluCb 
8.11696 120.86833   179.43359   25ValH   25ValN   24GluC 
8.12834 120.88494   66.98732    25ValH   25ValN   25ValCa 
7.67166 119.73603   177.79420   26AspH   26AspN   25ValC 
7.67112 119.75520   57.33229    26AspH   26AspN   26AspCa 
7.67423 119.76199   40.00098    26AspH   26AspN   26AspCb 
7.63776 122.12124   179.09192   27AlaH   27AlaN   26AspC 
7.64575 122.15890   54.75571    27AlaH   27AlaN   27AlaCa 
7.64406 122.16374   17.13439    27AlaH   27AlaN   27AlaCb 
8.69933 120.10104   59.46819    29GluH   29GluN   29GluCa 
8.69918 120.12587   27.97331    29GluH   29GluN   29GluCb 
7.46909 119.35586   180.02562   30ArgH   30ArgN   29GluC 
7.47119 119.38174   59.18256    30ArgH   30ArgN   30ArgCa 
7.47502 119.35606   28.72845    30ArgH   30ArgN   30ArgCb 
7.93019 120.39838   178.00595   31GluH   31GluN   30ArgC 
7.93780 120.39955   59.54647    31GluH   31GluN   31GluCa 
7.93993 120.41759   28.87115    31GluH   31GluN   31GluCb 
9.16279 121.87584   180.44903   32ValH   32ValN   31GluC 
9.16279 121.87715   66.27237    32ValH   32ValN   32ValCa 
9.16421 121.83937   30.54130    32ValH   32ValN   32ValCb 
7.98732 120.81154   177.15588   33GluH   33GluN   32ValC 
7.97939 120.77975   66.23371    33GluH   33GluN   33GluCa 
7.98771 120.82967   28.52139    33GluH   33GluN   33GluCb 
9.13516 119.27950   179.08484   48AspH   48AspN   47ArgC 
9.13639 119.26357   56.07009    48AspH   48AspN   48AspCa 
9.14294 119.24992   38.13894    48AspH   48AspN   48AspCb 
7.15420 122.01146   177.62461   49AlaH   49AlaN   48AspC 
7.16215 122.03063   54.27314    49AlaH   49AlaN   49AlaCa 
7.15450 122.06588   16.77960    49AlaH   49AlaN   49AlaCb 
7.24473 117.94621   181.06085   50TyrH   50TyrN   49AlaC 
7.24636 117.95440   60.59295    50TyrH   50TyrN   50TyrCa 
7.24626 117.97245   36.69622    50TyrH   50TyrN   50TyrCb 
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 7.76398 120.66163   178.95904   51IleH   51IleN   50TyrC 
7.77429 120.62945   65.60977    51IleH   51IleN   51IleCa 
7.46788 117.05473   56.07646    52AspH   52AspN   52AspCa 
7.46851 117.05534   40.18396    52AspH   52AspN   52AspCb 
7.41018 116.50492   177.34971   53GluH   53GluN   52AspC 
7.41027 116.53782   56.05751    53GluH   53GluN   53GluCa 
7.41137 116.51965   29.45080    53GluH   53GluN   53GluCb 
7.87599 122.92091   176.35626   54IleH   54IleN   53GluC 
7.87642 122.92503   60.09820    54IleH   54IleN   54IleCa 
7.87611 122.91005   36.77654    54IleH   54IleN   54IleCb 
8.39986 131.81070   53.90712    55AlaH   55AlaN   55AlaCa 
8.39896 131.80418   17.79159    55AlaH   55AlaN   55AlaCb 
9.03160 114.28375   178.78751   56GluH   56GluN   55AlaC 
9.02850 114.24436   57.03967    56GluH   56GluN   56GluCa 
9.02984 114.25316   27.17864    56GluH   56GluN   56GluCb 
7.43870 119.26275   175.08883   57PheH   57PheN   56GluC 
7.43908 119.27574   62.63886    57PheH   57PheN   57PheCa 
7.44074 119.27763   39.24428    57PheH   57PheN   57PheCb 
8.96807 117.28183   176.43329   58TrpH   58TrpN   57PheC 
8.97093 117.29165   59.97826    58TrpH   58TrpN   58TrpCa 
8.96971 117.30671   27.84035    58TrpH   58TrpN   58TrpCb 
7.96864 121.32231   178.03452   59LysH   59LysN   58TrpC 
7.96865 121.33476   59.23945    59LysH   59LysN   59LysCa 
7.96716 121.32765   31.15416    59LysH   59LysN   59LysCb 
8.14267 121.11021   179.83563   60IleH   60IleN   59LysC 
8.14923 121.16569   63.96170    60IleH   60IleN   60IleCa 
8.14674 121.17360   36.22540    60IleH   60IleN   60IleCb 
7.48793 120.03720   174.78658   64GlnH   64GlnN   63SerC 
7.49179 120.01344   54.80670    64GlnH   64GlnN   64GlnCa 
7.49148 120.00207   28.47833    64GlnH   64GlnN   64GlnCb 
7.25989 120.94059   175.94673   65HisH   65HisN   64GlnC 
7.26040 120.94434   58.79756    65HisH   65HisN   65HisCa 
7.26090 120.94853   29.86138    65HisH   65HisN   65HisCb 
7.67074 126.90381   176.76962   66ValH   66ValN   65HisC 
7.67158 126.90423   65.25836    66ValH   66ValN   66ValCa 
7.67168 126.89720   31.02804    66ValH   66ValN   66ValCb 
8.29147 115.74991   177.36565   67SerH   67SerN   66ValC 
8.29379 115.79056   63.48213    67SerH   67SerN   67SerCb 
8.29452 115.79215   59.89988    67SerH   67SerN   67SerCa 
9.59884 125.86020   176.57064   68PheH   68PheN   67SerC 
9.59510 125.87167   61.94084    68PheH   68PheN   68PheCa 
9.59302 125.89680   38.28202    68PheH   68PheN   68PheCb 
7.69855 116.12300   175.96932   69AlaH   69AlaN   68PheC 
7.69966 116.13561   53.82696    69AlaH   69AlaN   69AlaCa 
7.70065 116.13316   17.52478    69AlaH   69AlaN   69AlaCb 
8.85053 125.86902   174.07751   96GluH   96GluN   95SerC 
8.85492 125.87992   57.20720    96GluH   96GluN   96GluCa 
8.85635 125.89380   28.35314    96GluH   96GluN   96GluCb 
7.92883 117.32253   176.09301   97MetH   97MetN   96GluC 
7.92844 117.32351   56.23611    97MetH   97MetN   97MetCa 
7.93397 117.34154   31.27464    97MetH   97MetN   97MetCb 
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 7.14433 118.17948   176.58800   98TyrH   98TyrN   97MetC 
7.14550 118.18666   58.38443    98TyrH   98TyrN   98TyrCa 
7.14484 118.18357   37.84289    98TyrH   98TyrN   98TyrCb 
8.84284 125.25164   175.22666   99AspH   99AspN   98TyrC 
8.84386 125.25180   53.34691    99AspH   99AspN   99AspCa 
8.84431 125.24913   43.60727    99AspH   99AspN   99AspCb 
8.66235 124.55474   70.35814    106ThrH  106ThrN  106ThrCb 
8.66204 124.55491   60.87055    106ThrH  106ThrN  106ThrCa 
9.20975 123.77610   172.77916   107PheH  107PheN  106ThrC 
9.21703 123.78148   55.54259    107PheH  107PheN  107PheCa 
9.21539 123.77917   42.85162    107PheH  107PheN  107PheCb 
8.24888 119.86026   175.25917   108HisH  108HisN  107PheC 
8.25572 119.86891   55.47979    108HisH  108HisN  108HisCa 
8.25714 119.86193   30.65000    108HisH  108HisN  108HisCb 
8.74666 123.57319   173.33042   109PheH  109PheN  108HisC 
8.75296 123.58553   55.75949    109PheH  109PheN  109PheCa 
8.75231 123.58376   40.33321    109PheH  109PheN  109PheCb 
9.50531 120.43360   176.89504   110HisH  110HisN  109PheC 
9.51084 120.41178   56.21597    110HisH  110HisN  110HisCa 
9.50954 120.41667   28.25164    110HisH  110HisN  110HisCb 
8.10505 117.21270   173.20647   115AspH  115AspN  114GlyC 
8.10880 117.22139   55.54532    115AspH  115AspN  115AspCa 
9.05407 120.15514   174.03693   116PheH  116PheN  115AspC 
9.05832 120.15468   54.04817    116PheH  116PheN  116PheCa 
9.05714 120.15984   42.84742    116PheH  116PheN  116PheCb 
8.71418 132.62956   173.89751   117LysH  117LysN  116PheC 
8.72189 132.64245   56.12526    117LysH  117LysN  117LysCa 
8.72162 132.64166   32.29410    117LysH  117LysN  117LysCb 
7.91779 122.58563   174.77695   118GluH  118GluN  117LysC 
7.91742 122.59312   55.87364    118GluH  118GluN  118GluCa 
7.91776 122.59827   28.25307    118GluH  118GluN  118GluCb 
7.96285 122.40506   176.64043   119GlnH  119GlnN  118GluC 
7.97334 122.39256   55.02207    119GlnH  119GlnN  119GlnCa 
7.96629 122.38073   33.13341    119GlnH  119GlnN  119GlnCb 
8.60864 122.56813   172.90953   120GlnH  120GlnN  119GlnC 
8.61582 122.57239   54.03726    120GlnH  120GlnN  120GlnCa 
8.61582 122.57016   30.42738    120GlnH  120GlnN  120GlnCb 
8.79848 121.98682   174.90585   121ValH  121ValN  120GlnC 
8.80485 121.99785   59.89070    121ValH  121ValN  121ValCa 
8.80585 121.99768   35.09991    121ValH  121ValN  121ValCb 
8.66141 123.07873   173.94045   122ThrH  122ThrN  121ValC 
8.67072 123.11225   71.03217    122ThrH  122ThrN  122ThrCb 
8.66606 123.04763   61.30968    122ThrH  122ThrN  122ThrCa 
9.27275 128.97590   172.31093   123LysH  123LysN  122ThrC 
9.27875 128.97965   54.33897    123LysH  123LysN  123LysCa 
9.27897 128.97831   36.34013    123LysH  123LysN  123LysCb 
8.69356 126.95478   173.11699   124ValH  124ValN  123LysC 
8.70114 126.94931   61.88147    124ValH  124ValN  124ValCa 
8.70094 126.91375   32.27312    124ValH  124ValN  124ValCb 
9.42410 131.92730   175.32266   125PheH  125PheN  124ValC 
9.43266 131.97250   56.41692    125PheH  125PheN  125PheCa 
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 9.43264 131.97112   40.22809    125PheH  125PheN  125PheCb 
8.65658 117.70706   173.44618   126GlnH  126GlnN  125PheC 
8.66345 117.70825   52.72943    126GlnH  126GlnN  126GlnCa 
8.66286 117.71064   33.49310    126GlnH  126GlnN  126GlnCb 
10.3644 129.07512   176.37131   127IleH  127IleN  126GlnC 
10.3644 129.07512   58.56358    127IleH  127IleN  127IleCa 
10.3644 129.07512   35.59607    127IleH  127IleN  127IleCb 
9.16724 129.40948   177.50527   128LysH  128LysN  127IleC 
9.15486 129.35323   54.77044    128LysH  128LysN  128LysCa 
9.15497 129.34791   34.23701    128LysH  128LysN  128LysCb 
8.53419 125.01918   175.71179   129LysH  129LysN  128LysC 
8.53460 125.02515   55.73051    129LysH  129LysN  129LysCa 
8.53477 125.02342   32.66546    129LysH  129LysN  129LysCb 
8.51936 111.25903   176.90814   130GlyH  130GlyN  129LysC 
8.51996 111.26543   44.47558    130GlyH  130GlyN  130GlyCa 
8.38513 121.17810   174.12998   131LysH  131LysN  130GlyC 
8.38536 121.17978   56.50625    131LysH  131LysN  131LysCa 
8.38700 121.18642   32.07670    131LysH  131LysN  131LysCb 
8.34563 119.72344   176.77523   132AspH  132AspN  131LysC 
8.34549 119.73292   54.29567    132AspH  132AspN  132AspCa 
8.34555 119.73175   40.46366    132AspH  132AspN  132AspCb 
8.13798 119.40923   175.99462   133AspH  133AspN  132AspC 
8.14566 119.44174   54.59711    133AspH  133AspN  133AspCa 
8.14516 119.44105   40.03627    133AspH  133AspN  133AspCb 
8.21757 118.90389   176.34267   134GlnH  134GlnN  133AspC 
8.21824 118.91077   55.60126    134GlnH  134GlnN  134GlnCa 
8.21825 118.91074   28.40227    134GlnH  134GlnN  134GlnCb 
8.12675 121.11834   176.40322   135GluH  135GluN  134GlnC 
8.12737 121.12561   56.41248    135GluH  135GluN  135GluCa 
8.12730 121.12459   29.64130    135GluH  135GluN  135GluCb 
8.30950 120.27123   176.15174   136AspH  136AspN  135GluC 
8.31017 120.27973   54.25578    136AspH  136AspN  136AspCa 
8.31018 120.27784   41.01096    136AspH  136AspN  136AspCb 
8.25203 108.44265   176.82222   137GlyH  137GlyN  136AspC 
8.25254 108.44992   44.90162    137GlyH  137GlyN  137GlyCa 
8.12374 116.87201   172.97055   138IleH  138IleN  137GlyC 
8.12131 116.87059   59.11825    138IleH  138IleN  138IleCa 
8.12165 116.87068   40.37399    138IleH  138IleN  138IleCb 
8.71317 125.42676   174.92612   139LeuH  139LeuN  138IleC 
8.71509 125.47916   55.56671    139LeuH  139LeuN  139LeuCa 
8.71363 125.48921   42.67233    139LeuH  139LeuN  139LeuCb 
8.42174 113.55472   175.99132   140ThrH  140ThrN  139LeuC 
8.42954 113.56175   59.66690    140ThrH  140ThrN  140ThrCa 
8.43100 113.56421   73.84115    140ThrH  140ThrN  140ThrCb 
8.46206 112.44140   173.38499   141SerH  141SerN  140ThrC 
8.46983 112.44647   63.12052    141SerH  141SerN  141SerCb 
8.47003 112.44549   55.07172    141SerH  141SerN  141SerCa 
7.63850 120.73718   173.35317   142GluH  142GluN  141SerC 
7.64714 120.73471   52.70593    142GluH  142GluN  142GluCa 
7.64623 120.74004   30.08161    142GluH  142GluN  142GluCb 
9.54017 128.75143   178.99412   150GlnH  150GlnN  149ProC 
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 9.54020 128.75674   58.27313    150GlnH  150GlnN  150GlnCa 
9.54073 128.76163   27.74661    150GlnH  150GlnN  150GlnCb 
8.78783 114.22606   179.70284   151SerH  151SerN  150GlnC 
8.78924 114.23804   62.42783    151SerH  151SerN  151SerCb 
8.78623 114.22511   60.88331    151SerH  151SerN  151SerCa 
7.67237 120.32192   175.39783   152TyrH  152TyrN  151SerC 
7.67425 120.33994   53.78447    152TyrH  152TyrN  152TyrCa 
7.67375 120.32204   36.04635    152TyrH  152TyrN  152TyrCb 
7.87530 122.56308   176.05800   153AspH  153AspN  152TyrC 
7.87984 122.56259   58.33186    153AspH  153AspN  153AspCa 
7.88125 122.56632   39.31892    153AspH  153AspN  153AspCb 
8.40988 111.03175   179.00313   154SerH  154SerN  153AspC 
8.41163 111.05365   62.70594    154SerH  154SerN  154SerCb 
8.40597 111.01515   60.22721    154SerH  154SerN  154SerCa 
7.26850 111.58944   174.32174   155IleH  155IleN  154SerC 
7.27104 111.58792   37.10056    155IleH  155IleN  155IleCb 
7.58857 118.60053   176.49142   159LeuH  159LeuN  158AspC 
7.59795 118.60678   53.82930    159LeuH  159LeuN  159LeuCa 
7.60205 118.62764   42.04266    159LeuH  159LeuN  159LeuCb 
6.91266 121.52420   177.38729   160IleH  160IleN  159LeuC 
6.91414 121.49844   62.02435    160IleH  160IleN  160IleCa 
6.91318 121.49393   38.45729    160IleH  160IleN  160IleCb 
8.15977 116.56796   175.06007   164ArgH  164ArgN  163LysC 
8.16771 116.58575   54.27715    164ArgH  164ArgN  164ArgCa 
8.16649 116.57789   41.60907    164ArgH  164ArgN  164ArgCb 
7.56759 117.87969   176.53364   165SerH  165SerN  164ArgC 
7.56886 117.88743   56.41550    165SerH  165SerN  165SerCa 
7.56825 117.88303   62.64962    165SerH  165SerN  165SerCb 
8.72587 116.91337   179.95754   167GluH  167GluN  166ProC 
8.72681 116.91465   58.90349    167GluH  167GluN  167GluCa 
8.72673 116.91039   28.53358    167GluH  167GluN  167GluCb 
8.13380 111.53851   179.08770   168GlyH  168GlyN  167GluC 
8.13768 111.53059   46.71921    168GlyH  168GlyN  168GlyCa 
8.74174 122.28006   176.34039   169LysH  169LysN  168GlyC 
8.74200 122.28470   59.40066    169LysH  169LysN  169LysCa 
8.74199 122.27456   31.69649    169LysH  169LysN  169LysCb 
7.39809 119.89238   179.79391   170LysH  170LysN  169LysC 
7.39935 119.89280   58.30785    170LysH  170LysN  170LysCa 
7.39932 119.90133   28.25845    170LysH  170LysN  170LysCb 
7.91207 120.35369   179.04717   171LysH  171LysN  170LysC 
7.91373 120.36574   59.25665    171LysH  171LysN  171LysCa 
7.91253 120.36378   31.31193    171LysH  171LysN  171LysCb 
8.50069 120.16887   178.01244   172TyrH  172TyrN  171LysC 
8.50149 120.16270   60.81107    172TyrH  172TyrN  172TyrCa 
8.50269 120.17506   38.10226    172TyrH  172TyrN  172TyrCb 
8.06497 118.73034   178.00155   173ArgH  173ArgN  172TyrC 
8.06512 118.73055   58.99905    173ArgH  173ArgN  173ArgCa 
8.06526 118.72665   29.42456    173ArgH  173ArgN  173ArgCb 
7.96176 117.37595   179.15414   174GlnH  174GlnN  173ArgC 
7.96176 117.38679   58.78175    174GlnH  174GlnN  174GlnCa 
7.96206 117.36970   27.61207    174GlnH  174GlnN  174GlnCb 
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 8.42057 107.23727   179.96317   175GlyH  175GlyN  174GlnC 
8.42142 107.23904   47.42214    175GlyH  175GlyN  175GlyCa 
8.12922 120.76916   177.64006   176MetH  176MetN  175GlyC 
8.12873 120.77207   55.67549    176MetH  176MetN  176MetCa 
8.12761 120.79843   30.79081    176MetH  176MetN  176MetCb 
7.09478 114.12142   175.50188   177LysH  177LysN  176MetC 
7.09444 114.12096   55.78481    177LysH  177LysN  177LysCa 
7.09466 114.12457   31.82792    177LysH  177LysN  177LysCb 
7.63178 109.47026   176.75727   178ThrH  178ThrN  177LysC 
7.63676 109.49940   73.96488    178ThrH  178ThrN  178ThrCb 
7.63931 109.50597   60.39343    178ThrH  178ThrN  178ThrCa 
10.1599 121.59590   177.35891   179IleH  179IleN  178ThrC 
10.1588 121.69450   36.64672    179IleH  179IleN  179IleCb 
9.12814 117.94972   173.99483   198AspH  198AspN  197GlyC 
9.13549 117.94023   54.71536    198AspH  198AspN  198AspCa 
9.13339 117.94538   37.68500    198AspH  198AspN  198AspCb 
7.48131 118.52078   177.34811   199SerH  199SerN  198AspC 
7.47508 118.54665   61.63254    199SerH  199SerN  199SerCb 
7.47413 118.55133   60.77990    199SerH  199SerN  199SerCa 
7.55440 121.90286   176.96796   200LeuH  200LeuN  199SerC 
7.56622 121.91559   56.79704    200LeuH  200LeuN  200LeuCa 
7.56528 121.95290   39.46101    200LeuH  200LeuN  200LeuCb 
7.16364 120.21842   176.79067   201AlaH  201AlaN  200LeuC 
7.16487 120.22446   55.91042    201AlaH  201AlaN  201AlaCa 
7.16381 120.24236   16.60208    201AlaH  201AlaN  201AlaCb 
8.00061 112.91385   179.35477   202SerH  202SerN  201AlaC 
8.00078 112.91927   62.03183    202SerH  202SerN  202SerCb 
8.00109 112.93078   60.90765    202SerH  202SerN  202SerCa 
7.14299 117.58059   176.08378   212CysH  212CysN  211PheC 
7.14754 117.56894   59.93262    212CysH  212CysN  212CysCa 
7.14110 117.57604   27.20628    212CysH  212CysN  212CysCb 
8.23067 122.63834   175.28308   213ValH  213ValN  212CysC 
8.22792 122.62153   67.20113    213ValH  213ValN  213ValCa 
8.22820 122.62777   30.43913    213ValH  213ValN  213ValCb 
7.43424 120.21359   177.53553   214LysH  214LysN  213ValC 
7.43685 120.24013   58.87183    214LysH  214LysN  214LysCa 
7.34565 117.93835   179.72729   215TyrH  215TyrN  214LysC 
7.34615 117.93475   59.97160    215TyrH  215TyrN  215TyrCa 
7.34311 117.92207   37.12276    215TyrH  215TyrN  215TyrCb 
8.43796 121.51918   177.97859   216TyrH  216TyrN  215TyrC 
8.43590 121.50976   61.79735    216TyrH  216TyrN  216TyrCa 
8.43493 121.51215   38.23811    216TyrH  216TyrN  216TyrCb 
8.50890 120.62347   177.27087   217AlaH  217AlaN  216TyrC 
8.51459 120.62749   54.52109    217AlaH  217AlaN  217AlaCa 
8.51031 120.62334   17.28465    217AlaH  217AlaN  217AlaCb 
7.84133 118.40102   181.00820   218GluH  218GluN  217AlaC 
7.84231 118.40558   58.26618    218GluH  218GluN  218GluCa 
7.84224 118.41090   28.81598    218GluH  218GluN  218GluCb 
7.44964 121.20542   178.14891   219AlaH  219AlaN  218GluC 
7.45783 121.21848   53.31136    219AlaH  219AlaN  219AlaCa 
7.45894 121.21482   17.93232    219AlaH  219AlaN  219AlaCb 
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 7.51058 115.63344   178.99748   220GlnH  220GlnN  219AlaC 
7.51874 115.64104   55.29031    220GlnH  220GlnN  220GlnCa 
7.51843 115.64003   27.60355    220GlnH  220GlnN  220GlnCb 
7.54574 120.61145   176.85826   221ArgH  221ArgN  220GlnC 
7.54654 120.61753   56.78384    221ArgH  221ArgN  221ArgCa 
7.54654 120.61568   29.63488    221ArgH  221ArgN  221ArgCb 
8.04293 120.57688   176.57182   222AspH  222AspN  221ArgC 
8.04342 120.58453   54.34379    222AspH  222AspN  222AspCa 
8.04347 120.58312   40.39640    222AspH  222AspN  222AspCb 
7.81917 121.81504   176.23294   223LeuH  223LeuN  222AspC 
7.81982 121.81977   54.92165    223LeuH  223LeuN  223LeuCa 
7.81933 121.82727   41.40303    223LeuH  223LeuN  223LeuCb 
8.09520 121.67596   177.42992   224GluH  224GluN  223LeuC 
8.09578 121.68587   55.95470    224GluH  224GluN  224GluCa 
8.09575 121.68542   29.77901    224GluH  224GluN  224GluCb 
7.87096 127.28196   175.41020   225AspH  225AspN  224GluC 
7.87158 127.28878   41.66717    225AspH  225AspN  225AspCb 
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 Appendix  4.  PCR  primer  sequences 
Primers  used  to  generate  mutants  for  the  assignment  of  the  methyl  groups  of  Vps75: 
 
Vps_V25I_R:  5’  CTCACGTTCAATAGCGTCGATTTCTTCTTCGCATTTAGC  3’ 
Vps_V25I_F:  5’  GCTAAATGCGAAGAAGAAATCGACGCTATTGAACGTGAG  3’ 
  
Vps_V32I_F:  5’  GACGCTATTGAACGTGAGATAGAATTATACAGATTGAACAAAATG  3’ 
Vps_V32I_R:  CATTTTGTTCAATCTGTATAATTCTATCTCACGTTCAATAGCGTC  3’ 
  
Vps_V61I_F:  5’  GAAATTGCAGAGTTCTGGAAAATTATCCTTTCACAACACGTTAGTTTTG  3’ 
Vps_V61I_R:  5’  CAAAACTAACGTGTTGTGAAAGGATAATTTTCCAGAACTCTGCAATTTC  3’ 
  
Vps_V124I_F:  5’  GAGCAGCAAGTCACCAAGATCTTCCAAATCAAAAAAGGCAAAG  3’ 
Vps_V124I_R:  5’  CTTTGCCTTTTTTGATTTGGAAGATCTTGGTGACTTGCTGCTC  3’ 
  
Vps_L188I_F:  5’  TGGTTCAGATGGACCGGCATAAAACCCGGGAAGGAGTTC  3’ 
Vps_L188I_R:  5’  GAACTCCTTCCCGGGTTTTATGCCGGTCCATCTGAACCA  3’ 
  
Vps_V213I_F:  5’  GGCCTCAGCATAGTACTTGATACAAAAAGGGTAGATCTCTTC  3’ 
Vps_V213I_R:  5’  GAAGAGATCTACCCTTTTTGTATCAAGTACTATGCTGAGGCC  3’ 
  
Vps_I28V_F:  5'  GAAGAAGTGGACGCTGTTGAACGTGAGGTAG  3' 
Vps_I28V_R:  5'  CTACCTCACGTTCAACAGCGTCCACTTCTTC  3' 
  
Vps_I54V_F:  5’  GCGTATATTGACGAAGTTGCAGAGTTCTGG  3’ 
Vps_I54V_R:  5’  CCAGAACTCTGCAACTTCGTCAATATACGC  3’ 
  
Vps_I72V_F:  5’  CACGTTAGTTTTGCGAATTACGTAAGGGCTTCAGATTTTAAATAC  3’ 
Vps_I72V_R:  5’  GTATTTAAAATCTGAAGCCCTTACGTAATTCGCAAAACTAACGTG  3’ 
  
Vps_I127V_F:  5’  GTCACCAAGGTGTTCCAAGTCAAAAAAGGCAAAGATG  3’ 
Vps_I127V_R:  5’  CATCTTTGCCTTTTTTGACTTGGAACACCTTGGTGAC  3’ 
  
Primers  used  to  generate  mutants  for  the  PRE  measurements: 
 
H3_R63C_F:  5'  CCACCGAGCTGCTCATCTGCAAACTGCCTTTCCAG  3' 
H3_R63C_R:  5'  CTGGAAAGGCAGTTTGCAGATGAGCAGCTCGGTGG  3' 
 
H3_Q76C_F:  5'  CCTGGTCCGGGAGATCGCTTGTGACTTCAAGACCGACCTG  3' 
H3_Q76C_R:  5'  CAGGTCGGTCTTGAAGTCACAAGCGATCTCCCGGACCAGG  3' 
 
H3_E94C_F:  5’  GCCGTTATGGCTCTGCAGTGTGCCAGCGAGGCTTATCTG  3’ 
H3_E94C_R:  5’  CAGATAAGCCTCGCTGGCACACTGCAGAGCCATAACGGC  3’ 
  
H3_C110A_F:  5’  CTTTGAGGACACCAACCTGGCCGCCATCCACGCCAAGAG  3’ 
H3_C110A_R:  5’  CTCTTGGCGTGGATGGCGGCCAGGTTGGTGTCCTCAAAG  3’ 
  
H4_Q93C_F:  5’  GTTGTTTACGCTCTGAAACGTTGTGGTCGTACCCTGTACGGTTTC  3’ 
H4_Q93C_R:  5’  GAAACCGTACAGGGTACGACCACAACGTTTCAGAGCGTAAACAAC  3’ 
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H4_Y98C_F:  5’  GTCAGGGTCGTACCCTGTGCGGTTTCGGTGGTTAAAG  3’ 
H4_Y98C_R:  5’  CTTTAACCACCGAAACCGCACAGGGTACGACCCTGAC  3’ 
  
Plasmids  containing  the  remaining  histone  mutants  (H4  R45C,  H4  T30C,  H4  T82C,  and  H3  C110A 
K115C)  were  a  kind  gift  from  Prof.  Dr.  T.  Owen-Hughes  lab. 
  
Primers  used  to  generate  mutants  for  validation  of  interaction  interfaces  and  activity  assays: 
  
H3Δ28_F:  5’  GTTTACTTTAAGAAGGAGATATACC  ATG  TCCGCTCCTGCTACCGGCGGA  3’ 
H3_ΔN  _R:  5’  GGGCTTTGTTAGCAGCCGGATTTAAGCCCTCTCGCCTCGGATTC   3’ 
 
H3Δ35_F:  5’  GTTTACTTTAAGAAGGAGATATACC  ATG  GTCAAGAAACCTCACCGTTACCGG  3’ 
H3_ΔN_R:  5’  GGGCTTTGTTAGCAGCCGGATTTAAGCCCTCTCGCCTCGGATTC  3’ 
 
Production  of  H3 29-135  and  H3 35-135  was  done  in  two  steps.  First,  megaprimers  (PCR  products  encoding   
a  gene  of  interest)  were  generated  using  the  above-stated  pairs  of  primers  and  the  pET3d  plasmid 
containing  wild-type  H3  sequence.  The  resulting  megaprimers  then  acted  as  a  primer  pair  in  a 
restriction-free  (RF)  cloning  protocol. 
  
H4Δ95_F:   5’  CGCTCTGAAACGTCAGGGTTAAACCCTGTACGGTTTCGGTG  3’ 
H4Δ95_R:  5’  CACCGAAACCGTACAGGGTTTAACCCTGACGTTTCAGAGCG  3’ 
  
Rtt109Δ424_R:  5’  TTGCTTTTTTACGCGGTTACAGCATGGTAATTGCCAG  3’ 
Rtt109Δ424_F:  5’  CTGGCAATTACCATGCTGTAACCGCGTAAAAAAGCAA  3’ 
  
Vps75Δ225_F:  5’  GAGGGACTTGGAAGACTAAGAAGGAGAATCCGG  3’ 
Vps75Δ225_R:  5’  CCGGATTCTCCTTCTTAGTCTTCCAAGTCCCTC  3’ 
  
Vps_E206A_F:  5'  GGCGTCATTGTTCAGTGCAGAGATCTACCCTTTTG  3' 
Vps_E206A_R:  5'  CAAAAGGGTAGATCTCTGCACTGAACAATGACGCC  3' 
  
Vps_EE206/207AA_F:  5'  GTCATTGTTCAGTGCAGCGATCTACCCTTTTGCTG  3' 
Vps_EE206/207AA_R:  5'  CAGCAAAAGGGTAGATCGCTGCACTGAACAATGAC  3' 
 
H3_R69E_F:  5’  CAAACTGCCTTTCCAGGAGCTGGTCCGGGAGATCG  3’ 
H3_R69E_R:  5’  CGATCTCCCGGACCAGCTCCTGGAAAGGCAGTTTG  3’ 
 
H3_R69E/R72E_F:  5’  CTTTCCAGGAGCTGGTCGAGGAGATCGCTCAGGAC  3’ 
H3_R69E/R72E_R:  5’  GTCCTGAGCGATCTCCTCGACCAGCTCCTGGAAAG  3’ 
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